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Abstract
Black widow spider venom (BWSV) contains high molecular weight proteins called latrotoxins
(LTX) that induce catastrophic neurotransmitter release from nerve terminals, and one toxin, D-
latrotoxin, is known to bind with high affinity to three neural proteins in mammals, including
latrophilin (lat-1) a member of the class B family of G-protein coupled receptors. 
We have established C.elegans as a model organism to study the function of the binding protein,
lat-1 and its role in regulating neurotransmitter release by latrotoxins. However, a lat-1-knock-
out worm is required for determining the function of the lat-1 gene. The lat-1(ok1465) allele has
a deletion of the lat-1 gene, and ~95-98% of lat-1(ok1465) homozygous worms arrest or die be-
fore adulthood, with only ~2-5 adult offspring per animal. Micro-injection of the B0457 cosmid,
that contains the full sequence of the lat-1 gene, or the lat-1a cDNA rescued the lethality of the
lat-1 worms, thereby showing that lat-1 gene is responsible for the developmental lethality in
these worms. Expression of the marker, GFP, under the control of the lat-1 promoter showed
that there was expression of GFP during epithelial morphogenesis, and strong expression in the
gut from the three-fold stage through to larval stages. The concordance between the site of ex-
pression of lat-1::gfp, with the sites of embryonic defects (epithelial enclosure defects; defec-
tive attachement of gut) in lat-1(ok1465) animals, provides further evidence that lat-1 is
essential for embryonic and larval development.
Deletion mutants of lat-1a were constructed to examine the role of domains of this protein. De-
letion of sequences after the 4xCys domain of lat-1a did not affect the ability to rescue lethality
in the lat-1 worm, while deletion of the C-terminus to the seven transmembrane domain im-
paired the ability of lat-1a to rescue lat-1 worms, and further deletion of six of seven transmem-
brane domains (the TM1 construct) yielded a construct that was unable to rescue lat-1 worms.
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These data suggest an important role for intracellular sequences and seven transmembrane in
lat-1a signalling. It was proposed that TM1 could decoy ligand, without causing intracellular
signalling. In agreement, the TM1 construct caused a mild phenocopy of the lat-1(ok1465) mu-
tant in wild-type worms, whereas full-length, or non-ligand binding variants of lat-1a caused no
such effect. To investigate the putative ligand-binding domain of lat-1a, deletion of residues 62-
147 (¨GBL), 62-250 (¨HRM) and 62-487 (¨N) was investigated; while the ¨N construct was
incapable of rescuing lat-1(ok1465) worms, deletion of ¨GBL had a minor effect on the ability
of lat-1 to rescue the null worms, while ¨HRM had a more marked effect. These data are con-
sistent with a model whereby residues 147-487 are required for ligand binding, and the seven-
transmembrane and intracellular domains transmit a signal to the inside of the cell.
Combined latrotoxins was highly toxic to wild-type C.elegans (LD50 ~4ng/ml), whereas the lat-
1 worms were highly (>105-fold) resistant to combined latrotoxins. Lat-1 worms that were
transgenic for B0457cosmid, or lat-1a cDNA, were as sensitive to combined latrotoxins as wild-
type worm. Truncation of the C-terminus of lat-1a to TM1 yielded worms that had 105-fold re-
sistance to combined latrotoxins, compared to wild-type; thus the intracellular domain of lat-1
is required for mediating combined latrotoxins toxicity. The deletion of galatactose-binding lec-
tin (¨GBL) in N-terminus lat-1a was sensitive as wild-type, but deletion of hormone receptor
motif (¨HRM) in N-terminus lat-1a showed a reduced sensitivity to combined latrotoxins by
~105-fold. These data showed presence of lat-1 gene was responsible for the rescue of lat-1
worms or toxicity of combined latrotoxins in lat-1 worms, and the absence of lat-1 gene was
responsible for the lethality of lat-1 worms and resistance to combined latrotoxins in lat-1
worms.
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Abbrevations
A                                 Adenine
Amp                             Ampicillin antibiotic
BWSV                         Black Widow Spider Venom
BSA                             Bovine Serum Albumin
bp                               Base pair
C                                Cytosine
cDNA                        Complementary Deoxyribonucleic acid
DAPI                         4',6-diamidino-2-phenylindole 
DNA                         Deoxyribonucleic acid
EDTA                        Ethylene diamine tetra acetic acid 
EtBr                          Ethidium Bromide
G                              Guanine
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IPTG                     Isopropyl-ȕ-D-thiogalactopyranoside
K                           Kanamycin Antibiotic
kb                         Kilobase
kDa                      KiloDalton
lat-1                     latrophilin
LB                       Luria-Bertani (Medium)
LCT                    Latrocrustatoxin
LDS                    Lithium Duodecyl Sulphate
LIT                     Latroinsectotoxin
LPH                   Latrophilin
LTX                   Latrotoxin
NGM                 Nematode Growth Medium
PAGE                Polyacrylamide Gel Electrophoresis
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PCR                 Polymerase Chain Reaction
RNA                Ribonucleic acids
RNAi               RNA Interference
SAP                Shrimp Alkaline Phosphatase
SDS                Sodium Dodecyl Sulphate
SEC                Size Exclusion Column
T                    Thymine
TAE               Tris/Glacial acetic acid /EDTA
TBE              Tris/Boric acid/EDTA
TBS              Tris Buffered Saline
TEMED         N,N,N,N-tetramethylethylenediamine
X-gal             5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside
UHP              Ultra High Purity
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Chapter 1 Introduction
Section 1.1 Latrophilin
Section 1.1.1 Latrophilin /calcium-independent receptor for Į-latrotoxin (CIRL) 
Latrophilin/CIRL is a seven-transmembrane protein that belongs to the secretin/calcitonin fam-
ily of G-coupled receptors. It was originally isolated from bovine brain membranes by affinity
chromatography as a glycosylated protein 120kDa [6], [7]. It is found mostly in neuronal or neu-
roendocrine tissues [6], and is the major protein to bind to immobilized Į-latrotoxin, a compo-
nent of Black Widow Spider Venom (BWSV), in the absence of divalent cations [8]. Latrophilin
has a long glycosylated extracellular domain, a transmembrane domain with seven-transmem-
brane segments, and a large cytoplasmic tail. The seven-transmembrane domain shows high
similarity to other members of the secretin/calcitonin sub-family of the GPCR superfamily
which induce the release of different subtances caused by peptide hormone binding [9]. The ex-
tracellular sequence has several identifiable domains, such as; I) the signal peptide; II) a lectin-
like sequence (~92 residues); III) the surface attachment of olfactomedin matrix protein and my-
ocilin, a longer domain (~290 residues) [8]  [130]; IV) a long domain (~280 residues) which is
homologous to BAI 1, 2, and 3 (brain-specific angio-genesis inhibitors) with unknown func-
tions [11]; V) a short, cysteine-rich sequence (90 residues) which is located just after N-terminal
of first transmembrane domain [1]. However, the hormone receptor motif domain (HRM) has
been found in G-protein coupled receptors which is presumably involved in ligand binding and
stalk domain that is essential for proteolytic cleavage [12] and G-protein coupled receptor pro-
teolysis. 
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It is thought that most members of latrophilin family are receptors for biologically active pep-
tides that regulate various secretory processes [13]. Only mammalian proteins have been stud-
ied so far, out of the three isoforms of latrophilin found in mouse, rat, cow and man. LPH 1 and
2 are calcium independent when they bind to Į-latrotoxin. LPH 1 is the only homologue that
binds Į-latrotoxin with high affinity, LPH 2 is expressed ubiquitously and has a 10-fold weaker
affinity, LPH 3 is highly expressed in mammalian brain [1]  [14] [15]. LPH 1, 2 and 3 are G-
Figure 1.1  Structural domains of latrophilin/CIRL. The CIRL is a G-protein coupled receptor with large extra-
cellular and intracellular domains. The extracellular domain has five structure motifs, as shown above the plasma membrane
and intracellular domain without identified homogous sequences. Extracellular domains shows an N-terminal signal pep-
tide (SP), a lectin-like domain that is homologous to olfactomedin and myocilin and a cysteine-rich domain. Also shown in
extracellular domain is a short linker sequence next to long sequence (BAI 1, 2, 3) found in G-protein-coupled receptor is
closely related to LPH1, 2, 3, as described in dotted lines. LPH 1, 2, 3 are also homologous to a number of G-proteins the
cysteine-rich domain CD97/EMr1 as shown in dotted lines. Seven transmembrane (7TMR) are similar to calcticotropin-re-
leasing factor (CRF) next to a long intracellular cytoplasmic tail at the C-terminal. Reproduced from [1].
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coupled protein receptors with interesting patterns of homology (Figure 1.1). Latrophilins are
unusually large, but few G- protein coupled receptors such as orphan receptors called BAI 1, 2,
3 are larger. As G-protein coupled receptors, both LPH 1, 2, 3 and BAI 1, 2, 3 share two extra-
cellular homology domains (the BAI homology region and cysteine-rich domain) and TMRs.
The overall structure of latrophilin suggests that they function to couple cell adhesion via the
olfactomedin- and lectin-like domains to cell signalling [1]. 
Section 1.1.1.1 Mechanism of action and binding of latrophilin to Į-latrotoxin
When latrophilin binds to Į-latrotoxin in the presence or absence of calcium, exocytosis is ac-
tivated [7]. During the binding process to Į-latrotoxin, four pathways were observed; (i) binding
of Į-latrotoxin to latrophilin as a receptor or to both latrophilin and neurexin; (ii) pore formation
(conformational change) after insertion into the plasma membrane; (iii) formation of Ca2+ chan-
nels; (iv) intracellular signalling after activation of receptor. It has been demonstrated that an-
other receptor neurexin triggers exocytosis through pore formation but this can only take place
in the presence of calcium [16]. 
It was found out that Į-latrotoxin becomes resistant to proteases after incubation with synapto-
somes, and this was proposed to be due to insertion of Į-latrotoxin into the plasma membrane
[17]. Two distinct conformational changes were observed under different incubation tempera-
tures, as identified by protease resistance patterns. There is a conformational change when Į-
latrotoxin binds to receptors at 4qC that changes its protease digestion pattern without increas-
ing protease resistance, and this was hypothesised to be receptor-induced change at the mem-
brane. The protease resistance pattern changed dramatically with almost total protection of Į-
latrotoxin from digestion when synaptosomes of receptor-bound Į-latrotoxin were heated to
37qC. The observation of protease protection was independent of the type of protease used, and
is proposed to be due to partial membrane insertion of the Į-latrotoxin.
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The intracellular activation of receptor is related to the calcium dependence in the action of Į-
latrotoxin and is also dependent on the involvement of type of neurotransmitter vesicle. During
the binding process, Į-latrotoxin acts as a channel that conducts Ca2+ in the membrane and the
influx of Ca2+ triggers a number of intracellular events. This leads to exocytosis of dense-core
vesicles containing noradrenaline, dopamine and neuropeptides or alternatively action of Į-la-
trotoxin occuring in a Ca2+ independent manner through stimulation of exocytosis of small clear
vesicles containing acetylcholine, glutamate and GABA [17]. The stimulation of exocytosis is
Figure 1.2 Model of the latrophilin or neurexin binding to Į-latrotoxin . Latrophilin binds to Į-latrotoxin or
neurexin; there is then a conformational change occurs at 4qC which stimulates membrane insertion that needs higher tem-
perature. The presence of lectin concanavalin A is involved in conformational change but does not prevent binding of recep-
tor. Ca2+ channel formation and translocation into the presynaptic intracellular space occur from membrane insertion
triggering two processes of exocytosis. N and C represent N-terminals and C-terminals of different proteins. Reproduced
from [2].
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caused by high doses of Į-latrotoxin that cause depletion of acetylcholine-containing vesicles
in the absence of calcium whereas neuropeptide-containing dense-core vesicles remain un-
changed in the absence of calcium during different actions at neuromuscular junction. These re-
ceptors bind Į-latrotoxin and stimulate exocytosis through a second messenger mechanism
[18], [1].
Section 1.1.2 Neurexin as Į-latrotoxin receptor
Neurexin, similar to latrophilin, can bind to Į-latrotoxin, but binding differs on the basis of cal-
cium dependence. Neurexins consist of polymorphic cell surface proteins that are expressed in
neurons and discovered in the process of cloning presynaptic receptor for Į-latrotoxin [19] [20].
Three neurexin genes (1-3) were identified in a rat brain cDNA library. Ushkaryov and co-au-
thors (1992) have observed that each neurexin gene has two independent promoters which gen-
erate two classes of mRNAs; Į-neurexin is encoded in the longer mRNAs, while ȕ-neurexin is
encoded in the shorter mRNAs. Neurexin has six principal isoforms (IĮ, Iȕ, IIĮ, IIȕ IIIĮ and
IIIȕ), of which neurexin IĮ corresponds to the high molecular weight component of the Į-latro-
toxin receptor. Neurexin-IĮ is a protein of 160-220kDa which was isolated on Į-latrotoxin col-
umn from solubilized bovine brain membrane using affinity chromatography [19] [20]. These
neurexins differ in their N-terminal structures but share the same C-terminal sequences [20]
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As shown in Figure 1.3, neurexins contain six domains and their dominant component is the
LNS domain which were named after repeated sequences Laminin A, Neurexins, and Sex hor-
mone-binding protein. The LNS domains are found in a large number of proteins, including se-
rum proteins which are the components of the extracellular matrix and cell surface receptors
involved in cell-cell interaction separated by EGF-like sequence [20]. Į-Neurexins contains an
Figure 1.3 Structural domains of neurexin. The diagram shows the structures of Į-neurexin and ȕ-neurexin.
Three cassettes of Į-neurexin are represented as I, II, III. Each cassette is made up of two domains (A&B) (red) with central
epidermal growth factor (EGF)-like sequence (blue) in between. ȕ-neurexin does not possess most of N-terminal domains
which are present in Į-neurexin but made up of only B domain of cassette III. Both Į-neurexin and ȕ-neurexin have car-
bohydrate attachment sequence (CH) (yellow), transmembrane domain (TMR) (black arrow) and short cytoplasmic tail
(C) (red). Five canonical positions are shown in black arrows (1-5) for extensive alternative splicing of Į-neurexin and
two (4-5) canonical positions of ȕ-neurexin in black arrow. Reproduced from[[ Sudhof, 2001 #35]]
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O-glycosylation sequence and a single transmembrane domain after the 3 sets of LNSA-EGF-
LNSB domains which is followed by a relatively conserved short cytoplasmic tail of 55 amino
acids. The genomic analysis has shown that NRXN1 gene contains 24 exons and spans 1.1Mb.
Exon 1 is more than 2kb in size, and encodes the first LNS domain and the EGF-like domain
[22]. It has been demonstrated that neurexin interacts with CASK, a potential intracellular sig-
naling molecule which is a cytosolic protein with calcium-calmodulin-kinase (CaMK) domain
and guanylate kinase domain, but their roles in mediating action of Į-latrotoxin and neurexin
are yet to be investigated [23].
Section 1.1.3 Protein tyrosine phosphatase ı is an Į-latrotoxin receptor
Protein tyrosine phosphatase ı (PTP ı) is a member of the LAR family of receptor tryosine
phosphatases and a third receptor that binds Į-latrotoxin (Į-LTX) in brain, and is a calcium-in-
dependent binding receptor like latrophilin. [24], [25]. Petrenko and his colleagues (2002) have
shown that PTP ı binds to Į-LTX through an extracellular cell adhesion-like region, with sim-
ilar affinity to latrophilin and neurexin. It is known that the extracellular region containing four
fibronectin type III repeats (FN3) of PTP ı binds to Į-LTX, allowing toxin insertion into the
membrane. Different types of membrane phosphatase have been discovered independently in
several laboratories called: PTPı, PTP NE-3, PTP-P1, LAR-PTP2 [26], [27]. PTP ı has been
identified as an essential protein for neuronal development and axonal path-finding in genetic
studies of mouse and Drosophila [28], [25]. However, a recent finding has demonstrated that
spliced 3 variant of PTP ı can mediate the insulin-secretion triggered by Į-LTX [29]. Even
though, PTP ı is important for the diverse processes such as axon development, lymphocyte ac-
tivation and cell motility through signaling, the mechanisms responsible for regulation of these
enzymes are yet to be fully understood [30].
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Section 1.2 Black widow spider venom (BWSV)
Section 1.2.1 History of Black Widow Spider Venom
Spiders as predators are known to feed on insects, anthropods, small animals and are always
found in the environment around human beings. Most spiders are not naturally aggressive,
harmless to humans and live in close association with man [31]. About 30,000 species of spider
are currently recognized worldwide and some produce venoms that could pose danger to human
health [32]. Though, no true incidence of death caused by venom from spider bite has been re-
ported due to the lack of adequate data collection of poisoning and envenomation cases in most
regions. It has been reported that data collected by Poisons Information Centres in various coun-
tries indicate that a good number of calls from general public was due to spider bite. About
0.04% incidence of calls regarding spider bite has been recorded from American Association of
Poison Control Centers data collection in USA. In the Asia-Pacific region, the report has shown
that a number of spider toxin can produce either serious systemic clinical envenomation syn-
dromes or significant local reactions [33].
Spider venom contains a rich cocktail of neurotoxins made up of a complex mixture of enzymes,
nucleic acids, amino acids, inorganic salts, monoamines and proteinaceous and non-proteina-
ceous materials, and many of these bioactive compunds are lethal to humans or insects [34]. It
is known that some toxins have been an important molecular tools for the indentification and
characterisaton of ion channels that stimulate the process of neurotransmitter exocytosis. While
some are under the investigation for the possibility of using them as bioinsecticidal agents for
pest control. 
However, Black Widow Spider is probably the most clinically significant group of spiders that
belongs to the genus Latrodectus, and they are found on all continents apart from Antarctica.
The European Black Widow spider Latrodectus tredecimguttatus neurotoxin has been isolated
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and reported up to date. The venom of this spider has been rarely fatal but may result in inca-
pacitating syndrome of severe local, regional, or systemic pain and autonomic features referred
to as Latrodectism, and if left untreated could last for several weeks and death may result even-
tually [35], [36], [37]. Other symptoms such as cardiac and respiratory include, tachycardia, hy-
pertesnsion, headache, cardiovascular collapse, weakness and chest pain, grunting, respiratory
distress, shortness of breath, respectively. The degree or severity of symptoms depends on var-
ious factors such as the number of bites, the amount of venom released during the bites and the
state and physical condition of the patient. Bites from Black Widow Spider appear to be severe
among young children, elderly people or individuals with delicate medical conditions [38]. The
grading system for envenomations by Black Widow Spider is described in the Table 1.1.
The envenomations of Black Widow Spider from mild to moderate can be managed and treated,
application of oral analgestics and parenteral opioids alongside benzodiazepines have been used
for mild and in moderate to severe cases respectively.
Table 1.1 The grading scale for envenomations of Latrodectus Black Widow Spider 
(modified from[38]) . 
Grade Symptoms
Class A No systemic symptoms
Local pain at the bite site
Normal vital signs
Class B Muscular pain in bitten extremity
Extension of pain to the chest or abdomen
Local diaphoresis at bite site/ extremity
Normal vital signs
Class C Generalized muscle pain to back, chest & abdomen
Diaphoresis distant from bite site/extremity
Hypertension/ tachycardia
Nausea/ vomiting
Headache
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It has been known over a long period of time that venom of a few spiders, especially the Black
Widow Spider (Latrodectus spp), contain toxins that affect the vertebrate nervous system [34].
The Black Widow Spider Venom (BWSV) contains several large protein toxins (latrotoxins).
Latrotoxins are targeted against groups of animals such as vertebrates, insects and crustaceans
[13]. The molecular masses of the latrotoxins studied range between 110 and 130kDa and they
are large acidic protein (pI~5.0-6.0). 
Section 1.2.2  Toxin of the Black Widow Spider Venom
The toxins from BWSV, latrotoxins, have been extensively used to investigate the molecular
mechanism of neuroscretion in vertebrates, insects and crustaceans for more than thirty years
[13]. It was discovered during the first attempt to isolate Į-latrotoxin from Lactrodectus species
using gel filtration and ion-exchange chromatography that several active toxic components af-
fect crustacean and insect nerve cell terminals [39], [40]). In order to classify and distinguish
the toxins, the toxins were named according to the animal groups affected. Seven different la-
trotoxins have been isolated from Latrodectus mactans tredecimguttatus up to date. They in-
clude: Į-latrotoxin (Į-LTX) specific for vertebrates with LD50 of 20-40 ȝg/kg of body weight
in mice [[Ushkarev Iu, 1986 #159]] but inactive in insects and crustaceans [41], Į-latrocrusta-
toxin (Į-LCT) is only active in crustacea, with the LD50 for crayfish (Procambarus cubensis)
being 100 ȝg/kg of body weight and doses up to 5 mg/kg harmless for insects and verterbrates.
Latroinsectotoxins are targeted against insects, and there are five known examples; Į-latroin-
sectotoxin (Į-LIT), ȕ-latroinsectotoxin (ȕ-LIT), Ȗ-latroinsectotoxin (Ȗ-LIT), į-latroinsectotoxin
(į-LIT) İ-latroinsectotoxin (İ-LIT). The LD50 of LIT on (Galiera mellonella) larvae is in the
range between 15 µg/kg for Į-LIT and 1 mg/kg for İ-LIT [42], [13].
Section 1.2.2.1 Į-Latrotoxin 
Į-Latrotoxin (Į-LTX) is the sole component of the black widow spider venom that is responsi-
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ble for the toxic effects in vertebrates [14]. The Į-LTX purified from venom glands, is the most
widely studied of all latrotoxins and is known to affect vertebrates by inducing massive release
of numerous transmitters. The molecular mass of Į-LTX is about 130 kDa with an isoelectric
point of 5.5 [43]. Į-Latrotoxin has been isolated and purified from black widow spider using
fractionation on a Mono Q column. A further isolation of individual protein was performed us-
ing a combination of two high-pressure ion-exchange chromatographies with hydrophobic
chromatography [44], [45]. The isolation and characterisation of many novel toxins from spider
venom have made a considerable contribution to studying physiological processes e.g identify-
ing and characterising ion channels, new selective insecticides. Apart from Į-LTX, three addi-
tional latrotoxin (Į-insectotoxin, į-latroinsectotoxin and Į-latrocrustotoxin) that act on
invertebrates have been cloned and purified from black widow spider. These three invertebrate
latrotoxins are homologous to each other and to Į-latrotoxin all over their entire length [2]. The
aligment of the sequences of four latrotoxins shows conserved regions extending over the entire
proteins with a conserved domain arrangement of latrotoxin genes [43]. į-Latroinsectotoxin
shares sequence identity of 37% with Į-latrotoxin and a sequence identity of 38% with Į-la-
troinsectotoxin, whereas Į-latroinsectotoxin shares a sequence identity of 34% with Į-latrotox-
in [46]. The latrotoxin molecule is made up of four structural domains as shown in Figure 1.3.
The first domain is a cleaved peptide, made up of 14-38 amino acids. Kiyatkin and his col-
leagues (1993) have shown that cDNA sequence of Į-latrotoxin lacks a signal peptide, but that
secretion of Į-latrotoxin suggests that this peptide is required for secretion. Domain II, is a con-
served N-terminal domain consisting of 450-480 amino acid residues, with hydrophobic regions
that may be transmembrane segments. The ankyrin-like repeat is Domain III which covers 557-
745 amino acid residues. Similar repeats are present in cytoskeletal proteins which are involved
in differentiation and transcription processes. The latrotoxin C- terminal domain has about 195-
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206 amino acid residues, and is cleaved during maturation of latrotoxin [3], [46], [2].
Thus the full-length cDNA of Į-latrotoxin does not yield functional, recombinant Į-latrotoxin;
there was no toxic activity obtained when the full-length of Į-latrotoxin precursor was ex-
pressed in insect cells using baculovirus vector [2], [47]. The N- and C-terminal sites undergo-
ing proteolysis would produce proteins with molecular masses similar to those of mature
latrotoxins, whereas the expression of truncated proteins produced toxins identical to their nat-
ural prototypes using SDS electrophoresis and specific activities [13].
The current data provide two models of action on the structures and functional properties of la-
trotoxins; the toxin tetramer binding to the presynaptic receptor and the formation of a cation
Figure 1.4 Model of structural domain of the latrotoxins. The primary structure of latrotoxins is divided into
four domains and shows respective amino acid positions. Domain I is not shown; a cleaved signal peptide is removed dur-
ing synthesis. Domain II is represented in black dotted box for the conserved N-terminal domains . Domain III is repre-
sented in black box, less conserved but include the series of ankyrin-like repeats and white box in between shows the
highest variation among the types of latrotoxins. Domain IV is the C-terminal, not conserved and proteolytically removed
upon the maturation of toxin. Reproduced from [3]
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channel as a result of insertion of toxin molecules into the membrane. Precise elucidation of the
mechanism of action of Į-latrotoxin will provide a major advancement and insight in our un-
derstanding of neurotransmitter vesicle exocytosis [47].
Section 1.2.2.1.1  Dimer and Tetramer formation of Į-LTX
Į-LTX was thought to exist as monomers of molecular mass of 130kDa, but under normal cir-
cumstance it behaves as larger molecular mass protein of 260kDa [48], [49]. The ability to form
dimers and tetramers is probably the most important charactersitic of Į-LTX, as its formation
of a stable dimer might be due to protein-protein interaction mediated through the presence of
C-terminal ankyrin repeats. Ashton and his colleagues (2000) have demonstrated that tetrameri-
sation of Į-LTX was triggered in the presence of Ca2+ or Mg2+ (divalent cations) or SDS. The
structure of Į-LTX provides information on the functional sites, its 130 kDa monomer has a U-
shape with one limb extended radially (Figure 1.5A-B). A frontal section of the latrotoxin te-
tramer on the extracellular membrane surface is shown, illustrating the presence of a pore (Fig-
ure 1.5C). In the model system, the formation of tetramer structure triggers insertion of tetramer
into the membrane, and this suggests that the binding sites for the receptor is located in the ex-
tended arms [49]. The tetramers are lipid-soluble, unlike dimers, and they are known to be the
active form and readily interact with hydrophobic surfaces. They show conformation changes
within the monomers during dimer-tetramer transition. During tetramerization or binding of re-
ceptor, changes of angle from 120û to 100û occur between two limbs of the U-shape in the des-
tination or region for membrane bilayer insertion. The use of electron microscopy (cryo-EM)
for individual image particle analysis has paved the way for determination of structures as small
as the 260kDa dimer [49]. The three-dimensional structure (3D) of Į-LTX is likely to share sim-
ilarity with other latrotoxins, and the 3D structure has shown that the molecule contains three
domains rather the two predicted by sequence information: the wing, the body and the head in
each Į-LTX monomer. 
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Another latrotoxin that tetramerises in the presence of trace amounts of SDS is į-LIT, and it
does not require divalent cations to undergo tetramerisation. į-LIT exists as a mixture of mono-
mers and tetramers, but tetramer production is reduced compared to Į-LTX, and an application
C
plasma membrane
Figure 1.5 The cryo-EM reconstruction and model system of Į-LTX tetramer . a is the top view of te-
tramer and b is the side view of tetramer. The inner limb of the U-shaped subunits lines the pore . The outer limbs have
radially projected outwards extensions. Measurement of latrotoxin square for one side is 180 Å , 100 Å is the side view
height. c shows the cut open channel of Į-LTX tetramer in membrane bilayer with wing attached to outer membrane
surface for the penetration of tetramer. The arrow shows the entrance of Ca2+ into the cytosol via the channel with cy-
toplasm and neurotransmitter norephinephrine (NE) on the left and right scale, respectively. Reproduced from [4]
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of an electric field leads to breakdown of oligomer [48]. In spite of this breakdown, the tetram-
ers are known to form pores [46], but the oligomeric structure of G-LIT is yet to be fully under-
stood.
Section 1.2.2.2 Crustacean-specific neurotoxin (Į-LCT)
Į-latrocrustatoxin (Į-LCT) is one of the components for the black widow spider venom with
molecular weight of about 120kDa, known to be lethal for the crayfish [50]. Little is known
about the understanding of action of Į-LCT on crustacean synapses. It has been previously
shown that Į-LCT increases transmitter release from crustacean nerve terminals and earlier in-
vestigation described the actions of either whole venom or a 65 kDa crustacean specific fraction,
but its relationship with currently investigated 120 kDa Į-LCT on either neurotransmitter junc-
tion or stretch receptor is unclear [51]. It was found out that Į-LCT shares many features togeth-
er with that of Į-LTX on vertebrate synapses, such as calcium independent binding, inhibition
of toxin action and dramatic enhancement of spontaneous release. Burmistrov and his col-
leagues (1997) reported that both electrophysiological and electron-microscopic data showed a
strong venom effect on the presynaptic terminals, and that Į-LCT action on the neuromuscular
synapse is known to be a good model of crustacean central synapses.
Section 1.2.2.3 Insect-specific neurotoxin (Į-LIT)
Į-latroinsectotoxin (Į-LIT) is a novel insect-specific toxin purified from venom glands of black
widow spider containing 1214 amino acids. The molecular mass of mature Į-LIT is approxi-
mately 130kDa probably derived from double processing of the N-terminal and C-terminal re-
gions of the primary translation product [3]. Į-latroinsectotoxin (Į-LIT) has a similar domain
structure to Į-latrotoxin (Į-LTX), showing that these toxins belong to a family of related pro-
teins [46]. The alignment of Į-LIT with that of Į-LTX amino acid sequences shows overall
identity of 34.1%, [3].
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However, Į-LIT is known to specifically cause neurotransmitter release at insect neuromuscular
junctions. Although, Į-LIT has no effect on frog motor nerve terminals at 50nM, it still causes
massive increase in transmitter release from blowfly (Calliphora vicina) motor nerve terminals
at 4nM [41]. The presynaptic effect of Į-LIT depends on the presence of divalent cations in the
external medium, since both Mg2+ and Ca2+ increase the transmitter release induced by Į-LIT
in Ca2+ free solutions [41]. The binding of Į-LIT to insect nerve membrane is similar to that of
Į-LTX binding to bovine membrane in terms of saturation and specificity. Therefore, the phe-
nomenology of Į-LIT action on insects resembles in some aspects described in the action of Į-
LTX on vertebrates. 
Section 1.3  Caenorhabditis elegans
Section 1.3.1 The experimental model organism C.elegans
Caenorhabditis elegans is a free-living, transparent, soil nematode, an unsegmented round-
worm of the phylum nematoda, developed as an experimental model organism in the early
1960s by Sydney Brenner [52], [53], [54]. C.elegans is small (~1mm in length), with a maxi-
mum diameter of ~80 µm (adult hermaphrodite dimensions). It is easy to culture on agar medi-
um containing Escherichia coli as nutrients and has a short generation time (~3 days at 20ûC)
with adult hermaphrodites giving birth to a large number of offspring (>300) by self-fertiliza-
tion [52]. The worm is a multicellular organism that goes through a complex process of devel-
opment, starting with embryogenesis, then continuing to morphogenesis and growth to the
adult. As a complex organism, about 40% of C.elegans genes are homologous to humans, and
it has become attractive to study human diseases. The genome size of C.elegans is relatively
small (97 Megabases), when compared to humans (3000 Megabases). It was the first multicel-
lular organism which had its entire genome fully sequenced. C.elegans as a model organism,
has played invaluable roles in understanding a wide range of biological processes such as neural
development, sensory processing and behaviour as well as other medical important processes
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(ageing) [55], [56]
Section 1.3.1.1  Sex and Chromosome
C.elegans has five pairs of autosomes (chromosome I, II, III, IV, V) and one pair of sex chro-
mosome X. There are two sexes of C.elegans: a self-fertilizing hermaphrodite (essentially mod-
ified female) has two X chromosomes designated as XX and a male has one X chromosome
designated as XO [57]. 
The adult hermaphrodite lays eggs controlled by a bilateral pair of neurons called HSN (Her-
maphrodite-specific neuron) and males do not lay eggs, so these neurons are absent due to re-
moval at an early stage in development by programmed cell death. Hermaphrodites can self-
fertilize or mate with males, producing 50% progeny males and 50% hermaphrodites. In the lab-
oratory, hermaphrodites are self-fertilized or crossed with males to produce progeny of desired
genotypes, and these are useful for genetic study of worms. An adult C.elegans is made up of a
tube, the exterior cuticle with two smaller tubes, the pharynx and the gut and the reproductive
system (Figure 1.5). A self-fertilized hermaprodite has the ability of producing 300-350 off-
spring or more when mated with males, and this process produces genotypes and phenotypes
for genetic analysis [58], [59]. The use of cell-specific markers such as green fluorescent protein
A
B
Figure 1.6 Schematic diagram of two sexes of C.elegans, adapted from Wood 1988. A shows the image
of self-fertilizing adult hermaphrodite (essential modified female), relatively large with sharp tail and capable of producing
both eggs and sperm for production of progeny. B shows the image of young male, relatively small with blunt tail and ca-
pable of producing sperm only and can be mated to hermaphrodite to produce progeny
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(GFP) and electron microscopy has paved ways for identification and examination of synaptic
connectivity of the worms 302 neurons or individual neurons for detailed analysis of neural
functions [55].
Section 1.3.1.2  Life Cycle
The nematode C.elegans has a short-life cycle. The life cycle of C.elegans depends on temper-
ature for the development of eggs to an adult stage. It has a reproductive life cycle from egg to
adult stage of 5.5 days at 15ûC, 3.5 days at 20ûC, and 2.5 days at 25ûC. The fertilization of eggs
takes place within an adult hermaprodite, which thereafter lays the egg at about the 40-cell
stage. After hatching of the eggs, animals go through 4 larval stages of development (L1-L4
stage) before the last stage (adult stage), and each adult hermaphrodite lays >300 eggs. The life
span of a single hermaphrodite or male C.elegans is around 2-3 weeks under normal living con-
dition. Its short life cycle reduces the time required for experiments and facilitates biological
study when compared to the use of mice as a model organisms [59], [60]. The shortage of food
Figure 1.7 The timing of development and life cycle of C.elegans. The diagram shows the life cycle of C.ele-
gans that goes through four larval stages starting from egg to adult in about 35 hours under favourable conditions. An alter-
native pathway leading to the dauer stage arises during development when conditions become unfavorable (low food or
crowding). The dauer larvae are capable of living for months in poor conditions and exit the dauer stage and mature to adult-
hood when conditions become more favourable.
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on the plate could result in C.elegans adopting an alternative developmental pathway known as
the Dauer stage, characterised by thin and plugged mouth, inability to eat but with viability
maintained for three months.
Section 1.3.1.3 Defecation cycle and feeding
The pharynx plays an important role in C.elegans feeding, and pumping of food into the gut is
aided by the pharynx made up of 66 different cells and 20 neurons [61]. The two motions that
control normal feeding are pumping and isthmus peristalsis [62]. In the first motion, a pump is
triggered through simultaneous contraction and relaxation of muscles of the corpus, anterior
isthmus and terminal bulb. The open lumen of the corpus is then filled with liquid containing
suspended bacteria through the mouth as the posterior isthmus is closed. As the terminal bulb
muscles are contracted, bacteria breaks up which allows the debris to be passed to the intestine.
This stage is followed by almost simultaneous contraction and relaxation with grinder to its rest-
ing position which paves way for closing the lumen of the corpus and expulsion of the liquid
and retention bacteria. The second motion involves completion of the relaxation that leads to
isthmus peristalsis. The bacteria that are trapped in the anterior isthmus are flushed back to the
grinder through peristaltic wave of contraction.
Defecation is defined as periodic activation of muscle contraction of C.elegans which involves
small number of muscles, a couple of neurons and only one neurotransmitter [63]. C.elegans
defecation occurs every 45 seconds as controlled by three-motor program; the posterior body
muscle contraction (pBoc), the anterior body muscle contraction (aBoc), and the expulsion mus-
cle contraction (EMC) [64]. A well-fed adult hermaphrodite defecates through the contraction
of body-wall muscle in four muscle quadrants which stimulate the internal pressure to increase
and cause the fluid contents of the intestinal lumen to be squeezed anteriorly. The relaxation of
the muscle after 1 minute causes the posterior flow of intestinal contents that seems to collect
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in a bolus of the preanal region. The body muscle near the head contracts as soon as relaxation
in four muscle quadrants is complete, and the piston-like rigid pharynx is driven by head con-
traction into the anterior intestine that helps let out the gut content through the anus. Three mus-
cle types (intestinal muscle, anal depressor, anal sphincter) near the anus contract almost
simultaneously as soon as contraction of anterior body reaches its climax. The posterior gut is
wrapped up by intestinal muscles that seem to pressurize the intestinal contents. This is followed
by movement of the anal-depressor muscle that runs from the dorsal wall of the anus to the dor-
sal body wall, which later contracts to open the anal canal [65]. Before anal muscle contraction,
the sphincter muscle is dilated and this causes almost simultaneous contraction of other anal
muscles that may act to limit the outflow of lumen contents or squeeze the posterior intestine
[66]. There are four anal muscles which are interconnected by gap junctions and they are re-
sponsible for the coupled contractions called the expulsion or enteric muscle contraction.
Section 1.3.2 The nervous system of C.elegans
The adult hermaphrodite of C.elegans has 959 somatic cells, some 302 are neurons with 118
distinct classes that form approximately 7000 synapses, of which only five neurons are required
for survival and reproduction in culture [67], [68]. The use of electron microscopy helps to re-
veal the structure and location of muscle and process bundles in the worm. The worm has three
process tracts in which the majority of synapses are found and they consist of nerve ring, ventral
nerve cord and dorsal nerve cord. Muscle in C.elegans is divided into ventral and dorsal which
are stimulated by excitatory cholinergic and inhibitory GABAergic neurons respectively. The
stimulation pattern occurs such that the ventral muscle is being excited by cholinergic neurons
while the dorsal side is being inhibited by GABAergic signaling that facilitates sinusoidal pro-
cess of the worm. C.elegans like many other nervous system, its nervous system is made up of
of sensory neurons, interneurons and motor neurons. The cell bodies of motor neuron, sensory
and interneurons are found in ventral nerve cord and a set of ganglia in the tail respectively. In-
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terneurons control the motor output through synapses onto the motor neurons. These series of
interneurons known as command neurons regulate fowards and backwards locomotions of C.el-
egans [69]. The migration and various patterns of cell division generates a complex array of
neurons. The cell lineage and expression of downstream genes for the mediation and signalling
events of neurogenesis is regulated by neuronal transcriptional factors [70], [67]. Analysis of
the mammalian unc-4 ortholog has been shown to regulate cholinergic motor neurons using
electron microcsopic reconstruction of identified neurons and behavioral studies in C.elegans
mutants [71]. The mec-3 gene in C.elegans is known to express in six touch receptor neurons.
The mec-3 gene is important for the differentiation of mechanosensory neurons which are used
for the detection of mechanical deformation, and the generation of mechanosensory neurons is
regulated by the mec-3 expression pattern ([72], [70]). The molecular genetic analysis of the
C.elegans nervous system is very important to understand how the network of gene expression
regulated by transcription factors regulates different types of neuronal cells. But the complexity
of gene expression seems to exceed other tissues in nervous system. This may depend on the
larger number of genes required to mediate the complex activity and function of various type of
cells in nervous system.
Section 1.3.3 Synaptic function 
C.elegans is an important experimental model organism used to study synaptic neurotransmis-
sion, identification of the key synaptic proteins and the regulation of synapses [73], [54]. Syn-
aptic transmission is the principal form of communication between neurons; the synaptic
junction is a specialised environment where synaptic vesicles fuse with the presynaptic mem-
brane at specific active zone under calcium regulated process in C.elegans [74]. 
During exocytosis, stimulation of synaptic vesicle from nerve terminal involves synthesis,
packing, release and re-uptake of neurotransmitter molecule by the neurons for the regulation
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of neurotransmitter metabolism and function in C.elegans. The vesicle transporters are used to
load the classical neurotransmitter such as acetylcholine, serotonin and GABA into synaptic
vesicle. This process is followed by the release of neurotransmitters through vesicular fusion,
separating the pre and post synaptic cells as it diffuses across the synaptic cleft and binds to re-
ceptor on the post synaptic cell. In the endocytosis step, clathrin adaptor is recruited to patch the
bud off from the plasmembrane, and in turn binds clathrin that results in a clathrin-coated bud.
After this process, the vesicles are uncoated and fused with synaptic endosomes which eventu-
ally result in mature vesicles which bud from the synaptic endosomes.
However, the response of the cell to chemical signals is determined by highly specific receptors
for transmitters and cell-specific expression. The presence of receptors influences the electrical
activity in postsynaptic cells either directly by permitting selective entry of ions or indirectly by
activating second-messenger pathways. Plasma-membrane transporters aid the re-uptake of
transmitter from synaptic cleft where the signaling pathway is terminated [129], [75] .
Using molecular genetics analysis and biochemical characterisation of proteins acting at syn-
apses, mutation have been created and isolated in many genes that encode components of the
neurotransmitter release pathway in C.elegans. Two strategies used to isolate mutants include
screening of behavioural mutants and mutants resistant to neuroactive compounds. It has been
demonstrated that several mutants with a synaptic defect are funtional and viable, whereas mu-
tants in analogous genes from other model organisms such as Drosophila and mice result in le-
thality [76]. Brenner, 1974 demonstrated that the AChE inhibitor lannate was toxic to wild-type
C.elegans, and mutant C.elegans were resistant to the toxin, e.g. the resistance of unc-17 mutant
to lannate. The use of the AChE inhibitor aldicarb and tricholiforn are prefered to lannate in cur-
rent studies, e.g. the testing of known uncoordinated mutants and selection schemes for toxin-
resistant mutants [77], [78]. The toxicity of AChE inhibitor causes over accumulation of excit-
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atory neurotransmitter acetylcholine, leading to paralysis or death. Toxins other than AChE in-
hibitor can be used to select mutants that confer drug resistance due to defects in synthesis,
packaging, release and in various aspects of presynaptic acetylcholine metabolism [79], [80].
Synaptotagmin has the ability as a synaptic vesicle protein to stimulate neurotransmitter release
in the presence of calcium [81], [82]. Binding of synaptotagmin to BWSV (Į-latrotoxin) is
known to trigger neurotransmitter release from synaptic vesicle during exocytosis [83]. There
is strong evidence that loss of synaptotagmin impairs synaptic transmission causing behavioral
defects, aldicarb resistance, acetylcholine accumulation, and physiological abnormalities ob-
served in snt-1 null mutants [74]. It has been shown that, the absence of synaptotagmin caused
reduction of synaptic transmission during the electrophysiological study of synaptotagmin mu-
tant in Drosophila and mice for synaptic transmission, therefore, synaptotagmin is important for
the regulation of synaptic transmission. [84], [85]. 
Section 1.3.4 Latrophilin the C.elegans homologue
Using the C.elegans genome database (http://www.sanger.ac.uk/Projects/C.elegans), the two
possible homologues of latrophilin in C.elegans were identified as B0457.1 and B0286.2. How-
ever, one of these two homologues B0457.1 shows higher homology to mammalian latrophilin-
1. B0457.1 is known as lat-1 and has been shown to have five strongly conserved domains [86].
The C.elegans homologue lat-1 and the mammalian lat-1 are both G-protein coupled receptors,
with sizeable extracellular and intracellular domains .
The heptahelical transmembrane receptor HC110R from Haemonchus contortus is a target for
anthelmintic, emodepside and it is homologous to lat-1(B0457.1) from C.elegans. This is
known to have significant similarity to latrophilins from human, cattle and rat, and a 54kDa ami-
no-terminal fragment binds latrotoxins [87]. Sequence analysis shows that lat-1 has 22%, 23%,
and 21% amino acid identities to rat, bovine and human latrophilin respectively. The C.elegans
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B0457.1 protein lacks an olfactomedin-like region but has several common N-terminal domains
(hormone receptor motif, stalk, G-coupled protein proteolysis site). This C.elegans lat-1 shows
a stronger similarity to vertebrate lat-1 when compared to insect orthologue sequence. Al-
though, neurexin and phosphatase ı are expressed in C.elegans, only RNAi knockdown of the
lat-1 gene in C.elegans were resistant to BWSV (Į-latrotoxin) [86]. It has been shown that C.el-
egans lat-1 mediates the effect of emodepside (anthelmintic drug) on the pharynx, and that the
mechanism of effect of emodepside is regulated by coupling to G-protein (GqĮ) and phospho-
lipase C (PLC-ȕ) via the latrophilin-signaling pathway [88]. The latrophilin signaling pathway
requires the UNC-13 protein to stimulate neurotransmitter release by vesicular exocytosis. 
Section 1.4 Summary
Latrophilin is the receptor of greatest interest for the action of BWSV, and it has been widely
studied to understand its role with respect to binding and signaling especially in mammals. The
genome analysis showed that latrophilin has a close homology to C.elegans B0457.1 (lat-1
gene) containing large extracellular domain and a G-protein coupled receptor cytoplasmic tail.
However, there is still much to be known about latrophilin with regard to the mechanism of ac-
tion of BWSV, and the interest in studying latrophilin in C.elegans is increasing. Recent find-
ings have shown the importance of latrophilin in mediating the toxicity of BWSV and effect of
emodepside in C.elegans. However, the difficulty in elucidating the role of latrophilin as a re-
ceptor for the BWSV in higher organisms has led to the establishment of C.elegans as an exper-
imental organism to study and understand mechanism of latrophilin for BWSV. The use of
RNAi experiments has shown that latrophilin is required for the toxicity of BWSV, but due to
the tissue-specific nature of RNAi, genetic knock down for latrophilin in C.elegans was carried
out to elucidate the role of latrophilin. Therefore, a study of the lat-1 gene was investigated in
lat-1 knock out C.elegans. 
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Section 1.5 Objectives of this Research Project
The understanding of role of the lat-1 as a receptor for BWSV in C.elegans is far from complete.
This study is aimed to contribute to our understanding of lat-1 in C.elegans. The following are
the fundamental questions to be addressed.
Section 1.5.1 Where is lat-1 expressed?
To answer this question, a nuclear tagged Green Fluorescent Protein (GFP)/ E-galactosidase
gene will be cloned under the control of the lat-1 promoter sequence. When this construct is
used to make transgenic C.elegans, the resulting worms are expected to show specific staining
in the cells where lat-1 is expressed, allowing cell identification during development. If possi-
ble, the intracellular localisation of lat-1 may be addressed by adding a C-terminal tag of GFP
to the lat-1 gene under the control of its own promoter. In transgenic C.elegans, the endogenous
localisation of lat-1 will be revealed by visualisation of GFP.
Section 1.5.2 What is the phenotype of the lat-1 null worm ?
A putative nullizygous worm will be obtained, and characterised. Determination of the lat-1 null
phenotype will be undertaken by a variety of methods to determine any abnormalities.Determi-
nation that these phenotypes are associated with lat-1 can be addressed by creating lat-1 null an-
imals that are transgenic for lat-1.
Section 1.5.3 What is the role of latrophilin in BWSV toxicity ?
The toxicity of BWSV can be determined in wild-type and nullizygous worms. The precise role
of the latrophilin receptor can be addressed by making lat-1 nullizygous worms that are trans-
genic for lat-1, and putative mutants.
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Chapter 2 Materials and Methods
Section 2.1 Materials
All the reagents were purchased at AnalaR grade purity or greater. LB Broth, Tris Base, Tryp-
tone, Bacto-agar, Bacto-yeast were were obtained from Melford laboratory Ltd. Mineral oil, po-
tassium cyanide, ferrous cyanide, ferric cyanide, SDS, potassium acetate, EDTA, hydrogen
peroxide, BSA, RNAse A were obtained from Sigma. Ammonium sulphate, ethanol, glycerol,
methanol were from BDH. Sodium chloride, potassium hydrogenphosphate, sodium hydrogen-
phosphate, potassium dihydrogenphosphate, acetic acid, choroform, magnesium chloride, phen
ol, coomassie blue were obatined from Fisher Scientific. All restriction enzymes were obtained
from either Biolabs or Promega. Bis-Tris Gel, MES SDS Running Buffer and Agarose were
provided by Invitrogen. E.coli, JM109, T4 ligase & ligase buffers, Wizard DNA-clean-up sys-
tem and other commercial plasmids were obtained from Promega. QIAGEN mini & maxi prep
were provided by QIAGEN. Alkaline phosphate, proteinase K, 1kb ladder, and 1kb+ DNA
marker ladder were obtained from GIBCO-BRL. High purity water (18.2 mega ohms) was sup-
plied by Purite select Bio system. Black Widow Spider Venom was provided by latoxan
(France). The Flaming/Brown micropipette puller (Model P-97) was produced by Sutter Instru-
ment Co. The Inverted microscope Axiovert 135TV was produced by ZEISS Germany. The ste-
reo microscope (SZX12) was produced by Olympus Japan. LeitZ micromanipulator was
obtained from Wetzlar Germany. Filter sets for microscopy such as; mCherry XF102-2 (exci-
tation: XF1067, 560AF55, dichroic: XF 2029, 595DRLP, emission: XF 3081, 645AF75), GFP
XF100-2 (excitation: XF1073, 475AF40, dichroic: XF2010, 505DRLP, emission: XF3038,
535AF45), CFP XF1071( excitation:440AF21, dichroic: XF2034 455DRLP, emission: XF3079
535AF26) were obtained from Glen Spectra UK. Other chemicals or compounds that were not
mentioned were obtained from Sigma, except where otherwise stated in the text.
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Section 2.2 Methods
Section 2.3 Molecular biology technique
Section 2.3.1 E.coli Cultures
Luria-Bertani (LB) broth (10g/L Bacto-tryptone, 10g/L NaCl and 5g/L Bacto-yeast extract)
with ultra high purity (UHP) water was used as a medium for the growth of E.coli cells. Solid
media (LB-agar) were prepared by the addition of 15g of agar into LB-broth medium. Prior to
use all media were sterilised by autoclaving. Ampicilin (500µl) was added to a final concentra-
tion of 100µg/ml to 1litre melted media (after the melted media had cooled down to approxi-
mately 55ûC) for the growth of strains containing plasmid-borne ampicilin resistance. Cultures
were grown overnight in 5ml LB/ Amp at 37ûC in the shaker
Section 2.3.2 E.coli calcium competent preparation
E.coli strain XL-1 or JM109 was stored at -80qC in 10% glycerol stock. Each tube containing
E.coli strain XL-1 (tetracycline resistant) or JM109 ( no antibiotic resistance) was thawed and
streaked on LB-agar with appropriate antibiotic, and incubated at 37qC overnight. A single col-
ony of XL-1 or JM109 strain was picked and inoculated in 5ml LB-broth with antibiotic added
where necessary. The culture was left to grow overnight at 37qC in a shaker. 2.5ml of the over-
night culture was added to 250ml of LB-broth in a sterile 500ml clonical flask and incubated
with appropriate antibiotic in a shaker at 37qC until it reached an OD600 of 0.7. After incubation,
cultures were allowed to chill for 20 mins on ice after which the cells were centrifuged in a ster-
ile maxi-prep tube at 4000g at 4qC for 15 minutes. The supernatant was discarded and pellet was
resuspended in sterile ice cold 0.1M CaCl2. Cells were centrifuged another time at 4000g at 4qC
for 15 minutes. After centrifugation, the supernatant was discarded and final pellet resuspended
in 2ml of sterile 0.1M CaCl2, 10% glycerol, then stored in 200Pl aliquots at -80qC.
Section 2.3.3 Transformation of calcium competent E.coli 
100Pl aliquots of cells were thawed on ice. 5-10Pl ligation reaction or 10-40ng of DNA was
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added to the cells and left on ice for 15 mins. The cell mixture was heat-shocked for 90 seconds
at 42qC and incubated on ice for 2 mins. Cell mixture were incubated again at 37qC in 1ml of
LB for 1hr. After incubation, 100Pl of the transformed cells were spread out on 9cm LB-agar
petri dishes containing appropriate antiobiotics, then incubated at 37qC overnight.
Section 2.3.4 E.coli electro-competent preparation
Colonies were treated using similar approach as in section 2.2.2, apart from the pellet that was
resuspended in 50ml of ice cold sterile UHP water after the first centrifugation step. The super-
natant was discarded and pellet resuspended in ice cold sterile UHP water, centrifuged at 4000g
at 4qC for 15minutes for a total number of five times and the cells were used immediately. Al-
ternatively, cells were resuspended in 2ml sterile ice cold UHP water, 20% glycerol and 200Pl
aliquots were stored at -80qC.
Section 2.3.5 Transformation of E.coli electro-competent
It is an efficient method of transforming DNA. After ethanol precipitation of DNA or ligation
reaction, the tube containing the mixture must be allowed to air-dry in order to get rid of left-
over salt in the tube after spining. A freshly prepared aliquot of thawed JM109 or XL-1 electro-
competent cells were mixed with 5-10Pl of ligation reaction or 10-40ng of DNA ( subjected to
ethanol-ammonium precipitation) in a 1.5ml eppendorf tube. The mixture of electro-competent
cells and DNA was added to a 2mm diameter electroporation cuvette and electroporated at a
voltage of 2.5kV/cm. The cells were immediately resuspended in 1ml of LB-broth, then allowed
to recover at 37qC for 45 minutes in a water bath. After incubation in the water bath, 100-200Pl
of transformed cells were plated out on an agar plate containing appropriate antibiotic.
Section 2.4 DNA Extraction and Purification
Section 2.4.1 Phenol-Chloroform extraction of DNA
500g of crystalline phenol was melted at 68qC for the preparation of Tris buffered phenol (pH
8.0) and 0.1% (w/v) hydroxyquinoline was added to the solution. An equal volume of 0.5M
Ademola Adenle   Section 2.4.2
Page 45
Tris-HCl (pH8.0) was added to melted phenol and stirred for 15 mins. The solution was allowed
to separate in two phases and the aqueous phase was discarded. An equal volume of of 0.1M
Tris-HCl (pH8.0) was added to the phenolic phase and stirred for 15 minutes. The solution was
allowed again to separate and the phenolic phase was collected and tested. The final extraction
was repeated until a phenolic phase pH greater than 7.8 was achieved. After equilibration of
phenol, 0.1 volume of 0.1M Tris-HCl (pH 8.0) was added to final aqueous phase that was re-
moved, and solution was stored in this state at 4qC in the dark for 4-6weeks. 
Phenol-chloroform was used to remove protein contaminants before precipitation with 100%
ethanol. An equal volume of phenol-chloroform was added to DNA solution to be purified in
1.5ml eppendorf tube. The DNA solution was mixed by vortexing and centrifuged at 12,000g
for 2 minutes at 4qC. After centrifuging the supernatant was carefully removed and transferred
to a fresh tube.
Section 2.4.2  Ethanol precipitation of DNA
Ethanol precipitation was carried out to recover DNA from solution. Two volumes of 100% eth-
anol and 1/4 volume of 3M ammonium acetate (pH 5.5) were added to DNA solution in 1.5ml
eppendorf tube. The DNA solution was gently mixed and incubated at -20qC for 1-2hrs. After
incubation, solution was centrifuged at 12,000g for10-20 minutes at 4qC. The supernatant was
carefully removed and the pellet was resuspended in 500Pl of 70% ethanol and centrifuged at
12,000g for 5 minutes. The supernatant was removed and air-dried for 30 minutes after centrif-
ugation. The dried pellet was then resuspended in UHP water.
Section 2.4.3 Alkaline lysis method of DNA preparation
A single colony from the transformation was inoculated into 5ml of LB medium containing ap-
propriate antibiotics in 25ml tube. The culture was incubated overnight at 37qC with vigorous
shaking. After incubation, 1ml of the culture was transferred to a 1.5ml eppendorf tube, centri-
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fuged at 12,000g for 30 seconds at 4qC. The supernatant was removed and the bacterial pellet
was resuspended in 100µl of ice-cold solution I (50 mM glucose, 25 mM Tris .Cl (pH 8.0), 10
mM EDTA) by vigorous vortexing. Then, 200µl of freshly prepared solution II (0.2M NaOH
1%SDS) was added and mixed by inverting the tube rapidly five times and placed on ice. To
this solution, 150µl of freshly prepared solution III (5 M potassium acetate, 11.5% glacial acetic
acid) was added to the tube and was vortexed gently for 10 seconds and stored on ice for 3-5
minutes. The mixture was centrifuged at 12,000g for 10 minutes at 4qC and the supernatant was
transferred to a fresh 1.5ml eppendorf tube. Equal volume of phenol:chlorom was added, vor-
texed and centrifuged at 12,000g for 2 minutes at 4qC before transfered to another fresh eppen-
dorf tube. The DNA was precipitated by adding two volumes of ethanol, vortexed and the
mixture was allowed to stand for 2 minutes at room temperature before centrifugation at
12,000g for 5 minutes at 4qC. The pellet was then washed in 1ml of 70% ethanol. The superna-
tant was gently removed and the tube was allowed to dry and the pellet was dissolved in UHP
water.
Section 2.4.4 Preparation of DNA using Qiagen mini-prep column
This method is used for the preparation of plasmid DNA on small-scale and is known to produce
high quality plasmid DNA for sequencing, micro-injection and several other purposes. To use
this method, a single colony from transformation was inoculated into 5ml of LB broth and in-
cubated overnight at 37qC in a shaker. After incubation, 3ml of the culture was transferred into
a tube and centrifuged at 15,000g for 60 seconds at 4qC. The supernatant was removed and the
bacterial pellet was resuspended in 300µl Buffer P1 (50mM, Tris-HCl pH8.0, 10mM EDTA,
10mg/ml RNAse A added). 300µl Buffer P2 (0.2M NaOH, 1% SDS) was added to the mixture
and inverted gently for 4-6 times. To this mixture, 350µl Buffer P3(3M-potassium acetate
pH5.5) was added and gently inverted for 4-6 times. The mixture was centrifuged at 15,000g
for 15 minutes forming a compact white pellet. While centrifugation was going on, QIAgen-Tip
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20 was equilibrated with 1ml of buffer QBT (750mM NaCl, 50mM MOPS pH7.0, 15% ethanol
and 0.15% Triton X-100) and was allowed to drain through the column. The supernatant was
gently removed and transferred to the QIAgen-Tip 20 column and was allowed to drain through
the column. The column was then washed 4 times with 1ml of buffer QC (1.0M NaCl, 50mM
MOPS pH 7.0 and 15% ethanol). The plasmid DNA in the column was eluted by adding 0.8ml
of buffer QF (1.25M NaCl, 50mM Tris-HCl pH 8.5 and 15% ethanol) and collected in a fresh
eppendorf tube. The DNA collected was then precipitated in 0.7 volumes of isopropanol and left
at room temperature for 20 mins. The DNA solution was centrifuged at 15000g for 30 mins,
then washed in ice cold 70% ethanol. After centrifugation, the supernatant was removed and the
pellet was allowed to air-dry before resuspension in 30µl of UHP water.
Section 2.4.5 Preparation of DNA using Qiagen-tip 500 maxi-prep column 
 A Qiagen-tip 500 maxi-prep column is used for large-scale preparation of high quality plasmid
DNA. A litre conical flask containing 500ml of overnight culture was used for this purpose and
a similar approach as described in section 2.3.4 was used according to the manufacturers in-
structions. Because it is a larger volume, the recovered DNA was resuspended in 250µl of UHP
water and stored at -20qC for long-term use.
Section 2.4.6 Preparation of Cosmid DNA
The cosmid vector is known to contain foreign DNA inserts and replicates more slowly than
smaller plasmid in culture due to its large size of up to 45kb. This protocol is a scaled-up version
of of 50ml maxi-prep protocol with yields ranging from 50µg-100µg of cosmid DNA. It re-
quires 2 overnight steps to amplify the cultures and half a day for DNA preparation. First day,
a freshly streaked single colony was inoculated into 5ml of LB medium containing the appro-
priate antibiotic and incubated at 37qC overnight in a shaker or on a roller drum. On the second
day, 1000µl of the overnight culture was inoculated into 1Litre sterile glass flask containing
500ml of LB medium containing appropriate antibiotic and incubated overnight at 37qC with
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vigorous shaking (~200 rpm). On the third day, the overnight culture was transfered to a maxi-
prep tube and centrifuged at 6000g 15 mins at 4qC. At this stage, RNAse A 10mg/ml was added
to the supernatant collected after centrifugation and mixed gently, then incubated on ice for 10-
20 mins. Addition of RNAseA at this stage before treatment with buffers completely digested
all the RNA present in the cosmid when compared to the sample without addition of RNAse A.
Subsequent treatment with buffer was carried out as described in section 2.3.4. according to the
manufacturers instructions. The final pellet was resuspended in 500µl of TE (pH 8.0) contain-
ing 0.02mg/ml RNAse A and incubated at 37qC for 30mins. A 10µl aliquot of DNA was run on
0.8% TAE agarose gel against concentration standards to check for purity and yield.
Section 2.4.7 Restriction enzyme digest of plasmid DNA
 A total reaction volume of 30µl was set up for restriction digest containing 1-4µg of DNA, 1-
2µl of restriction enzymes and 3µl of 10X buffer and making up the final reaction with UHP
water. The mixture was incubated at 37ûC for 1-2hrs. After incubation, the sample was checked
by agarose gel eletrophoretic analysis.
Section 2.4.8 DNA agarose gel electrophoresis
DNA was analysed on 0.8-1.0% w/v agarose gel in 1XTAE (40mM Tris-HCl, 1mM EDTA,
5.70% glacial acetic acid). Agarose was heated in microwave to dissolve in 1XTAE and was
allowed to cool down until temperature reaches 55ºC. After cooling down, ethidium bromide at
10mg/ml was added to a final concentration of 0.5µg/ml. The agarose gel solution was poured
into the gel casting mould with the right size of forming comb and was allowed to set before it
was placed in electrophoresis tank containing running buffer (1XTAE). DNA samples were
mixed with 10% loading buffer (30% glycerol, 0.25% bromophenol blue, 0.25% xylene cyanol
FF) and loaded alongside markers of known sizes (1kb and 1kb+ DNA ladders). DNA electro-
phoresis was carried out for 30-60 minutes at 100V until the blue dye had migrated 2/3 of the
length of the gel. DNA bands were visualised under a UV trans-illuminator and pictures were
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taken using a Bio-Rad Gel-Doc 
Section 2.4.9 DNA purification using QIAEX II gel extraction kit
The DNA purification from 0.8-1.0% agarose gel in 1xTAE buffer (40mM Tris-HCl, 1mM ED-
TA, 5.71% glacial acetic acid) was carried out using QIAEX II gel extraction kit. Gel extraction
of DNA was done by following manufacturers instruction. The QIAEX II gel extraction kit
contains silica particles which bind freely to DNA, without contamination. The DNA band was
excised from the gel using a clean scalpel and transfered into clean eppendorf tube. The gel slice
was weighed in the tube and 3 volumes of QX1 buffer was added to the gel. The tube was incu-
bated at 50ºC for 10 mins to solubilize the gel and allow the DNA to bind to silical particles.
During the incubation, the tube was vortexed every 2mins to keep QIAEX II in suspension. The
sample was centrifuged at 15000g for 30-60s after incubation and supernatant was removed.
500µl of QX1 buffer was added to the resultant pellet and vortexed before centrifugation at
15000g for 30s. The supernatant was removed and the pellet was washed twice in 500µl of PE
buffer to remove salt contamination by centrifugation at 15000g for 30s. After removing the su-
pernatant, the pellet was air-dried for 30mins and 10µl of 10mM Tris pH 8.0 was added and re-
suspended by vortexing. The sample was incubated at room temperature for 10mins to elute the
DNA from the silica complex . After 10mins incubation, the sample was spun down at 15000g
for 30s, the supernatant was carefully removed and the pellet was resuspended in UHP water
and kept at -20ºC.
Section 2.4.10 C.elegans genomic DNA extraction
Worms were washed-off the NGM plates overlaid with 1% agarose (agar contains material that
inhibit enzymatic manipulation of DNA) with water and transfered into 5ml centrifuge tube.
The tube was spun down at 3000 rpm for 2 mins and supernatant was removed before adding 5
volumes lysis buffer (0.1M Tris-Cl pH 8.5, 0.1M NaCl, 50mM EDTA, 1% SDS, aliquots kept
at -20ºC and proteinase K 0.1mg/ml was added before use) to the resultant pellet. After adding
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lysis buffer, the tube was incubated at 65ºC for 2hrs and the tube was further incubated at 95ºC
for 20-30 mins. The RNAse 0.1mg/ml (DNAse free) was added to the mixture and incubated at
37ºC for 1hr. After incubation the sample was extracted for 3times with 1 volume phenol/
choloroform. To this sample, 0.1volume of 3M sodium acetate and > 2volumes of 100% of eth-
anol were added, mixed and incubated at room temperature or at -20ºC for 1hr. The sample was
centrifuged at 14000rpm for 15 mins after incubation. The supernatant was removed after cen-
trifugation and pellet was washed with 70% ethanol. Ethanol was removed and pellet was al-
lowed to air-dried before resuspension in UHP water or TE buffer. The C.elegans DNA
extracted at this stage is clean enough for restriction digest but further purification is required
for micro-injection.
Section 2.4.11 Purification of DNA using Wizard DNA Clean-up system
The Wizard DNA clean-up system was used for further purification of C.elegans DNA extract-
ced using the method described in section 2.4.10. Purification of DNA was carried out using
manufacturers instruction. 400µl of Virtual Lysate Mixture [(150µl GTE;50mM glucose,
25mM Tris-Cl pH 8, 10mM EDTA), (150µl 1M NaOH/0.1%SDS), (150µl 5M
KOAc;3MKAc& 2MHAc), SDS and KOAc form precipitate which can be removed by spin-
ning at 14000rpm for 5mins] was added to 20µg-40µg of DNA. To this mixture, 1ml of sus-
pended Promega Wizard prep resin (in manufacturers resin suspension solution) was added to
tube and mixed gently by inverting 3-5times. The sample mixture was loaded into 3ml syringe
fitted into the column. The manufacturers instructions were followed for washing and recovery
of DNA from the column. After washing and recovery of DNA from the column, ammonium
acetate was added, followed by phenol/chloroform extraction and ethanol precipitation before
resuspension in 20µl of TE or UHP water. 
Section 2.4.12 DNA treatment using alkaline phospatase 
Shrimp alkaline phosphatase (SAP) is an enzyme used to remove the 5-terminal phosphatase
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from nucleic acid. Alkaline phosphatase prevents recircularising of linearised cloning vectors
by dephosphorylation. A total volume of 20µl is set up for alkaline phosphatae treatment; 10µl
of DNA sample, 2µl of 10X shrimp alkaline phosphatase buffer (0.2M Tris-HCl (pH8.0), 0.1M
MgCl2) and 1µl SAP (1µl/µg DNA) and UHP water was added to make up final volume of 20µl.
The reaction mixture was incubated at 37ûC for 15-30mins (works for both 5 and 3 overhangs
or blunt ends) . After incubation, the reaction mixture was heat inactivated at 65ûC for 15 mins.
The final reaction can be used directly for ligation reaction or can be further cleaned up using
phenol:chloroform extraction after which ethanol precipitation is carried out to recover the pel-
let DNA.
Section 2.4.13 Ligation of DNA
 The process of introducing DNA fragments of interest into plasmid vectors using DNA ligases
is known as a ligation reaction. The formation of a phosphodiester bond between adjacent nu-
cleotides (5-phosphate and 3-hydroxyl group of DNA) with hydrolysis of ATP to AMP occurs
during ligation. Using the correct balance between ratio of insert DNA to vector DNA is impor-
tant for a succesful ligation. For ligation set up, the vector and insert DNA were usually mixed
in a 1:3 molar ratio. The total reaction volume used was 10µl; 1µl vector, 3µl insert DNA, 1µl
T4 DNA ligase, 1µl 10X buffer ( 250mM Tris-HCl pH 7.6, 50mM MgCl2, 5mM DTT, 25% (w/
v) PEG-8000) and UHP water was added to make up final volume of 10µl. The tube containing
the DNA solution was gently mixed by flipping. The reaction was incubated at 4ºC overnight
for transformation. 
Section 2.5 Polymerase chain reaction (PCR)
The polymerase chain reaction is a technique for amplifying a specific sequence in DNA by re-
peated cycles of synthesis driven pairs of reciprocally oriented specific primers. This method
can be used to make multiple copies of DNA. Base-pair mismatches were introduced into the
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primers to generate particular restriction enzyme sites. Each amplification reaction contained
200ng of genomic DNA or cDNA using 1µl each as a template, 1µl 5 primer (~70pmol), 1µl
3 primer (~70pmol), 5µl of 10X Extensor Buffer 1(22.5mM MgCl2), 0.5µl of Extensor Hi-Fi-
delity PCR Enzyme Mix (5U/µl)2, 5µl of dNTPs (5mM of each dNTP), and was diluted to 50µl
with UHP water. A negative control contained all other reagents apart from DNA templates.
The PCR reaction was overlaid with 60µl of mineral oil to prevent evaporation taking place in
the reaction. PCR was carried out on a Perkin Elmer DNA Thermal Cycler 480 for 25 cycles at
2 minutes denaturing at 95ûC, 1 minute annealing at 50ûC-70ûC (depending on the primers) and
1 minute polymerisation at 72ûC, 10 minutes extension temperature at 72ûC. The PCR reaction
was run on 0.8% agarose (TAE) gel electrophoresis alongside a marker and negative control to
confirm the amplification of PCR product.
Conditions:-
95ûC for 1 minute (1)
50ûC for 1 minute (2)
72ûC for 1 minute (3)
Step 1-3 are repeated for 30 cycles
55ûC for an additional 5 minutes
72ûC for an additional 10minutes
Section 2.5.1  Purification of PCR products
PCR products to be purified were run on 0.8-1.0% agarose gels 1X TAE at 100V for 30-60 min-
utes. The bands corresponding to the correct size of the fragments were visualised on the Dark
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Reader and excised from agarose gels with a clean scalpel. The gel slice was weighed in a color-
less tube and 3 volumes of buffer QG was added to 1 volume of gel (100mg ~ 100µl), incubated
at 50ûC for 10 minutes and the reaction was vortexed for 2-3 minutes to dissolve properly. After
incubation, the color of the mixture was checked if it was similar to yellow buffer QG and en-
sured that the gel slice was dissolved completely. One volume of isopropanol was added to in-
crease the yield of DNA fragment <500bp and >4kb. Sample was applied to QIAquick spin
column that was provided in a 2ml collection tube and centrifuged at 12,000g for 1 minutes. Af-
ter centrifugation, the flow-through was discarded and the QIAquick column was placed back
in the same collection tube. The addition of 0.5ml of buffer QG to QIAquick column was op-
tional, this was done to remove all traces of agarose. To wash, 0.75ml of buffer PE was added
to QIAquick column and centrifuged at 12,000g for 1 minute, the flow-through was discarded
and further centrifuged at 12,000g for additional 1 minute to get rid of residual ethanol. The
QIAquick was placed in 1.5ml eppendorf tube, and 50µl of buffer EB (10mM Tris-Cl, pH8.5)
was added to the centre of the QIAquick membrane and centrifuged at 12,000 for 1 minutes.
The DNA was stored at -20ûC for future use.
Section 2.6 C.elegans Methods
Section 2.6.1 Growth and Maintenance of C.elegans
C.elegans was maintained on Nematode Growth Medium (NGM) agar and kept at temperature
between 15ûC and 25ûC for growth or development during the experiment. NGM agar was pre-
pared using following reagents; 3g NaCl, 17g agar and 2.5g peptone dissolved in 975ml of dis-
tilled water, then autoclaved for 50 mins. The mixture was cooled at 55ûC in water bath for
15mins after cooling, these reagents(1ml 1MCaCl2, 1ml 5mg/ml cholestrol in ethanol, 1ml 1M
MgS04, 25ml 1MKP04 buffer) were added and swirled to mix well. NGM solution was dis-
pensed into 3cm or 9cm petri plates 2/3 full of agar using sterile technique and the plates were
seeded with an E.coli OP50 lawn. The seeded plates were allowed to air-dry under sterile con-
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dition before incubation at 37ûC overnight. After incubation, the plates were ready for the ma-
nipulation of C.elegans or were left in an air-tight container at room temperature which are
usable for 2-3 weeks.
Section 2.6.2 Culturing of C.elegans
C.elegans can be cultured by transferring from one petri plate to another using different methods
under a dissecting stereomicroscope (standard 10X eyepieces with magnification of 0.6X to
50X). The chunking method is relatively easy and fast, a scalpel sterilized with flame and al-
lowed to cool is used to transfer a chunk of agar from old plate (containing hundred of worms)
to the fresh plate where they feed on bacteria (E.coli OP50)and multiply in number. The worm
washing method involves washing an old starved plate with sterile water and transfer the wash-
ing into an eppendorf tube and placing on ice for 5-10 mins. After 10 minutes the worms settled
at the bottom of the tube and the water is carefully removed without disturbing the worm pellet.
Worm pellets are then distributed on fresh plates. Another method is the use of worm picker to
pick a single animal from one plate and transfer it to another. A worm picker can be made by
attaching 0.5-1.0 inch piece of gauge platinum wire into the tip of pasteur pipette over the flame
until it becomes melted and glued to the pipette. The worm picker is then ready to be used by
flaming and cooling (to avoid contamination) each time a worm is being transferred. As a start-
er, it takes a bit of experience to use worm picker as holes are likely to be created in an attempt
to pick the worms, therefore worms crawl into the holes and this makes it difficult to see or pick
them. This problem can be avoided by gently rubbing the tip of worm picker on the edge of bac-
teria lawn to touch the worms and pick them.
Section 2.6.3  Worm Harvesting
 Worms were washed off the culture plates with 5-10mls of M9 buffer (KH2P04 3g, Na2P04 3g,
NaCl 5g, 1M MgS04 1ml in 1litre distilled water, sterilized by autoclaving and store at 20ûC )
or K-medium (KCl 2.39g, NaCl 3.09g in 1litre distilled water, sterilized by autoclaving and
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store at 20ûC ) and allowed to shake or swirl for a few seconds before pipetting into 50ml cen-
trifuge tube . The same steps were repeated again and pipetted into the 50ml tube. Worms were
spun down at low speed for 1 minute or placed on ice for 20-30mins. The supernatants were
removed and washed with M9 or K-medium 2 or 3 times to remove as much bacteria as possi-
ble. Finally, worms were spun down for 1 minute or placed on ice for 20-30mins to remove the
supernatant with some liquid left in the worm pellet before stored at -80ûC until it is ready to be
used.
Section 2.6.4 Removal of contamination and egg isolation of C.elegans
Presence of contaminants such as yeast and bacteria make the scoring and transfer of worms dif-
ficult on the culture plates, even though they dont harm the worm. Therefore, it is important to
remove the contaminants. Contaminated culture plates that have gravid hermphrodites were
washed with distilled water and collected in 5ml centrifuge tube. Worms were treated by adding
freshly prepared 5% bleaching solution (200µl sodium hypoclorite, 100µl 5M NaOH, 700µl
H20, mixed by vortexing) into the centrifuge tube and vortexed for 5-10mins. After vortexing,
the tube was centrifuged at 1300g for 30-60seconds to release pellet eggs. The supernatant was
removed and left liquid up to 0.1ml in the tube containing pellet eggs. 5ml of distilled water was
added to the pellet eggs and spun at 1300g for another 30-60seconds. The supernatant removed
and pellet eggs isolated was transfered on bacteria plates seeded with bacteria lawn (E.coli
OP50) using sterile pasteur pipette. Culture plates were left at 20ûC to hatch into larvae.
Section 2.6.5 Synchronization of worms
Isolated eggs (section 2.6.4) were transfered into sterile 500ml flask containing 100-300ml of
M9 buffer (section 2.6.3) and allowed to incubate at 20ûC overnight with gentle shaking to ob-
tain larval 1 starved animal. On the second day, the flask was placed on the ice to allow the
worms to settle down and most of the liquid was removed. The remaining liquid was transfered
to 50ml centrifuge tube and spun at 1300g for 60mins to pellet the worms. Pellet worms were
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transfered to 100-300ml of S-basal medium (5.85g NaCl, 1g K2HP04, KH2P04, 1ml cholestrol
[[5mg/ml in ethanol]] in 1litre distilled water, sterilized by autoclaving and store at 20ûC) inoc-
ulated with concentrated E.coli OP50 in 500ml flask. This was monitored by checking a drop
of culture under the microscope, and the following harvests were collected many hours later;
almost 8hrs a mid-larvae 1 was harvested at 20ûC, almost 18hrs a mid-larval 2 was harvested at
20ûC, almost 28hrs a mid-larval 3 was harvested at 20ûC and almost 37hrs a mid-larval 4 was
harvested at 20ûC. A small scale sychronization was carried out by transfering the eggs into 3cm
or 9cm plate containing 1ml or 9ml of M9 buffer (section 2.5.3) respectively and was incubated
at 20ûC overnight, followed by transfering starved L1 animals on bacteria (E.coli OP50) seeded
plate.
Section 2.6.6  Freezing of worms
C.elegans can be frozen and stored at -80ûC indefinitely [54]. The majority of starved L1 ani-
mals survived from mixed population of frozen worms. Animals that are well fed including
adult and eggs did not survive the freezing. Bacteria seeded plates containing mostly starved L1
animals and other stages of worm were washed off with S basal medium (section 2.5.5) and
transfered into 5ml tube. The tube was placed on ice for 10-20mins to allow worms to settle at
the bottom of the tube. Liquid was gently aspirated to 1.5ml to avoid touching the pellet worms.
An equal volume of freezing solution 1.5ml ( 1M NaCl 200ml, 1M KP04 pH6.0 100ml, glycerol
600ml in 2litres distilled water, distributed into 200ml, sterilized by autoclaving. add 0.06ml
sterile 1M MgS04 per 200ml bottle ) was added to the 1.5ml pellet worm in S basal medium.
1ml of mixture was aliquoted into the labelled cryotubes and stored at-80ûC for future use. The
following day at least 12hrs later, one cryotube from -80ûC was thawed and transfered on NGM
plate to ensure enough worms survived.
Section 2.6.7 Imaging
The Stereo Microscope (SZX12) or the Inverted Microscope Axiovert (135TV) were used for
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imaging with different types of filters. The pictures of worms were taken using the following
set of filters; mCherry filter has red-fluorescence (XF102-2), GFP filter has green flourescence
(XF100-2), CFP filter has blue fluorescence (XF1071). The magnification used was between
40x-100x. 
Section 2.6.8 Mounting worms for imaging
The method given below was used for the observation of worms using appropriate GFP filter or
DIC microscopy as described in section 2.6.7. 3% agarose was boiled in water and kept warm
on a heating plate. A clean sandwiched slide was placed between the two taped slides on a flat
surface. Using a pasteur pipette, a drop of agar was placed on the clean slide and the agar was
covered with another clean slide placed on top of three slides in a perpendicular fashion. The
slide on top was pressed gently to flatten the dropped agar to a circle about 0.4mm thick. Air
bubble was avoided in the agar in order not to create space for worms to stick in. The taped
slides were gently pulled as soon as agar solidified and the remaining two slides by sliding rel-
ative to one another were separated. Agar pad adhered to one of the slides particulary the bottom
one in most cases and the slide with agar pad was rested up on the bench top until ready to be
used. Worms can be mounted by placing a 1-2µl drop of M9 buffer or water containing 10-
25mM sodium azide (NaN3 anesthezises the worm so that worm can not move around) onto the
middle of agar pad. On the drop of sodium azide, the worm was placed and covered with a cover
slip for observation under the microscope.
Section 2.7 Transformation of C.elegans
DNA transformation is an important tool for C.elegans manipulation. This has been used to
over-express gene or express tagged protein and also to study the function of a protein domain
under the control of its regulatory elements. Transformation has widely employed the use of mi-
cro-injection for introducing DNA into C.elegans [89]
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Section 2.7.1 Micro-injection of Dextran into C.elegans
Worms mounted on an agar pad were injected with flourescently labelled rhodamine-dextran
(70,000 MW). The injection of dextran was targeted into the gonad of adult worms and observed
for red fluorescence under mCherry filter microscope. 20-30 worms were injected with dextran
to test the penetration and consistency of gonadal injection.
Section 2.7.2 Micro-injection of DNA into C.elegans
Micro-injection is a relatively simple proven method for introducing DNA into C.elegans ([90],
[91]). In C.elegans, the occurence of transformation requires effecient micro-injection of DNA
into syncytial gonads where extrachromosomal arrays are formed. An adult C.elegans hermaph-
rodite has two distal arms of the gonad; each gonad has a syncytium made up of cytoplasm sur-
rounded by germ line nuclei that form oocytes ( two U-shaped arms). Micro-injection of DNA
into immature oocyte nuclei produced high level of germline transformation compared to mi-
cro-injection of DNA into mature oocyte nuclei (cytoplasm) as shown in Figure 2.1 ([91] [92]).
Therefore, targeting syncytial gonads (immature oocyte) is vital to the succesful transformation
of C.elegans. 
Transformation of C.elegans using the relative new technique of gene bombardment has been
shown to integrate transgenes into genome at low copy number when compared to micro-injec-
Figure 2.1 The Syncytial gonad of C.elegans . The image shows the syncytial gonad of C.elegans hermaphro-
dite. The first arrow shows immature oocytes surrounded by germ line nuclei with direction of needle for micro-injection,
and this particular area is always targeted for injection that leads to high level of germline transformation. The second
arrow shows the U-shaped arm of mature oocyte nuclei (cytoplasm) and the germline transformation is relatively low.
This image is extracted from wormbook.
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tion [93]. Although, micro-injection of DNA into C.elegans is technical demanding but offers
so many advantages over gene bombardment. The sequencial processes required to carry out a
succesful micro-injection are summarised below.
Section 2.7.2.1 Agarose pad preparation
The use of an agarose pad is important for micro-injection. The pad is prepared by dropping 2%
agarose boiled in water on the center of cover slip (24x50mm) using a pasteur pipette and gently
place another cover slip on the top. This idea of placing the cover slip on the top flattens the hot
agarose into a thin pad and must be carefully done to avoid air-bubbles. After 2 mins, one of the
cover slips was gently removed and allowed to incubate at 37ûC overnight. On the next day, the
pad was baked in vacuum drying chamber for 2-4hrs before use. Agar pads can be stored in petri
plate or coverslip box for several months until it is ready to be used.
Section 2.7.2.2 Mounting of worms on agar pad
It is very important to be able to mount worms on agar pad and recover them with standard M9
buffer (5mM Hepes 7.2, 3mM CaCl2, 3mM MgCl2, 66mM NaCl, 2.4mM KCl, 4% (w/v) glu-
cose in 1 litre of distilled water, sterilized by autoclaving and stored at 4ûC) before micro-inject-
ing with DNA of interest. To mount the worm for practice, an agar padded slide was moistened
by breathing a couple of times and a drop of mineral oil or halocarbon oil was placed on the
moistened agar pad. A young adult hermaphrodite was picked with a worm picker and placed
on top of oil on agar pad and gently dragged to straighten it for gonad to be visible enough. This
was repeated for 3 or 4 worms on the same agar pad with oil on it. After 2-4mins, all the worms
mounted on the agar pad were recovered with M9 buffer and recovered worms started wiggling
in the M9 buffer. The recovered worms were transfered to different NGM plates seeded with
E.coli OP50 and allowed to incubate at 20ûC for 2-3hrs. Worms that recovered were identified
through laying of eggs and the worms that did not recover were either slow in movement or
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failed to lay eggs as a result of injury suffered or stayed too long on the agar which made them
to dry out. The recovery of worms with M9 buffer after mounting was estimated to be between
60-100% for an average of 20 worms mounted, successful mounting can be achieved with reg-
ular practice 
Section 2.7.2.3 Preparation of Micro-injection needle
The needle for micro-injection must neither be too short nor too long but rather has to be perfect
and sharp for good penetration into the worms. Micro-injection needles were produced using a
mechanical needle puller (Flaming/Brown micropipette puller Model P-97). Setting up an ap-
propriate parameter for needle-pulling is vital for making a good needle. The needle-pulling pa-
rameters (heat, pull, velocity and time) must be adjusted in a trial and error manner. During
the experiment, the parameters used for needle-pulling is stated as follows; Heat-660, Pull-60,
Velocity-100, Time-200, and this gave approximately ~2mm for the length of the needle mouth.
However, I noticed that the parameters were altered when the heating elements of needle puller
became naked, therefore the needles produced were shorter. After the replacement of the old
heating element with new one, the parameters such as Heat and Pull only were slightly increased
or lowered regardless of whether the previous Heat and Pull were altered or not. No changes of
Velocity and Time were made, replacement of heating element did not affect these two param-
eters only (take note). This alteration of needle caused by replacement of heating element has
been confirmed by another colleague as the problem. To make the needle, the glass filament was
inserted under aluminium foil of the needle puller without touching filament to the heating ele-
ment (to avoid damage) and both ends were gently clamped with the knob on each side. The
start button was pressed (make sure the settings are checked and correct before pressing the start
button) and needles were pulled within 60 seconds. The pulled needles were stored by resting
across the clay with both ends standing free in the box to the hold needles.
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Section 2.7.2.4 Loading of DNA solution into the needle
The loading of the needle with DNA solution was done by pulling a 20µl pipet capillary over
an ethanol flame until it became a long-stretched thin tip. This was cut-off with sterile razor until
it was about 3cm long, to make needle filler. Micro-injection DNA prepared by mini or maxi-
prep (section 2.3.4) and further ethanol precipitation for the recovery of cleaner DNA (section
2.3.2) is important for C.elegans transformation. Ethanol precipitation of DNA is resuspended
in TE buffer (1M Tris-HCl 1ml, 0.5M EDTA 0.2ml in 100ml of distilled water, filter-sterilize
and stored at 4ûC) instead of distilled water for micro-injection. The average concentration of
DNA for micro-injection during the experiment was between 20-50µg/ml to obtain transgenic
animals. Co-injection of two different plasmid DNAs used various ratios, it was either ratio of
1:1 for plasmid A (DNA of interest) and plasmid B (selectable marker) respectively or ratio 1:3
for plasmid A (DNA of interest) and plasmid B (selectable marker) respectively. The DNA so-
lution for micro-injection was loaded by inserting the needle filler to draw DNA from the tube
to fill the needle by capillary action. This was carefully done to avoid air-bubble and the needle
was placed in vertical of needle holder until the DNA solution drawed to the tip without space
in between . 
Section 2.7.2.5 Mounting and breaking of the needle
A loaded needle was mounted onto a micromanipulator and the needle was positioned such that
it was in the centre of the inverted microscopes field of view. The needle was slightly resting
on the edge of rough surface of agar pad that contains a drop of mineral oil under 10X objective
using X-Y control of micromanipulator. As soon as it was positioned, the objective was changed
to 25X or 40X and the needle was gently being rubbed against the rough surface of agar pad
once or twice to break the needle and at the same time applying the pressure until the DNA so-
lution starts flowing. Once the flow of DNA solution was continously achieved within 1 or
2mins of the break of needle by applying the pressure, it showed the break was good and there-
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fore, it can be used for injection.
Section 2.7.2.6 Micro-injection technique and worm recovery
This is one of the most important aspect of micro-injection and every step has to be carefully
done. Before micro-injection started, I ensured that the valve of the pressure tank and regulator
were switched on. The injection pressure was set to be approximately 500hPa (7psi) to regulate
the influx of DNA solution. Micro-injection of worms began by filling the needle with DNA
solution and mounting on the micromanipulator. The needle was broken as described in section
2.6.1.5. and broken needle was lifted out of the mineral oil. 2 or 3 worms were mounted on agar
pad as demonstrated in section 2.6.1.2. The mounted worms were placed on the microscope
stage and the 10X objective was used to find the worms. Using the micromanipulator, the needle
was brought into the same focal plane and the worms were oriented at a 30û or 45û angle to the
direction of needle. The magnification was changed to 40X objective and syncytial gonad was
brought into focus. 
The worm was pushed against the needle tip until the cuticle distends inward and the stage was
gently touched to pinch the cuticle. At this point, the needle was in the centre of the syncytial
gonad, the pressure was then applied so that DNA solution moved freely in both directions
throughout the gonad until the swelling of gonad was noticeable (Figure 2.2). The needle was
A B C
Figure 2.2 Demonstration of micro-injection of DNA into the C.elegans. A shows the needle in focal plane
close to the gonad of a young adult hermaprodite C.elegans. B shows how needle was inserted into the gonad of the worm
using control X-Y of micromanipulator or worm was gently pushed against the needle tip until the gonad wall distends in-
ward. C shows the insertion of needle into the worm by gently tapping side of the stage to cause the needle to puncture or
pinch the gonad wall and the DNA solution was continously injected into the gonad until it swelled up by touching the ped-
dle with the feet. The needle was removed immediately and tested for the flow of DNA.
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pulled off the worm and was tested for the flow of DNA solution and moved to the next worm
to repeat the same step. A clogged needle was gently robbed against the rough surface at the end
of agar pad or otherwise the needle was replaced immediately. Worms were returned to the dis-
secting microscope and recovered with 5-10µl of standard M9 buffer. Once the worms started
swimming in M9 buffer, a worm picker was used to transfer at least two worms per bacteria
seeded plate and incubated at 20ûC. After 1-2hrs, injected worms were examined for survival
and the worms that failed to lay eggs and move around on the bacteria lawn were scored dead.
More worms were injected if there was low survival after injection.
Section 2.7.3 Micro-injection of Black Widow Spider Venom (Combined latrotoxins)
Worms were injected with combined latrotoxins to test its toxicity. The control experiment was
set up by injecting potassium cyanide (KCN) into the worms. Purified combined latrotoxin was
diluted in micro-injection buffer (20mM Tris at pH 8.0, 150mM NaCl) before injection. The in-
jected worms were recovered in M9 buffer and transfered onto NGM bacteria seeded plates be-
fore incubation at 20ûC for 3hrs. 20 worms were injected per point for individual genotype.
After incubation, worms were scored for survival or lethality. 
Section 2.7.4 Integration of transgene array in C.elegans
Transformation of C.elegans from micro-injection of transgenes exist in extrachromosomal ar-
ray. This extrachromosomal array could be lost from the germ line after some times. Therefore,
it is important to integrate the extrachromosomal array into the chromosome in order to have
homozygous transgenic animals for characterization of transgene. The integration of transgene
array in C.elegans was carried as follows; twenty transgenic animals per bacteria seeded plate
at the L4 stage for each line were Ȗ-irradiated for 5 minutes at 813 rad/mins [Ȗ-irradiation dose;
4065 rad]. From each plate, 200 F1 progeny supposedly carrying the array were picked and plat-
ed individually, and 4 F2 progeny were picked from each F1 plate and screened for 100% trans-
mission of the array to F3 progeny. Each integrated line gave rise to one homozygous strain with
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100% transmission of array after self-fertilization of F3 progeny. The strains created from inte-
grated lines were bred against wild-type worms (N2 Bristol) five times to remove any unwanted
mutation from background.
Dose calculation;1Gy= 100 rad, central dose rate =8.13Gy/min, therefore 5 minutes Ȗ-irradia-
tion; 100 x 8.13x 5 = 4065 rad. The standard dose is between 2000 and 4000 rad. 
Section 2.7.5 Staining C.elegans for ȕ-galactosidase expression
 X-gal staining was carried out to detect the expression of ȕ-galactosidase in transgenic animal
carrying gfp-lacZ (nuclear localisation signal). Synchronised worms of different stages includ-
ing embryos were washed off the culture plate with standard M9 buffer (section 2.6.1.2), and
these worms were washed several times to remove excess bacteria. The worms were spun down
in 1.5ml eppendorf tubes at 3000 rpm for 1minute and the supernatant was carefully aspirated.
The tubes were frozen in liquid nitrogen or incubated at -80ûC for 1hour. Tubes caps were
opened and placed in a vacuum jar for 45mins for worms to lyophilize. After lyophilization,
250µl cold acetone was added to each tube and left in the freezer for 3mins. Acetone was care-
Table 2.1 X-gal staining solution. 
Reagents Volume added (µl) Final concentration Stock
distilled water 620
PBS 250 1X 10X
MgCl2 1 1mM 1M
SDS 4 0.004% 1%
Redox buffer 100 10mM 100mM
Kanamycin 15 75µg/ml 5mg/ml
DAPI 2 2µg/ml 1mg/ml
X-gal (in dimethyl formamide 8 0.04% 5%
Each reagent from individual stock was added in order for 1ml volume as described above . X-gal was added last to
avoid precipitation. The freshly prepared X-gal staining solution can be kept for 2 days in aluminium foil. The
following reagent stock; Redox buffer, Kanamycin, DAPI, and X-gal were kept at-20ûC and the rest were kept at 4ûC.
Redox buffer: equal volumes 100mM potassium ferricyanide and potassium ferrocyanide were freshly from the stock
each time they are being used. (caution:contains nasty toxic cyanide, wear gloves). 10XPBS ( Nacl 80g, KCl 2g,
Na2HP04 11.5g, KH2P04 2g in distilled water, sterilized by autoclaving ).
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fully removed and allowed to air-dry for 2mins. Alternatively, fixation in 1-3% formaldehyde
for 10mins at room temperature could replace lyophilization and acetone. Worm pellets were
resuspended in ~200µl X-gal staining solution (Table 2.1) depending on the amount of worms
and allowed to incubate at 37ûC overnight. On the next day after the worms have been con-
firmed to be properly stained, worms were washed twice in 1xPBS. Stained worms were mount-
ed on agar padded slides and examined under the microscope.
Section 2.8 Developmental and Behavioural assay in C.elegans
Section 2.8.1 Embryonic culture
Embryos were studied for either lethality or survival during development. A gravid well-fed
adult hermaphrodite was sliced open to release the eggs in a drop of water on a depression slide
under the dissecting microscope using sterile razor needle. Eggs were carefully pipetted onto
the middle of an agar pad and the worm picker was used to draw eggs a close as much as pos-
sible. A cover slip was gently placed on the eggs with aid of forcep. Vaseline was used to seal
the cover slip across the edges and was studied for developement on the inverted microscope at
20ûC overnight or for a given number of hours by timing. Embryos were analysed for survival
or lethality by counting.
Section 2.8.2 Larval culture
Embryos were collected as described in section 2.8.1. Eggs were transfered into 9cm plates con-
taing M9 buffer and incubated at 20ûC overnight. On the next day, larval one (L1 stage) animals
were aliquoted on NGM plate seeded with bacteria and scored. Embryos that failed to develop
to L1 stage were scored dead. All the worms undergoing development were examined and
scored until the adult stage.
Section 2.8.3 Measurement of brood size
Brood size is the total number of offspring produced over a given period of a single adult her-
maphrodite life time. Brood size measurements were all performed at 20ûC. Brood sizes were
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measured by plating an L4 hermaphrodite on bacteria seeded plate and transfered everyday until
it stopped laying eggs. Total number of offspring were scored (ie; eggs laid) for each brood size
of genotype. 10-20 animals were analysed for each genotype reported.
Section 2.8.4 Defecation cycle
 Defecation is defined as the periodical activation of muscle contraction of C.elegans. This nor-
mally occurs every 45 seconds when the worm excretes gut contents. The defecation cycle was
measured using motor programe pBoc to pBoc (posterior body muscle contraction). An L4 her-
maphrodite was placed on bacteria seeded plate a day prior to the study of defecation cycle and
incubated at 20ûC overnight. The following day, the young adult hermaphrodite was allowed to
settle down for few minutes and studied for defecation cycle under stereo olympus microscope
using 50X objective. The animal was closely watched and everytime a defecation cycle occured
the time was measured. 10-20 animals were studied for individual genotype.
Section 2.8.5 Touch sensitivity
Worms were examined for touch sensitivity after micro-injecting with toxic substances. Ani-
mals were stroked with worm picker by touching their heads and body. Ability to respond to the
worm picker by moving around on the bacteria seeded plate meant animal was still alive and
was scored. Failure to respond to worm picker and animal was not able to move around meant
animal was dead and was scored. 20 animals were examined for touch sentivity for each geno-
type.
Section 2.9  Protein methodologies
Section 2.9.1 Preparation of combined latrotoxin protein 
5mg was weighed from combined latrotoxins (BWSV) stock (100mg) and dissolved in 500µl
micro-injection buffer (20mM Tris at pH8.0, 150mM NaCl). An eppendorf tube containing
BWSV mixture was incubated on ice for 30mins. After incubation, the tube was spun down at
13000 rpm for 10 mins. The supernatant was removed into another eppendorf tube and spun
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down at 13000rpm for 5 mins. After centrifugation, the supernatant was collected in another
fresh tube and placed on ice. 250µl of supernatant was loaded onto the Sephacryl S-200 column
for each run and fractions were collected at 0.5ml/min. Protein fraction concentration was de-
termined using method by Bradford 1976. 
Section 2.9.2 Bradford protein assay (Coomassie blue)
Protein concentration was determined using Braford assay method as described by Braford in
1976. Braford reagent made up of 100mg Coomassie Brilliant Blue G-125 was dissolved in
50ml 95% of ethanol and 100ml of 85% phosphoric acid was added. The solution was diluted
to 1 litre when dye was completely dissolved and filtered through just before use. 4-20µl of as-
say samples were prepared and 1ml of Bradford reagent was added, then vortexed immediately.
Absence was read at 590nm in an UV cuvette. A standard curve of bovine serum albumin (BSA)
was generated between the range of 0-40µg/ml for determination of protein concentration. All
assay samples including standards were done in triplicate and the means obtained were deter-
mined. The linear regression obtained from plot of BSA concentration against absorbance at
590nm for standard curve produced a linear plot and was used for sample reading to calculate
protein sample concentration. Standard curve values with R2>1 were used.
Section 2.9.3 Lithium duodecyl sulphate-polyacrylamide gel electrophoresis (LDS-
PAGE)
The NuPAGE Novex Bis-Tris Gel system which provides the best separation and resolution of
small to medium sized protein at low pH was used. The LDS-PAGE was peformed using a Nu-
PAGE Novex Bris-Tris kit. A NuPAGE gel was removed from its pouch and the gel cassette
was rinsed with distilled water. The tape was peeled from the bottom of cassette and the comb
was gently pulled from the cassette in one smooth motion. Sample wells were rinsed with 1X
NuPAGE SDS running buffer ( 20X MES Running Buffer 50ml in 1litre of distilled water) by
squirting with pipette. This process was repeated twice any inverting and shaking to remove the
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buffer. Two gels were oriented in a Mini-Cell such that the notched well side of the cassette fac-
es the inward towards the buffer core. The gels were seated on the bottom of Mini-Cell and were
locked into place with gel tension wedge and plastic buffer dam was used for one running gel.
The upper buffer chamber was filled with small amount of upper buffer chamber running buffer
containing antioxidant (200µl of antioxidant in 200ml of 1X NuPAGE SDS running buffer) to
check the tighness of the seal and was further filled until it exceeded level of well. 5-10µg of
sample (13µl of sample protein, 5µl NuPAGE loading buffer, 2µl of NuPAGE reducing agent,
mixed and boiled for 10 mins) were loaded alongside molecular weight marker. The lower
chamber at the gap near the locking mechanism was filled with 600ml NuPAGE SDS running
buffer and run at 200v for 30-60mins. Gels were removed after running by inserting the knife
in between the plates and gently ripped the plates apart producing some cracking noise as the
bond between the plate were broken. Plates were gently separated and gels were transfered for
staining.
Section 2.9.4 Coomassie blue gel staining
Coomassie blue method was used to stain the gels. Staining of the gel was carried out for 30-
60mins or overnight for better staining at room temperature with gentle shaking using Coomass-
ie Blue stain (0.25g Coomassie blue R250, 90ml methanol:water (1:1), 10ml acetic acid and fil-
tered prior to use). After 1hour or overnight staining, Coomassie blue was removed and washed
with Coomassie destaining solution on the shaker (30% Methanol, 10% acetic acid (v/v)) until
bands were clearly visible.
Section 2.10 Experimental design of Plasmids
Plasmids were designed to study various DNA fragments of lat-1 gene. DNA fragment of lat-1
gene or lat-1a cDNA was cloned into the pGEMT-Vector and sequenced to check no mutations
had been generated by PCR procedure before further subcloning into the expression vector in
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all the plasmids constructed. The first cloning into pGEMT-Vector was carried out due to the
presence of compatible overhang for the PCR products that aids the digestion of restriction en-
zymes before subsequent cloning into the expression vector. All the plasmids constructed for
the analysis of the lat-1 gene or lat-1a cDNA and their respective markers are discussed below.
Section 2.10.1 Construction of 5 end of lat-1 promoter 
To investigate in which cells the lat-1 gene is expressed using lacZ reporter gene or gfp reporter
gene, two different putative promoter regions of the lat-1 gene were amplified using a high fi-
delity PCR system with B0457 cosmid (contains the full-sequence of the lat-1 gene) as the tem-
plate and the gene specific oligonucleotides as described in section 2.10.1.1 and 2.10.1.2
respectively. 
Section 2.10.1.1  Creation of lat-1::lacZ constructs
Two different lengths of lat-1 promoter of PCR products were obtained using the primers de-
scribed in the Table 2.2. The first PCR product containing ~1.5kb of the 5 regulatory region of
lat-1 and four amino acid of exon 1 sequence of open reading frame was cloned into pGEMT-
Vector. ~1.5kb fragment insert was excised with restriction enzymes BamHI and HindIII from
pGEMT plasmid and subcloned into BamHI-HindIII sites of expression vector pPD96.04 (Nu-
clear locisation signal (NLS)-green fluorescent protein (GFP)-lacZ from Andrew Fire lab) to
create [P1.5kb lat-1::Exon 1(lat-1)::LacZ-gfp] plasmid designated as pAA411 (Figure 2.3A). 
Table 2.2 Oligonucleotides of lat-1::lacZ constructs. 
Name Sequence 5 ĺ 3 Restriction sites Description
LPH exon 5 (NLS) AAGCTTCCCAGTCAATTTGGCA
ACAGACGGTAATCATC
Hind III 5 end obtained from Hold-Dye paper 
with HindIII site on 10108-10130bp of 
B0457 cosmid (lat-1 gene) sequence
LPH exon 3 (NLS) GGATCCTCACGTCGCATCAGTG
CATACTATTTTGTTCGT
BamHI  3 end with BamHI site on 11580-
11609bp of B0457cosmid (lat-1gene) 
sequence 
5 primer design GGATCCTATTTCCTGCCATACTG
AAGGCGTGAGAAC
BamHI  5 end with BamHI site of 8612-
8640bp B0457cosmid (lat-1gene) 
sequence 
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The second PCR product containing ~3kb of the 5 regulatory region of lat-1 and three amino
acid of exon 1 sequence of open reading frame was cloned into pGEMT-Vector. ~3kb fragment
3 primer design GGATCCCGTCGCATCAGTGCATA
CTATTTTGTTCGTCGAGTGTA
BamHI  3 end with BamHI site on 11572-
11609bp of B0457cosmid (lat-1gene) 
sequence
Table 2.2 Oligonucleotides of lat-1::lacZ constructs. 
Figure 2.3 The map of lat-1::lacZ constructs. A The map shows the transcriptional reporter fusion of ~1.5kb, 5
regulatory region of lat-1 promoter with four amino acid of exon 1 sequence. Restriction enzymes; HindIII and BamHI show
their restriction sites at 2 and 1512 position respectively upon fusion to pPD96.04 reporter gene (green fluorescent pro-
tein(gfp)-lacZ; nuclear localisation signal (NLS). The resulting plasmid is designated as pAA411 with the size of 9.6kb. B
The map shows the transcriptional reporter fusion of ~3kb, 5 regulatory region of lat-1 promoter with three amino acid of
exon 1 sequence. Restriction enzymes; BamHI and BamHI show their restriction sites at 32 and 3036 position respectively
upon fusion to pPD96.04 reporter gene (green fluorescent protein(gfp)-lacZ; nuclear localisation signal (NLS). The resulting
plasmid is designated as pAA412 with size of 11kb.
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insert was excised with restriction enzyme BamHI from pGEMT plasmid and subcloned into
BamHI sites of expression vector pPD96.04 to create [P3kb lat-1::Exon 1(lat-1)::LacZ-gfp] plas-
mid designated as pAA412 (Figure 2.3B).
Section 2.10.1.2  Creation of lat-1::GFP construct
To investigate comparison between expression pattern of lat-1 fused to gfp reporter gene and
lat-1 fused to lacZ reporter gene, the lat-1 promoter of PCR product was obtained using LPH
exon 5(NLS) and LPH exon 3 (NLS) primers as described in Table 2.2 above. The PCR prod-
uct containing ~1.5kb of the 5 regulatory region of lat-1 and four amino acid of exon 1 se-
quence of open reading frame was cloned into pGEMT-Vector. ~1.5kb fragment insert was
subcloned into Hind III-BamHI sites of expression vector pEGFP-N1 to create [P1.5kb lat-1::Ex-
on 1(lat-1)::gfp] plasmid designated as pAA410 (Figure 2.4).
Section 2.10.2 Construction of plasmids for the rescue of lat-1(ok1465) worms
To study the rescue of lat-1 (ok1465) worms, plasmids were created using lat-1a cDNA reporter
fusion. The construction of truncations of lat-1a cDNA are important to determine the function-
ality of various domains of lat-1a cDNA for the rescue of lat-1(ok1465) worms. To construct
Figure 2.4 The map of lat-1::GFP construct. The map shows the transcriptional reporter fusion of ~1.5kb, 5 reg-
ulatory region of lat-1 promoter with four amino acid of exon 1 sequence. Restriction enzymes; HindIII and BamHI show their
restriction sites at 623 and 2133 position respectively upon fusion to pEGFP-N1 reporter gene (green fluorescent protein;gfp).
with two coding sequences CDS 1&2 The resulting plasmid is designated as pAA410 with the size of 6.2kb
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the full-length lat-1a cDNA, C-terminal or N-terminal of lat-1a cDNA, the putative lat-1a
cDNA was amplified using the high fidelity PCR system and gene specific oligonucleotides as
described in section 2.10.2.1, 2.10.2.2 and 2.10.2.3 respectively.
Section 2.10.2.1 Creation of full-length lat-1a cDNA construct
To create the full-length lat-1a cDNA construct, two different PCR products were obtained be-
fore further subcloning into expression vectors using primers described in Table. The first PCR
product containing ~1.5kb of 5 regulatory region of lat-1 and intron between exon 1 and exon
2 of coding sequence was cloned into pGEMT-Vector resulting to pGEMT.lat-1 5, exon 1, 2
plasmid, and the primers used are LPH genomic 5and LPH genomic 3. The second PCR prod-
uct containing lat-1a cDNA only was cloned into pGEMT-Vector resulting to pGEMT.lat-1a
cDNA plasmid, and the primers used are LPH gene 5 and LPH gene 3. The next approach was
to make a full-length clone of lat-1a cDNA, with a reporter gene (GFP) fused to the C-terminus
of the protein. To make a full-length lat-1a cDNA construct, pEGFP-N1 expression vector was
excised with restriction enzymes XhoI and NotI and subcloned into XhoI and NotI restriction
sites of pGEMT.lat-1a cDNA resulting to pGEMT.lat-1a cDNA.GFP plasmid. The pGEMT.lat-
1a cDNA.GFP plasmid was excised with restriction enzymes AvrII and NotI and subcloned into
AvrII and Not I restriction sites of [pGEMT.lat-1 5, exon 1, 2] plasmid resulting to [P 1.5kb lat-
1::FL(lat-1a cDNA)::gfp] plasmid designated as pAA401 (Figure 2.5)..
Table 2.3 Oligonucleotides of full-length lat-1a cDNA construct. 
Name Sequence 5 ĺ 3 Restriction sites Description
LPH genomic 5 GGTACCGGTTTCCCAGTCATTTGG
CAACAGACG
KpnI 5 end with KpnI site on 10104-
10130bp of B0457cosmid (lat-1gene) 
sequence
LPH genomic 3 AAGCTTAGGAAGGAAACAGCGAC
AGAGAATCTTCC
HindIII 3 end with HindIII site on 14610-
14639bp of B0457cosmid (lat-1gene) 
sequence 
LPH gene 5 CACACAATATGTGATGGTGAAGCT
GCT
5 end on 122-148bp of lat-1a cDNA 
sequence
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Section 2.10.2.2  Creation of C-terminal lat-1a cDNA construct
Truncation of C-terminal lat-1a cDNA resulted into three different constructs to detemine their
individual functionality. To create these constructs, three PCR products obtained were individ-
ually cloned into pGEMT-Vector before further subcloning into expression vectors. The first
PCR product for the truncation of C-terminal of lat-1a cDNA to the area of four cysteine domain
(4xCys) was cloned into pGEMT resulting to pGEMT.4xCys (lat-1a cDNA) plasmid, and the
primers used are LPH gene 5 and 4xCys 3. The second PCR product for the truncation of C-
LPH gene 3 GGATCCCTCGAGTAAATCTTGACA
ATACATGCTCGG
XhoI, BamHI XhoI site engineered at 3043bp of lat-
1a cDNA sequence for 3 end of full-
length
Table 2.3 Oligonucleotides of full-length lat-1a cDNA construct. 
Figure 2.5 The map of full-length lat-1a cDNA. TThe map shows translational reporter fusion of full-length lat-
1a cDNA to GFP under the control of ~1.5kb 5 regulatory region of lat-1 promoter with an intron between exon 1 and exon
2. The restriction sites are shown for the engineering of the fragments by the restriction enzymes. The resulting plasmid is
designated as pAA401 with the size of 11kb. 
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terminal of lat-1a cDNA to the seven transmembrane domain (TM7) was cloned into pGEMT
resulting to pGEMT.TM7(lat-1a cDNA) plasmid, and the primers used are LPH gene 5 and
TM7 3. The last PCR product for the truncation of C-terminal of lat-1a cDNA to the one trans-
membrane domain was cloned into pGEMT resulting into pGEMT.TM1(lat-1a cDNA) plasmid,
and the primers used are LPH gene 5 and TM1 3. The next step was to make a truncated clone
of lat-1a cDNA, with a reporter gene (GFP) fused to C-terminus of the protein. To undertake
this, pEGFP-N1 expression vector was excised with restriction enzymes XhoI and NotI and sub-
cloned into XhoI and NotI restriction sites of [pGEMT.4xCys(lat-1a cDNA)] resulting to
[pGEMT.4xCys(lat-1a cDNA).GFP] plasmid. The [pGEMT.4xCys(lat-1a cDNA).GFP] plas-
mid was excised with restriction enzymes AvrII and NotI and subcloned into AvrII and Not I
restriction sites of pGEMT.lat-1 5, exon 1, 2 plasmid resulting to [P 1.5kb lat-1::4xCys(lat-1a cD-
NA)::gfp] plasmid designated as pAA402 (Figure 2.6A). This same step was repeated for
pGEMT.TM7(lat-1a cDNA) plasmid or pGEMT.TM1(lat-1a cDNA) plasmid by subcloning
into AvrII and Not I restriction sites of pGEMT.lat-1 5, exon 1, 2 plasmid with resulting [P 1.5kb
lat-1::TM7(lat-1a cDNA)::gfp] plasmid designated as pAA403 (Figure 2.6B) or [P 1.5kb lat-
1::TM1(lat-1a cDNA )::gfp] plasmid designated as pAA407 (Figure 2.6C) respectively.  
Table 2.4 Oligonucleotides of C-terminal lat-1a cDNA construct. 
Name Sequence 5 ĺ 3 Restriction sites Description
LPH gene 5 CACACAATATGTGATGGTGAAGCT
GCT
the same 5 sequence used for all the 
truncations of C-terminal
4xCys 3 CTCGAGCATTTGATTAGGATGATTC
ATTATTCCATT
XhoI XhoI site engineered at 2622bp of lat-
1a cDNA sequence for 3end of 
4xCys
TM7 3 CTCGAGTTTACGCATTTTTTCAGC
AAAGACGACGTGG
XhoI  XhoI site engineered at 2404 bp of 
lat-1a cDNA sequence for 3end of 
TM7
TM1 3 CTCGAGTCTGCTGAAAATCAAGTA
GGCGAAGAAAGTG
XhoI XhoI engineered at 1735bp of la-
1acDNA sequence for 3 end of TM1
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Figure 2.6 The map of C-terminal lat-1a cDNA. Each map shows translational reporter fusion of C-terminal trun-
cation of lat-1a cDNA to GFP under the control of ~1.5kb 5 regulatory region of lat-1 promoter with an intron between exon
1 and exon 2. All the restriction sites are shown for the engineering of the fragments by the restriction enzymes. A shows the
map of C-terminal truncation of lat-1a cDNA to the area four cysteine domain (4xCys) and the plasmid is designated as
pAA402 with the size of 10.7kb. B shows the map of C-terminal truncation of lat-1a cDNA to the seven transmembrane do-
main (TM7) and the plasmid is designated as pAA403 with the size of 10.5kb. C shows the map of C-terminal truncation of
lat-1a cDNA to one transmembrane domain (TM1) and the plasmid is designated as pAA407 with the size of 9.8kb. 
Ademola Adenle   Section 2.10.2
Page 76
Section 2.10.2.3  Creation of N-terminal lat-1a cDNA construct
To determine the functionality of N-terminal lat-1a cDNA, three individual constructs were
made. These constructs were created by individually cloning three different PCR products into
pGEMT before further subcloning. The first PCR product for the truncation of N-terminal of
lat-1a cDNA between 62-147 amino acid position is delta galactose-binding lectin domain
(¨GBL) cloned into pGEMT with resultant product pGEMT.¨GBL plasmid, using oligo lat-
1N147 5 and oligo lat-1Nterdeletion 3 primers. The second PCR product for the truncation of
N-terminal of lat-1a cDNA between 62-250 amino acid position is delta hormone receptor motif
domain (¨HRM) cloned into pGEMT with resultant product pGEMT.¨HRM plasmid, using ol-
igo lat-1 N250 5 and oligo lat-1Nterdeletion 3 primers. The last PCR product for the truncation
of N-terminal of lat-1a cDNA between 62-487 amino acid position is the rest of N-terminal do-
main (¨N) cloned into pGEMT with resultant product pGEMT.¨N plasmid, using oligo lat-1
N487 5 and oligo lat-1Nterdeletion 3 primers. A further step was taken by cloning individual
resultant pGEMT.¨GBL, pGEMT.¨HRM and pGEMT.¨N plasmid into AvrII and HindIII re-
striction sites of [P 1.5kb lat-1::FL(lat-1a cDNA)::gfp] plasmid (section 2.10.2.2) with resultant
plasmids; [P 1.5kb lat-1::¨GBL(lat-1a cDNA)::gfp] designated as pAA404 (Figure 2.7A), [P 1.5kb
lat-1::¨HRM(lat-1a cDNA)::gfp] designated as pAA405 (Figure 2.7B) and [P 1.5kb lat-1::¨N(lat-
1a cDNA)::gfp] designated as pAA408 (Figure 2.7C) respectively. 
Table 2.5 Oligonucleotides of N-terminal lat-1a cDNA construct. 
Name Sequence 5 ĺ 3 Restriction site Description
Oligo lat-1N147 5 GTCCTAGGATCAACTACT
ACAACCGATAGCAGTTTG
3 amino acids (valine) added to 5 end on 
439-465bp of lat-1a cDNA sequence for 
¨GBL
Oligo lat-1N250 5 GTCCTAGGAGTTATTTCGA
GTGAGGATGTCTCTGGA
3 amino acids (valine) added to 5 end on 
748-774bp of lat-1a cDNA for ¨HRM
Oligo lat-1N487 5 GTCCTAGGATCGTCAGTC
CGTCATTTGAGCAATCCG
3 amino acids (valine) added to 5 end on 
1459-1485bp of lat-1a cDNA for ¨N
Oligo lat-1Nterm 
deletion 3
ACCGTCGACTGCAGAATT
CGAAGCTTGAGC
3end for all truncation of N-terminal on 
7363-7391bp full-length construct 
sequence around HindIII site
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Figure 2.7 The map of N-terminal lat-1a cDNA. Each map shows translational reporter fusion of N-terminal
truncation of lat-1a cDNA to GFP under the control of ~1.5kb 5 regulatory region of lat-1 promoter with an intron between
exon 1 and exon 2. All the restriction sites are shown for the engineering of the fragments by the restriction enzymes. A shows
the map of truncation of N-terminal lat-1a cDNA for the galactose-binding lectin domain (¨GBL) and the plasmid is desig-
nated as pAA404 with the size of 10.9kb. B shows the map of truncation of N-terminal lat-1a cDNA for the hormone receptor
motif domain (¨HRM) and the plasmid is designated as pAA405 with the size of 10.6kb. C shows the map of truncation of
N-terminal lat-1a cDNA for the rest of N-terminal domain (¨N) and the plasmid is designated as pAA408 with the size of
9.9kb
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Section 2.10.3 Construction of aex-3 plasmid
The aex-3 plasmid is constructed for constitutive expression of lat-1 in the nervous system. To
create this construct, two different PCR products were cloned into pGEMT before further sub-
cloning. The first PCR product containing ~1.3kb 5 regulatory region of aex-3 gene was cloned
into pGEMT resulting to pGEMT.aex-3 plasmid using aex-3 cosmid DNA as template and oli-
gonucleotides Aex gene 5 and 3 as described in Table 2.6. The second PCR product containing
exon 1 and exon 2 of B0457 cosmid (full sequence of lat-1 gene) was cloned into pGEMT re-
sulting to [pGEMT. exon 1, 2] plasmid using B0457 cosmid DNA as template and oligonucle-
otides lat-1 5 and lat-1 genomic 3 as described in Table 2.6. Further step was taken by cloning
pGEMT.exon 1, 2 plasmid into AvrII and Not I restriction sites of pGEMT.lat-1a cDNA plas-
mid resulting to pGEMT.lat-la cDNA. exon 1, 2 plasmid. Lastly, the pGEMT.lat-1a cDNA.ex-
on 1, 2 plasmid was cloned into BglII and NotI restriction sites of pGEMT.aex-3 plasmid with
resultant product [P 1.3kb aex-3::FL(lat-1a cDNA)::gfp] plasmid designated as pAA409 (Figure
2.8)..
Table 2.6 Oligonucleotides of aex-3 constructs. 
Name Sequence 5 ĺ 3 Restriction site Description
Aex gene 5 GGATCCACAAAAACTGCCGCTT
CAATTCTCCATG
BamHI 5 end with BamHI site on 28996-29015bp 
of aex-3 cosmid sequence (complimentary)
Aex gene 3 AGATCTATTCATTTTTTATTAGGA
TAGGTACATTGGTGC
BglII 3 end with BglII site on 27683-27714bp 
aex-3 cosmid sequence (complimentary)
lat-1 5 AGATCTCGACGTAACAAAACGA
CTTATTCGTTGCTCC
BglII  5 end with BglII site on 11605-14639bp 
of B0457 cosmid (lat-1 gene) sequence
lat-1 genomic 
3
AAGCTTAGGAAGGCAAACAGCG
ACAGAGAATCTTCC
HindIII 3end with HindIII site on 14610-14639bp 
B0457 cosmid (lat-1 gene) sequence
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Section 2.10.4 Construction of selectable markers
The selectable markers were constructed for the selection and identification of transgenic ani-
mals. The unc-54::cfp plasmid was a gift from Jody Winter, and is designated as pAA413 plas-
mid while unc-54::mCherry plasmid was constructed during this experiment. To create this
plasmid, the PCR fragment was cloned into pGEMT before further subcloning into pPD30.38
(unc-54 gene, body-wall muscle expression of the mCherry GFP) [Andrew Fires lab]. The PCR
product containing 700bp of mCherry was cloned into pGEMT resulting to pGEMT.mCherry
plasmid using mcherry DNA as template and oligonucleotide 5 primer mcherry and 3 primer
mCherry as described in Table 2.7. A further approach was taken by cloning pGEMT.mCherry
plasmid into SacI restriction sites of pPD30.38 plasmid; this plasmid is unc-54::mCherry and
the resulting plasmid designation is pAA414 (Figure 2.9).
Figure 2.8 The map of aex-3 plasmid. The map shows translational reporter fusion of full-length lat-1a cDNA to
GFP under the control of ~1.3kb 5 regulatory region of aex-3 promoter with an intron between exon 1 and exon 2. The re-
sulting plasmd is designated as pAA409 with size of 10.9kb and appropriate restriction sites are shown on the map.
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. 
Section 2.10.5 Statistical analysis
Statistical analysis using paired students t-test with a confidence limit of 95% was carried out
by Sigma Plot 10 spread sheet or Microsoft Excel spread sheet programs for two groups. To ob-
tain LD50, dose response curve of combined latrotoxins effect was fitted using Graph Pad Prism
5.
Section 2.10.6 Worm strains
All the constructs given in the Table 2.8 were made during the experiments with the expception
of pRF4 plasmid (roller phenotype) and pEGFP (green fluorescent protein) provided as gifts.
Transgenic strains were obtained from micro-injection of individual constructs with appropriate
selectable markers as stated in the Table 2.8.
Table 2.7 Oligonucleotides of selectable marker unc-54::mcherry. 
Name Sequence 5 ĺ 3 Restriction site Description
5 primer mcherry GAGCTCATGGTGAGCAAGGGCG
AGGAGGAT
SacI 5 end with SacI site on 1-24bp of 
mCherry sequence
3 primer mcherry GAGCTCTTACTTGTACAGCTGCT
CCATGCC
SacI 3end with SacI site on 689-711bp of 
mCherry sequence
Figure 2.9 The map of unc-54::mcherry plasmid. The map shows inframe fusion of mcherry to unc-54 gene
(pPD30.38). SacI restriction sites were used to introduce mcherry fragment to pPD30.38 plasmid. The resulting plasmid is
designated as pAA414 with the size of 5.5kb
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Table 2.8 List of transgenic strains. 
Strain Genotype DNA Marker
DA101-104 lat-1(ok1465) [P 1..5kb lat-1::FL(lat-1a cDNA)::gfp; 
unc-54::mCherry] 
pAA401;pAA414 unc-54::mCherry
DA201-203 lat-1(ok1465) [P 1..5kb lat-1::4xCys(lat-1a 
cDNA)::gfp; unc-54::mCherry]
pAA402;pAA414 unc-54::mCherry
DA 301-303 lat-1(ok1465) [P 1.5kb lat-1::TM7(lat-1a cDNA)::gfp; 
unc-54::mCherry]
pAA403;pAA414 unc-54::mCherry
DA401-402 lat-1(ok1465) [P 1.5kb lat-1::ǻGBL(lat-1a cDNA)::gfp; 
unc-54::m-cherry]
pAA404;pAA414 unc-54::mCherry
DA501 lat-1(ok1465) [P 1.5kb lat-1::ǻHRM(lat-1a 
cDNA)::gfp; unc-54::mCherry]
pAA405;pAA414 unc-54::mCherry
DA601-603 lat-1(ok1465)[B0457;unc-54::cfp] pAA406;pAA413 unc-54::cfp
DA701-703 N2 [P 1.5kb lat-1::FL(lat-1a cDNA)::gfp; unc-
54::mCherry]
pAA401;pAA414 unc-54::mCherry
DA801-803 N2 [P 1.5kb lat-1::TM1(lat-1a cDNA)::gfp; unc-
54::mCherry]
pAA407;pAA414 unc-54::mCherry
DA901-903 N2 [P 1.5kb lat-1::ǻN(lat-1a cDNA)::gfp; unc-
54::mCherry]
pAA408;pAA414 unc-54::mCherry
DA111-113 N2 [P 1.3kb aex-3::FL(lat-1a cDNA)::gfp; unc-
54::mCherry]
pAA409;pAA414 unc-54::mCherry
DA211-213 N2 [P 1.5kb lat-1::Exon1(lat-1)::gfp;unc-54-mCherry] pAA410;pAA414 unc-54::mCherry
DA311-313 N2 [P 1.5kb lat-1::Exon1(lat-1)::LacZ-gfp;rol-6] pAA411; pRF4 rol-6(su1006)
DA411-413 N2 [P 3.0kb lat-1::Exon1(lat-1)::LacZ-gfp;rol-6] pAA412; pRF4 rol-6(su1006)
DA511-513 N2 [LacZ-gfp;rol-6] pPD96.04; pRF4 rol-6(su1006)
DA611-613 N2 [lat-1(GST)::unc-54;rol-6] pAA411; pRF4 rol-6(su1006)
DA711-713 N2 [GST::unc-54;rol-6] pAA412; pRF4 rol-6(su1006)
DA811-813 N2 [unc-54::cfp] pAA413 unc-54::cfp
DA911-913 N2 [unc-54::mCherry] pAA414 unc-54::mCherry
DA920 N2[gfp;unc-54::mCherry] pEGFP;pAA414 unc-54::mCherry
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Chapter 3 Results
Section 3.1 Optimisation of Microinjection
Section 3.1.1 Injection of Rhodamine-Dextran into C.elegans
Initial attempts to create transgenic C.elegans by micro-injection failed to yield transgenic off-
spring, although animals survived injection and manipulation (data not shown). Microinjection
of fluorescently labelled Rhodamine-dextran (70,000 MW) was carried out, to investigate
whether the injection into the syncytial arm of gonad of C.elegans was successful. When rhod-
amine-dextran was injected into the gonad, fluorescence was restricted to the arm of the gonad
(Figure 3.1A). Injection of water yielded worms which showed negligible red fluorescence
(Figure 3.1C), while injection of fluorescent dextran yielded a strong fluorescent signal (A, B). 
The whole body of an adult hermaphrodite showed red fluorescence when the gonad was not
Figure 3.1 Injection of rhodamine dextran into adult hermaphrodite.   (A) Top, image of fluorescence using
mCherry red-filter, of a worm which was injected in the gonad with rhodamine-dextran. The arrow indicates the position of
the distal arm of the gonad in the adult hermaphrodite. Bottom image shows the same field taken under visible light, using DIC
optics. (B) An adult hermaphrodite was injected with rhodamine-dextran in the body cavity. The left (mCherry fluorescence
filter) image was taken under fluorescence, and under visible light which was slightly out of focus in the right panel. (C) Adult
hermaphrodite was injected with water, and imaged with fluorescence (mCherry red-filter-top) and under visible light, with
arrow indicating distal arm of gonad where water was injected. Scale bar; 50 µm. All images were captured at 40x magnifica-
tion.
 B  C A
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specifically targeted for injection (B). These data show that the red fluorescent signal is depend-
ent upon injection of rhodamine-dextran, and is therefore the fluorescence from rhodamine it-
self. The microinjection into the gonad was accurate, and the injected fluid remained within the
gonadal syncytium. This is held to be an important control for the technique for injecting C. el-
egans (J. Ahringer, personal communication). Subsequent to this experiment, it was noted that
the room used for microinjection had high (>25°C) and variable temperature. Air conditioning
was installed in this room, so that the temperature was controlled to 20°C. Subsequent experi-
ments, therefore, benefited from temperature control.
Section 3.1.2  Effect of DNA Concentration on Transformation of C.elegans
The effect of DNA concentration was measured by injecting various DNA concentrations into
wild-type C.elegans, to determine suitable DNA concentrations that would reproducibly form
heritable extrachromosomal arrays (stable lines) in transgenic offspring. Plasmid pRF4 contains
rol-6 (su1006), conferring the roller phenotype [91] and plasmid pAA413 contains unc-54::cfp
(body-wall muscle expression of the Cerulean CFP) [94] [95]; these were used as selectable
markers, and were individually injected into wild-type C.elegans. The plasmids were injected
over a concentration range from 12.5 to 800 Pg/ml in this experiment, and the number of trans-
formant rollers and fluorescent worms obtained per injection were compared at each concentra-
tion. Plasmid DNA at 800 Pg/ml produced the highest number of stable transgenic animals, 29
% and 73% respectively (Table 3.1). As the concentration of injected DNA decreased, the
number of stable transgenic animals decreased (Table 3.1). The ability of an inherited transgene
to transmit beyond the F2 generation is an indication that a stable line has been formed, and the
percentage of stable transgenic lines with either transformant roller or fluorescent worm is
shown (Table 3.1). 
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The stable lines obtained from injection of both pRF4 and CFP account for 13%-73% of off-
spring, and where tested, the transgene inherits in a non-Mendelian segregation pattern (data not
shown). This result showed that the DNA concentration determined the number of transgenic
animals. Therefore, DNA concentration is an important factor for C.elegans transformation suc-
cess.
Table 3.1 Effect of DNA concentration on transgenesis. 
DNA(µg/ml) No of worms 
injected
No of progeny 
per F1
No of transgenic 
F1
No of stable line 
(S)
% of stability S/
F1
pRF4
800 16 294±5 24 7 29%
400 10 296±4 20 5 25%
200 20 292±2 17 3 18%
50 18 301±27 14 2 14%
12.5 20 294±7 6 0 0%
unc-54::cfp (CFP) 
800 19 300±6 33 24 73%
400 14 295±13 25 17 68%
200 17 287±8 20 13 65%
50 25 282±5 15 7 47%
12.5 23 288±10 8 1 13%
The concentration of pRF4, or CFP injected was between 12.5-800 µg/ml . F1 generation has the total number of progeny 
including transformants (Mean± Standard Deviation). The number of offspring with consistent transmission of the array 
from an individual line is regarded as a stable line either for the transgenic roller or fluorescent worm. Percentage of sta-
bility was calculated by dividing stable line S over transgenic F1. A stable line is a line that transmits a transgene beyond 
the F2 generation.
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Section 3.2  Structure of lat-1 ok1465 allele
Section 3.2.1 Deletion of lat-1 allele
The ok1465 allele of the lat-1 gene was provided as a worm strain VC965 by the C.elegans
Gene Knockout Consortium. The deletion breakpoint for the ok1465 allele is between bases
18185 and 20395 of the B0457 cosmid sequence. Three different transcripts (B0457.1a,
B0457.1b, B0457.1c) are produced from lat-1 gene with only two transcripts (a b) yielding
putatively functional protein coding sequences, as a result of differential splicing of third exon
(see www.wormbase.org). In the lat-1(ok1465) allele, these two transcripts will give rise to dys-
functional variants. The lat-1a transcript (B0457.1a) has a deletion from exon 3a-5, resulting in
the direct splicing of exon 2 and exon 6. This yields a transcript which is in frame, thus produc-
ing a protein of 531 amino acids. The lat-1b transcript (B0457.1b) has a deletion in the middle
of exon 3b, which is then fused to intron sequence, and would therefore be expected to yield a
truncated protein of 371 amino acids. The structure of the wild-type lat-1a has five conserved
domains, with sizeable extracellular domains containing a galactose-binding lectin domain, a
hormone receptor motif domain (HRM), and a G-protein coupled receptor proteolysis site
(GPS). The transmembrane domain is typical of the secretin/class II family of G Protein Cou-
pled Receptors (GPCRs). The intracellular domain is also relatively large, but the only identifi-
able domain structure is an area containing a four cysteine motif (4xCys). Figure 3.2 shows the
structure of the protein arising from the lat-1(ok1465) deletion for the lat-1a transcript, where
amino acids 100-583 of the protein were deleted. As well as a substantial region of the extracel-
lular domain, the first transmembrane helix of the 7-transmembrane domain has been deleted,
and therefore it will be expected to yield a non-functional protein.
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Figure 3.2 The ok1465 lat-1 allele.  A The top picture shows a cartoon of the lat-1 gene (wild-type) in the B0457 cos-
mid, lat-1 ok1465 allele deletion spans nucleotides 18185-20395 between exon 3b and exon 5. Exons 1-8 of lat-1 gene (wild-
type) are depicted in black boxes apart from 3a and 3b which are depicted in red and blue respectively, introns are indicated
as black lines. B, C The middle pictures show cartoons of the lat-1 ok1465 gene. B The splice variant of lat-1 ok1465
(B0457.1a) that shows in-frame deletion of exons 3-5, skipping 3b due to alternative splicing. C shows the splice variant of
lat-1 ok1465 (B0457.1b) which has an out of frame deletion in the middle of exon 3b and finishes in the intron before exon 6.
D The bottom picture is the predicted lat-1a protein. The picture shows putative domains of the lat-1 protein, including the
secretion region (a blue arrow), the galactose-binding lection domain (Lectin), the hormone receptor motif domain (hormone
binding domain), the G-protein coupled receptor proteolysis site (GPS proteolysis motif, with the site of cleavage indicated by
a blue triangle), the transmembrane domain receptors (TM1, TM2,TM3, TM4, TM5, TM6, TM7) , the area of four cysteine
domain (4xCys). The position of the amino acids deleted in the ok1465 deletion is shown by a light pink box marked ok1465
deletion. The extracellular domains are highlighted in green colour, The seven transmembrane domains is shown in yellow
colour, and the intracellular domains are C-terminal, in purple colour. 
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Section 3.2.2 Phenotype of lat-1 ok1465 allele
The ok1465 allele was balanced by mIn1[dpy-10(dpy), mIs 14 (gfp)] ([96]), to maintain the al-
lele as the stable heterozygote, mIn1/lat-1- which has the wild-type phenotype, is selectable by
the GFP marker, and the lethality of the lat-1 homozygotes is balanced by the poor fecundity
and phenotype of the dumpy mIn1 homozygotes. ok1465 wild-type and deletion alleles were
confirmed by PCR, using internal and external primer sequence (DRB personal communica-
tion). The mIn1/lat-1 worm was only outcrossed once after mutagenesis by C.elegans Gene
knockout Consortium, and the lat-1 allele was outcrossed five times against N2 worms (DRB,
unpublished) prior to use in this thesis. In order to characterise whether the lat-1(ok1465) allele
had an adverse effect, the number of offspring from the mIn1/lat-1(ok1465) worms was deter-
mined. 
Individual mIn1/lat-1 animals were singly plated, and allowed to self-fertilise, moving the ani-
mals on to a fresh plate every day. At three days after laying, the offspring (at L4/ adult stage)
Table 3.2 Measurement of offspring survival. 
Genotype % embryonic lethality (n=10) % larval lethality (n=10) % survival to adulthood (n=10)
lat-1(ok1465) 33% (68/208) 65% (136/208) 2% (4/208)
Wild-type 0% (0/285) 0% (0/285) 100% (285/285) 
Offspring from lat-1 (ok1465) allele hermaphrodites were measured for the survival during development. Embryos were
dissected from N2 or lat-1(ok1465) hermaphrodites (n=10), and incubated on an agar pad in water overnight at 20ºC (sec-
tion 2.8.1); images of devleopment were acquired at 5 minute intervals for 24 hours. The resulting movie was reviewed
to count the number of embryos that died prior to L1 stage (% embryo lethality). From 208 embryos of lat-1 null animals
counted, 68 embryos died at pre-coma stage (33%), whereas in wild-type, no death was recorded out of 285 embryos
counted (0%). Embryos were also dissected from N2 or lat-1 (ok1465) allele hermaphrodites for larvae survival and
placed in the plates with M9 buffer, incubated at 20ºC overnight and transfered to bacteria seeded plates for count (section
2.8.2). Out of 208 larva of lat-1 (ok1465) animals counted, 136 larva died by larvae 2 stage (65%), and no death was re-
corded from 285 larva of wild-type counted (0%). Only ~4 adult hermaphrodites survived from 208 embryos counted
(2%) for lat-1 (ok1465) animal, whereas in wild-type 285 embryos produced 285 surviving adults (100%). n is the number
of animals analysed.
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were counted, giving 1677 mIn1/mIn1 (i.e. dumpy phenotype and showing green fluorescence),
3540 mIn1/lat-1 (i.e. wild-type appearance, and showing green fluorescence), and 32 lat-1/lat-
1 (no green fluorescence) offspring. This number of offspring shows a significant deviation
from the 1:2:1 ratio expected from mendelian genetics (F2- test, P<0.05). However, there was
no significant difference when comparing between expected ratio of 25% (mI/n1/mI/n1): 50%
(mIn1/lat-1) and the observed numbers of 1677 (mIn1/mI/n1): 3540 (mIn1/lat-1) (F2- test,
P>0.05). However, the ratio observed for lat-1/lat-1 (0.6%) is significantly different from the
expected ratio of 25% (F2- test, P<0.05). Therefore, this data shows that the lat-1/lat-1 are sig-
nificantly under-represented, possibly due to the genotype causing a developmental defect or
lethality. 
There were only ~2-5% of the expected number of lat-1 null adult homozygous offspring, but
these were from heterozygous parents; it was not clear if the wild-type parent was providing
function to the offspring which affects its survival. To investigate whether there is a maternal
effect, the lethality of lat-1(ok1465) must also be determind in homozygous animals. To deter-
mine the number of viable, adult offspring from homozygous lat-1(ok1465) worms, single L4
hermaphrodites of lat-1 null were self-fertilised and transfered everyday until egg-laying
stopped. The number of offspring for each individual plated animal was counted, and each an-
imal produced only ~4 surviving adult offspring; 2% (4/208) (n=10) with embryonic and larva
lethality. The proportion of surviving adults that are lat-1(ok1465) homozygous are similar
whether the parent is heterozygous, or homozygous; and this finding excludes the possibility
that this is a maternal effect gene.
Offspring were examined to determine the stages during which the lethality occured for the lat-
1(ok1465) animals. Embryos were dissected from lat-1(ok1465) adult hermaphrodites, and
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wild-type hermaphrodites as a negative control, to study embryonic and larval lethality, and sur-
vival to adulthood. The results showed that lat-1(ok1465) worm had 33% (68/208) (n=10) em-
bryonic lethality, and 65% (136/208) (n=10) larval lethality, whereas analysis of wild-type
offspring yielded 0% (0/285) embryo (n=10) or 0% (0/285) (n=10) larval lethality with 100%
(285/285) (n=10) survival to adulthood (Table 3.2). The phenotype of lat-1(ok1465) animal off-
spring is characterised by a variety of failures of epithelial migration and failure of gut attach-
ment to pharynx in the larvae. A typical example of embryonic or larval death in lat-1
homozygous animals is shown in Figure 3.3. Thus, this result demonstrates that 33% and 65%
lethality occured throughout the stages of embryo and larval development, respectively. 
This is consistent with the bioinformatic analysis that suggests that the function of the lat-1 gene
will be lost in the ok1465 allele. However, these data do not exclude the possibility that the phe-
notype of lat-1(ok1465) worms could arise from a mutation in a closely linked gene; given that
A B
Figure 3.3 Phenotypes of lat-1(ok1465) worms and wild-type (N2 Bristol).  Embryo from lat-1 worms were
allowed to develop at 20ûC after harvesting, then viewed under DIC optics (A) is a typical example of lat-1 worm
arrested larva with gut detached from pharynx as indicated by arrow. (B) is a typical example of a lat-1 worm embryo.
The arrow points to a rupture, with cells extruding from the head during the elongation stage. (C) is a typical example
of wild-type L1 with gut attached to pharynx. The scale bar is shown as a thin black line, and represents 50 µm.
 
C
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the ok1465 allele has only been outcrossed six times, this could be a considerable portion of the
genome, and closely linked (and potentially mutated) genes would be likely to remain linked to
the lat-1 allele.
Section 3.3 Expression pattern under the lat-1 gene promoter
The aim was to study the expression pattern of the lat-1 gene promoter during developmental
and adult stages, and thus to determine in which cells the lat-1 gene is expressed. Therefore, two
different regions of the 5 end of the lat-1 gene, putatively including the promoter sequences,
were fused to either a lacZ reporter gene (encoding a nuclear localization signal) or to a gfp re-
porter gene. Transgenic animals were created with the resulting constructs, and the expression
patterns of lacZ or gfp determined.
Section 3.3.1 Generation of lat-1::LacZ transgenic animals
Two different lengths of the lat-1 promoter were fused to a lacZ reporter gene as described in
Figure 3.4. The first lat-1 promoter contains ~1.5kb of the 5 regulatory region of lat-1, and a
minimal region of exon 1. The exon 1 sequence contains four amino acids of the open reading
frame, which was fused in-frame to the reporter gene lacZ-gfp from plasmid pPD96.04 (http://
www.ciwemb.edu; [97]; this plasmid is the 1.5kb lat-1 construct, [P 1.5kb lat-1::Exon1(lat-
1)::LacZ-gfp], and the resulting plasmid designation is pAA411. The second lat-1 promoter con-
tains ~3kb of the 5 regulatory region of lat-1, also contains a minimal region of exon 1 with
three amino acids which was fused in-frame to reporter gene lacZ-gfp to give plasmid ~3kb lat-
1 construct, [P 3.0kb lat-1::Exon1(lat-1)::LacZ-gfp] and designation pAA412. These two lat-1
promoters were compared to find out if there was any difference in terms of expression patterns. 
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The ~1.5kb lat-1 construct or ~3kb lat-1 construct were co-injected with rol-6(su1006) [pRF4],
as a selectable marker into wild-type worms, while in the negative control the lacZ reporter plas-
mid, without an insert, [pPD96.04] was co-injected with pRF4 into wild-type worms. Transgen-
ic animals generated were identified by the roller phenotype, and none of these transgenic
animals showed green fluorescence when using appropriate GFP filters. Three independent sta-
ble lines were obtained from these different injected F0 animals for each combination of plas-
mids.
Stable lines were obtained from injection of the ~1.5kb and ~3kb lat-1 constructs for 13%-33%
and 13%-26% respectively of the transgenic F1, while the negative control LacZ-gfp gave stable
lines from 7%-16% of transgenic F1 (Table 3.3). 
Figure 3.4 Transcriptional fusions of lat-1 gene promoter to lacZ-gfp. A) The cartoon shows an in-frame
transcriptional fusion of lat-1 gene, with ~1.5kb lat-1 promoter (5 regulatory region) including a minimal region of exon 1
with four amino acids, which was then fused to reporter gene; green fluorescent protein (gfp) with nuclear localisation signal
and E-galactosidase (lacZ). The resulting plasmid from this fusion is [P 1.5kb lat-1::Exon1(lat-1)::LacZ-gfp] designated as
[pAA411] (see section 2.7.1). B) The cartoon shows in-frame transcriptional fusion of lat-1 gene. ~3kb lat-1 promoter (5
regulatory region) was fused to a minimal region of exon 1 with three amino acids, which was then fused to a reporter gene
encoding green fluorescent protein (gfp) with nuclear localisation signal and E-galactosidase (lacZ), resulting in the plasmid
[P 3kb lat-1::Exon1(lat-1)::LacZ-gfp] designated as[pAA412] (see section 2.10.1).
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Section 3.3.2 Generation of lat-1::GFP transgenic animals
In order to follow the expression pattern of lat-1 gene during development, the lat-1 promoter
(~1.5kb, 5regulatory region of lat-1) which contains minimal region of exon 1 with four amino
acids was transcriptionally fused in-frame to the reporter gene gfp; this plasmid is ~1.5kb gfp
construct [P 1.5kb lat-1::Exon1(lat-1)::gfp] [pAA410]. Figure 3.5 shows a schematic of the tran-
scriptional gfp fusion with the lat-1 gene promoter.
Table 3.3 Characterisation of lat-1 reporter and pRF4 transgenesis. 
DNA injected No of transgenic (F1) No of stable line (S) % stability (S/F1)
[P 1.5kb lat-1::Exon1(lat-1)::LacZ-
gfp;rol-6][pAA411;pRF4] 
18 4 22%
24 8 33%
15 2 13%
[P 3.0kb lat-1::Exon1(lat-1)::LacZ-
gfp;rol-6] [pAA412;pRF4]
23 6 26%
16 2 13%
19 4 21%
[LacZ-gfp;rol-6][pPD96.04;pRF4]
19 3 16%
17 2 12%
15 1 7%
The plasmid DNA of ~1.5kb lat-1 construct, ~3kb lat-1 construct, or gfp-lacZ with rol-6(su1006) at concentration of 50-
100ȝg/m1. Transgenic animals were identified at L3 stage by the roller phenotype. The number of transgenic( F1), and
stable line (S) from each injected animal is shown; a stable line is defined as a line where the roller phenotype propagates
through three generations. Percentage stability (%) is the number of stable lines, divided by number of transgenic (F1)
from each injected animal.
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The reporter fusion ~1.5kb gfp construct was co-injected with mCherry (unc-54::mCherry des-
ignated as pAA414, the body-wall muscle expression of mCherry GFP) as a selectable marker
into wild-type (N2 Bristol) worms, while plasmid pEGFP-N1, containing the GFP construct
without a relevant promoter as a negative control, was co-injected with mCherry (a positive con-
trol for transgenesis) into wild-type worms. Transgenic animals obtained were identified by red
fluorescent body-wall muscle, and the negative control only showed red fluorescence in body-
wall muscle, with no green fluorescence. At least 2-3 independent stable lines were generated
Table 3.4 Characterisation of lat-1 reporter and unc-54::mCherry . 
DNA injected No of transgenic F1 No of stable line (S) % stability (S/F1)
[P 1.5kb lat-1::Exon1(lat-1)::gfp;unc-
54::mCherry] [pAA410;pAA414].
27 9 33%
21 3 14%
17 3 18%
[gfp;unc-54::mCherry] [pEGFP;pAA414]
23 5 22%
14 2 14%
10 0 0%
The plasmid DNA of ~1.5kb gfp construct or GFP plasmid with mCherry was injected into the syncytial gonad of wild-
type worms at the concentration of 50-100ȝg/m1. Transgenic animals were identified by red fluorescent body-wall
muscle using mCherry red filter. The number of transgenic( F1), and stable line (s) from each injected animal is shown; a
stable line is defined as a line where selectable marker mCherry transgene propagates through three generations .
Percentage stability (%) is the number of stable lines divided by number of transgenic (F1) from each injected animal. 
Figure 3.5 Transcriptional gfp fusion with the lat-1 gene promoter.  The cartoon shows an in- frame
transcriptional fusion of lat-1 gene with ~1.5kb lat-1 promoter (5 regulatory region) that includes a minimal region
of exon 1 with four amino acids, which was then fused to a reporter gene encoding green fluorescent protein (gfp),
that leads to a resulting plasmid [P 1.5kb lat-1::Exon1(lat-1)::gfp] designated as [pAA410] (see section 2.10.1).
Ademola Adenle   Section 3.3.2
Page 94
from three different injected F0 animals for each plasmid combination..
Transgenic stable lines obtained from injection of ~1.5kb gfp construct account for 14%-33%
of the transgenic F1, while the negative control GFP plasmid account for 14%-16% of the trans-
genic F1 (Table 3.4). 
Section 3.3.2.1 Integration of extrachromosomal arrays by J-irradiation
All the transgenic animals obtained from micro-injection of either ~1.5kb lat-1 construct and
~3kb lat-1 construct and ~1.5kb gfp construct including negative controls are said to be stable
as they transmit the transgene beyond the F2 generation, presumably as an extrachromosomal
array. However, it is important to characterise lines which have a stably integrated chromosom-
al copy of the transgene, as this will give more consistent transmission in homozygous animals,
and also may lead to more consistent expression. At least one line each from all the three lines
generated from injection of individual construct was J-irradiated (section 2.7.4). The strains cre-
ated from integrated lines were bred against wild-type five times to remove any unwanted mu-
Table 3.5 Integration of LacZ reporter transgenes. 
Integrated strain % transmission ( rol-6(su1006) Brood size Adult assayed (n)
[P 1.5kb lat-1::Exon1(lat-1)::LacZ-
gfp;rol-6][pAA411;pRF4]
DA311 100% 285±7 10
DA312 100% 272±10 10
[P 3.0kb lat-1::Exon1(lat-1)::LacZ-
gfp;rol-6] [pAA412;pRF4]
DA411 100% 281±5 10
DA412 100% 291±13 10
[LacZ-gfp;rol-6][pPD96.04;pRF4]
DA511 100% 276±9 10
Strains are the integrated lines created from transgenic animals for micro-injection of individual reporter constructs;
~1.5kb lat-1 construct , ~3kb lat-1 construct, LacZ-gfp. The percentage of transmission for the integrated strains was
measured for the adult transgenic offspring that transmit the roller phenotype. Brood size is the total number of offspring
that exhibits roller phenotype per individual transgenic adult animal (Mean±Standard deviation); an adult hermaphrodite
was singly plated and transferred every day, and offspring with roller phenotypes were counted. n is the number of adult
transgenic animal assayed for the study 
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tation from background.
The lat-1::lacZ reporter gene constructs gave two integrated strains each and transmitted the in-
tegrated array at 100% with relative brood sizes as described in Table 3.5. The lat-1::gfp reporter
gene construct also gave two integrated strains and transmits 100% integrated array with rela-
tive brood sizes as shown in Table 3.6. In the negative controls, each reporter gene (lacZ or gfp)
has only one integrated strain and transmits the integrated array to 100% offspring. The results
showed that the strains of lacZ reporter gene and gfp reporter gene obtained after irradiation
transmit the array to all of the offspring and are, therefore, integrated arrays.
Section 3.3.2.2 Characterisation of reporter gene expression
Section 3.3.2.2.1  Expression pattern of lat-1::GFP or lat-1::LacZ during embryonic 
development
To study the activation of the lat-1 promoter during egg development, transgenic adult her-
maphrodites were sliced open and eggs examined over time under the appropriate gfp filter as
described in section 2.4.1. Egg development was followed from 40-cell stage; gastrulation pe-
riod all through to 3-fold stage for the transgenic worm carrying ~1.5kb, 5 regulatory region
Table 3.6 Integration of GFP reporter transgenes. 
Integrated strain % transmission ( mCherry) Brood size Adult assayed (n)
[P 1.5kb lat-1::Exon1(lat-1)::gfp;unc-
54::mCherry] [pAA410;pAA414]
DA211 100% 297±4 10
DA212 100% 280±8 10
[gfp;unc-54::mCherry] 
[pEGFP;pAA414]
DA920 100% 269±3 10
Strains are the integrated lines created from transgenic animals for micro- injection of individual reporter construct;
~1.5kb gfp construct or GFP plasmid. The percentage of transmission for the integrated strains was measured for the adult
transgenic offspring that transmit selectable marker mCherry transgene. Brood size is the total number of offspring that
transmits mCherry transgene per individual transgenic animal (Mean±Standard deviation); an adult hermaphrodite was
singly plated and transfered everyday, and offspring with mCherry were counted. n is the number of adult transgenic
animal assayed for the study
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fused to gfp reporter gene, while different stages of the transgenic worms carrying either ~1.5kb
or ~3kb, 5 regulatory region fused to lacZ reporter gene were stained for ȕ-galactosidase ex-
pression, as it was not possible to follow egg development for histochemical staining (section
2.7.5). In the negative control, transgenic worms either carrying gfp or lacZ without insert were
treated as described above. 
Expression of the ~1.5kb and ~3kb, 5 regulatory regions fused to lacZ reporter gene respec-
tively, was examined for any difference in the expression pattern. In 3-fold stage embryos, ȕ-
galactosidase expression detected corresponds to the positions of gut cell (Figure 3.7A). The ex-
pression pattern observed in ~1.5kb promoter of lat-1 was similar to ~3kb promoter of lat-1,
therefore both promoters drive reporter gene at the embryonic stage. Results from the negative
control showed that ȕ-galactosidase expression was not detected, showing that rol-6 transgene
did not cause spurious expression of the transgene by itself (data not shown).
The expression pattern of the 1.5kb, 5 regulatory region fused to the gfp reporter gene during
Figure 3.6 Embryonic expression pattern of lat-1::GFP. The diagram shows the photographs of different
stages of embryo development of transgenic animal carrying ~1.5kb, 5end of lat-1 fused to gfp reporter gene. Embryos
were dissected from integrated lines of transgenic animals . All images were taken under GFP filter and visible DIC using
the same focal point (A) embryo at 40-cell stage before GFP detection (post-fertilization) (B) GFP fluorescence was first
detected at the position of gut cells (white arrow), 60 mins post-fertilization (C) a dorsal sheet of gut cells (white arrow)
intercalation (D) migration of dorsal gut cells (white arrow) (E) beginning of gut cells expression at 2-fold stage with
twitching (white arrow) (F) gut cells expession at 3-fold stage (white arrow). Scale bar is 25ȝm, and all images were cap-
tureed at 40x magnification.
A B C
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embryonic development was compared with either ~1.5kb or ~3kb, 5 regulatory region fused
to lacZ reporter gene. During egg development, gfp fluorescence corresponding to gut cell was
first detected 1hr post-fertilization (Figure 3.6B), before epidermal morphogenesis stage, then
became higher in both intensity and number of fluorescent cells during later embryogenesis.
Sixty minutes later, dorsal gut cells start intercalation during the early stage of epidermal enclo-
sure (Figure 3.6C). Development of dorsal cell began toward the end of epidermal enclosure al-
most an hour later before the 2-fold stage (Figure 3.6D). At the 2-fold stage, the gut was
apparent, and could be clearly seen at the 3-fold stage. However, twitching of the embryo during
the 2 or 3-fold stage prevents extended exposures of gut cells. 
When compared to expression pattern of either ~1.5kb or ~3kb, 5 regulatory region fused to
lacZ reporter gene, staining of ȕ-galactosidase corresponding to gut cell was consistently ob-
served in 3-fold stage of embryo. From this experiment, the same expression pattern was no-
ticed as observed in gfp embryonic expression. These data showed that the activity of the lat-1
promoter was detected at different stages of embryonic development, particularly in gut cells.
The study of embryo during development for the negative control (gfp without an insert) did not
show any fluorescence, indicating there was no effect of mCherry transgene (data not shown).
Section 3.3.2.2.2  Post embryonic expression of lat-1 gene promoter
The expression of the lat-1 gene promoter was examined in transgenic animals using two dif-
ferent lat-1 promoters, containing ~1.5kb and ~3kb of the 5 regulatory region fused to lacZ re-
porter gene respectively. The aim of this experiment was to find out any difference in the
expression pattern between ~1.5kb and ~3kb promoter of lat-1. Integrated lines obtained from
individual reporter constructs were analysed for the expression pattern of lacZ. 
In the post-embryonic stages, a tail neuron cell and gut cell were observed in L1-L3 stages. A
typical example of L1 stage is represented in Figure 3.7B-C. From L4 to adult stage, ȕ-galac-
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tosidase expression was strong in gut cells (Figure 3.7D-E). In the negative control, transgenic
animals carrying lacZ and rol-6 did not yield gut staining, indicating that rol-6 transgene did not
affect expression pattern (Figure 3.7F). The results show no difference in the expression pattern
between ~1.5kb, 5end of lat-1 and ~3kb, 5end of lat-1. These data showed that both ~1.5kb
and ~3kb promoters of lat-1 were individually capable of driving expression of reporter gene
lacZ in the transgenic animals, therefore, they are both functional promoters.
The ~1.5kb promoter lacZ reporter construct was compared with ~1.5kb promoter fused to gfp.
In ~1.5kb or ~3kb lacZ fusion, L1-L3 stage showed the same level of expression in gut and two
tail neuron cells, but ~1.5kb gfp fusion showed strong gut cell expression in the body of L1-L3
stages. But, in the L4 to adult stage, the intensity of gfp fusion expression started diminishing
restricting the expression to gut with two tail neurons identified to be PVQL and PVQR in the
posterior region of the adult tail as shown in Figure 3.8D&F. Identification of the two tail neu-
rons was based on the criteria set in the worm atlas for cell identification. A similar expression
pattern of the lacZ fusion was seen in L4 to adult stage worms (Figure 3.7). The negative control
experiment only showed mCherry fluorescent body-wall muscle expression of the animals that
were transgenic for gfp vector and mCherry, indicating that no effect was caused by the mCher-
ry transgene (Figure 3.8G). Therefore, the result shows a distinct expression pattern for gut cells
of all stages with the gfp transcriptional fusion driven by ~1.5kb promoter of lat-1 (Figure 3.8A-
G).
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Figure 3.7 Expression pattern of lat-1::LacZ in wild-type. Integrated lines of transgenic animals carrying
~1.5kb, 5end of lat-1 reporter construct and ~3kb, 5end of lat-1 reporter construct were created respectively as described
in Table 3.5. and stained for ȕ-galactosidase (see section 2.4.7). (A ) A typical example of ~1.5kb or ~3kb with ȕ-galactos-
idase staining of gut cell (white arrow). (B) An example of L1 stage of ~1.5kb ȕ-galactosidase expression showing tail neu-
ron cell (blue arrow) and gut cell at the beginning of gut (white arrow). (C) An example of L1 stage ~3kb showing similar
expression pattern. (D) L4 stage of ~1.5kb reporter expression of tail neuron cell (blue arrow), gut cell (white arrow), and
the body twist of the animal is due to expression of selectable marker roller phenotype. (E) The L4 stage of ~3kb reporter
construct shows similar expression pattern with L4 stage of ~1.5kb reporter construct. (F) The L4 stage of transgenic animal
carrying lacZ and roller phenotype, but no expression of ȕ-galactosidase. (G) The reporter expression of ~1.5kb construct
at adult stage (anterior side) showing gut cell (white arrow). (H) The reporter expression of ~1.5kb construct at adult stage
(posterior side) showing gut cell (white arrow), tail neuron cell (blue arrow), the twist in both pictures was due to roller
phenotype. (I) The adult stage (anterior side) and (J) adult stage (posterior side) of ~3kb reporter construct similar to ex-
pression pattern of ~1.5kb reporter construct. Scale bar is 50 ȝm. All images were captured at 100x magnification.
A B C
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Figure 3.8 Expression pattern of lat-1::GFP in wild-type. Integrated lines of transgenic animals carrying
~1.5kb, 5end of lat-1 reporter construct was created as described in Table 3.6. All images were captured at 100x magnifi-
cation for GFP expression under GFP filter, mCherry filter and visible DIC filter for pseudo-colour. (A & B) An example
of L1 stage showing intensely fluorescent gut cells (yellow arrow) with developing tail neuron (red arrow), B image captured
at higher magnification. (C) The L4 stage (anterior side) showing gut cell (yellow arrow). ( D) The L4 stage (posterior side)
showing gut cell (yellow arrow) and two tail neuron cells identified as PVQL and PVQR ( two red arrows respectively). (E)
The adult stage (anterior side) showing a gut cell (yellow arrow). (F) The adult stage ( posterior side) showing two tail neu-
rons ( PVQL and PVQR) (two red arrows respectively) and gut cell (yellow arrow). (G) The L4 stage of transgenic animal
carrying pEGFP and mCherry, image captured under GFP filter (black), image captured under mCherry filter showing body-
wall muscle expression of mCherry and image captured under visible DIC showing autofluorescence. Scale bar is 50 ȝm,
all images captured at 100x, only A captured at 40x magnification
F G
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The result showed overlapping expression pattern between the lacZ and gfp fusion constructs.
Expression pattern in the lacZ and gfp fusions with the lat-1 promoter in L1-L3 stage worms
showed tail neuron and gut cell from the begining to the end of intestine (Figure 3.7 & Figure
3.8 A-B). The lacZ transcriptional fusion of ~1.5kb and ~3kb promoter of lat-1 were detected
in the same pattern at all developmental stages, from embryos all through to the adult stages.
However, ȕ-galactosidase and GFP are detected in intestinal cells of each developmental stage
of all transgenic animals, and coupled with tail neuron cells detection which are obvious at the
adult stage of transgenic animals. In summary, these results showed the same significant level
of expression of ~1.5kb, ~3kb, 5 end of lat-1 lacZ fusion and ~1.5kb, 5end of lat-1 gfp fusion.
Hence, these data showed that all the lat-1 promoter constructs tested are functional and confer
a similar pattern of expression. Thus, the ~1.5kb lat-1 promoter construct contains sufficient in-
formation to yield correct tissue-specific and developmental expression.
Section 3.4 Effect of B0457 cosmid
Section 3.4.1 B0457 cosmid rescues the lat-1 (ok1465) allele
The lat-1(ok1465) allele has a deletion of the lat-1 gene and ~95-98% of lat-1(ok1465) ho-
mozygous worms arrest or die before adulthood, with only ~2-5 adult offspring per animal (see
section 3.3.1). However, it is unclear if this lethality is due to the deletion in the lat-1 gene, or
to adventitious mutations introduced during the process of mutagenesis to create this allele.
Hence, it is necessary to complement the lethality of lat-1(ok1465) worms in order to prove that
the lat-1 gene is responsible for the phenotype. The B0457 cosmid contains the full-sequence of
the lat-1 gene, and was tested to see if it rescues embryonic lethality of lat-1(ok1465) worms
before determining functional regions within the cosmid. Therefore, B0457 cosmid DNA and
CFP were co-injected into lat-1 worms, while CFP selectable marker only was injected into lat-
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1 worms as a negative control. 
The idea of injecting CFP is to ensure that rescue of lat-1 worms is not caused by the effect of
CFP. Five different injected F0 worms gave rise to independent stable lines from injection of
B0457 and CFP, as indicated by blue fluorescent body-wall muscle expression from early em-
bryogenesis to adulthood. In the negative control, seven different injected F0 worms with CFP
produced blue fluorescent embryos, with six transgenic F1 reaching adulthood without produc-
ing any stable lines (Table 3.7). After injection with the plasmid CFP, there were six surviving
adults from >80 transgenic embryos. The statistical significance of the difference in proportion
of embryos that reached adulthood after injection of B0457;unc-54::cfp or CFP, was deter-
Table 3.7 Effect of B0457 Cosmid and unc-54::cfp DNA on lat-1 (ok1465) worms. 
DNA injected Transgenic embryo (F1)  Transgenic adult (F1) Stable transgenic line
B0457;unc-54::cfp 20 20 18*
12 12 6
26 26 15
23 23 17
27 27 20
 Total 108a 108a 76
unc-54::cfp (CFP) 8 0 0
10 1 0
6 0 0
12 1 0
18 2 0
24 2 0
9 0 0
 Total 87b 6b 0
DNA was injected into the syncytial gonad of lat-1 (ok1465) worms at a concentration of 50-100µg/ml, and transgenic
offspring were determined by the presence of blue fluorescence in the body wall; uninjected animals yielded no offspring
with blue fluorescence (data not shown). The number of transgenic embryos, transgenic adults and stable transgenic lines
from each animal is shown. The statistical significance of the proportion of transgenic worms surviving to adulthood
between B0457;unc-54::cfp and CFP was determined by a Chi squared test, and the difference between a and b was found
to be highly significant (P<0.05). * includes a stable line with 100% transmission of the array.
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mined by F2 analysis, and found to be statistically significant (P<0.0001). Therefore, the B0457
cosmid rescued the lethality of lat-1(ok1465) worms. 
Section 3.4.1.1 Stability of unc-54::cfp transgene on lat-1 (ok1465) worms
The stability of the CFP transgene was investigated for five independent stable lines obtained
in Table 3.7. Each stable line yielded one strain (DA601-605), as named in Table 3.8, and the
strains transmit the CFP to progeny at between 95%-100%. All the strains were examined for
brood size and the percentage of transmission of the extrachromosomal array was assayed by
measurement of the blue fluorescence from CFP.
Strain DA601 is the only tested stable line that transmits 100% CFP transgene with brood size
of 282±6 from all 18 lines obtained, other tested stable lines transmit below 100% (Table 3.8).
The result shows that the level of stability from five independent stable lines differ from one
another as reflected in the percentage of transmission of CFP transgene and brood sizes. One
line was examined to ascertain if the extrachromosomal array introduced via microinjection is
integrated into a chromosomal site in the transgenic worms. The transgenic stable strain that
Table 3.8  The unc-54::cfp transgene stability . 
 Stable transgenic strain % transmission ( CFP) Brood Size Adult assayed
DA601 100% 282±6  20
DA602 97% 272±4  10
DA603 95% 257±12  10
DA604 95% 276±7  15
DA605 98% 284±10  15
Strain DA601-DA605 are the trangenic stable lines obtained from injection of unc-54::cfp transgene. The percentage of
transmission was measured for the adult transgenic offspring that transmit CFP (blue fluorescence); the number of
transgenic adult was divided over the total number of offspring including offspring without cfp (blue fluorescence). Brood
size is the total number of offspring per individual animal (Mean ± Standard ); an adult hermaphrodite was singly plated
and transfered everyday, offsprings with CFP (blue fluorescence) were counted. n is the number of adult transgenic animal
assayed for the study. 
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shows 100% transmission of the array was chosen for the outcross analysis. Wild-type males
 
 
 
  
 
 
 
    
  a) F0         [lat-1(ok1465)-/- (B0457;unc-54::cfp)]   x            [+/+ lat-1(N2)] 
 F1            [ lat-1(ok1465) +/- (B0457;unc-54::cfp)+/-]    x                [ +/+ [N2]
 Select for blue fluorescent
F2                                              [lat-1(ok1465)+/- (B0457; unc-54::cfp)+/-]
 
 [lat-1(ok1465)+/+ ( B0457;unc-54::cfp)+/-]
 
Select for blue fluorescent
 F3          78% (1126) (B0457; unc-54::cfp) positive           22% (310) (B0457;unc-54::cfp) negative
 
b) F0            [lat-1(ok1465)-/- (B0457;unc-54::cfp)] x              [+/+ lat-1(N2)] 
Select for blue fluorescent
F1                [ lat-1(ok1465) +/- (B0457; unc-54::cfp)+/-] x          [+/+ [N2] 
F2                                        [lat-1(ok1465) +/- (B0457;unc-54::cfp) +/-]    x       [    [+/+ [N2] 
                                            [lat-1(ok1465) +/+ ( B0457;unc-54::cfp) +/-]  x            [+/+ [N2] 
F3                                                                  51% (576) (B0457;unc-54::cfp) positive 
Figure 3.9 Segregation of (B0457;unc-54::cfp) transgene. The figure shows annotated diagram of outcross anal-
ysis between B0457, unc-54::cfp on lat-1 (ok1465) worms and N2-wildtype. a) F0 represents the start of the cross for L4
transgenic hermaphrodites (-/-) against young N2 wild-type (+/+). Blue fluorescent transgenic male progeny F1 (+/-) was
selected and was crossed to L4 hermaphrodite N2 wild-type (+/+). F2 blue transgenic hermaphrodite progeny (+/-,+/+)
was selected but on two different chromosomes and self-fertilize, leading to a total number of 1126 progeny blue fluorescent
(78%) and a total number of 310 progeny non-blue fluorescent (22%). b) F0 represents the start of the cross for L4 transgenic
hermaphrodites (-/-) against young N2 wild-type (+/+). Blue fluorescent transgenic male progeny F1 (+/-) was selected
and was crossed to L4 hermaphrodite N2 wild-type (+/+). F2 blue fluorescent transgenic male progeny (+/-,+/+) was se-
lected but on two different chromosomes and was crossed to L4 hermaphrodite N2 wild-type (+/+) producing total
number of 576 male progeny 51% (+/-). Five individual sets of experiment were set up for all the crosses and this was
repeated two times. 
Hermaphrodite male
Self-fertilize
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(N2 Bristol) were crossed against transgenic hermaphrodites with B0457;unc-54::cfp, produc-
ing a total number of 568 males and 556 hermaphrodites.
Resulting males showing body wall fluorescence (i.e. unc-54::cfp) were crossed to wild-type
hermaphrodite (N2 Bristol). From the progeny of this cross, L4 transgenic hermaphrodites
showing body wall fluorescence were placed individually on plates and allowed to self-fertilize.
The progeny were screened for the presence and absence of the blue fluorescence, and the out-
come of cross analysis for the ratio was calculated by F2- test to determine whether the results
fit or deviate from Mendelian genetics. There were 1126 blue fluorescent transgenic hermaph-
rodites (78%) and 310 non-fluorescent wild type hermaphrodites (22%), which is not signifi-
cantly different from the expected Mendelian ratio of blue fluorescent (75%) and non-
fluorescent (25%) (F2- test, P>0.05). Another cross was done in parallel by taking heterozygous
F2 males with B0457;unc-54::cfp and crossed to wild-type hermaphrodites. The offspring
(1130) had 576 male offspring that were blue-fluorescent (51%), which is not significantly dif-
ferent compared to an expected result of 50% (F2- test, P>0.05). Five individual sets of experi-
ment were set up for all the crosses and repeated two times to confirm the same result. The
results show that this particular stable line exhibits Mendelian segregation of array and, there-
fore, is integrated.
Section 3.4.2 Phenotypic effect of B0457 cosmid and CFP on lat-1 (ok1465) worms
The phenotypic effect of the B0457 cosmid and CFP on lat-1 (ok1465) was studied to find out
if the micro-injection of the transgene rescued lat-1(ok1465) brood size and defecation cycle de-
fects. This analysis of transgene should define the role of the B0457 cosmid (containing the full
sequence of lat-1 gene) in rescuing of lat-1(ok1465) phenotypes. Therefore, it is important to
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characterise the rescued lat-1 animals and compare with wild-type. DA601, an integrated line
(Table 3.8) containing B0457 and CFP on the lat-1(ok1465) background, was examined for de-
velopmental lethality, brood size and defecation cycle. 
Section 3.4.2.1  Effect of B0457 on developmental lethality in lat-1(ok1465)
Developmental lethality was determined by counting the number of embryos per animal for a
period of seven days until they stopped laying eggs, and comparing this to the number of adults
produced from these embryos. The number of embryos and adults counted from B0457;unc-
54::cfp on lat-1(ok1465) worms and wild-type worms were not significantly different (286±6
and 304±14), whereas in the lat-1 (ok1465), only 3 offspring per animal reached adulthood (Ta-
ble 3.9). P values were calculated relative to wild-type by t-test analysis to determine level of
significance. N2 worms gave rise to 304±14 offspring per adult, while the lat-1 worms showed
a slightly reduced number of embryos laid (220±13; P<0.05), and the number of surviving
adults was greatly reduced, at 3±8 offspring per adult: this was significantly different from N2
worms (P<0.0001). However, lat-1 animals carrying the B0457 cosmid laid 286±6 embryos per
animal (P<0.05, compared to lat-1), and the number of surviving adult offspring per animal was
286±6 (P<0.0001, compared to lat-1). Thus, lat-1 animals show small numbers of surviving
adult offspring due to lethality during embryogenesis and larval stages (Section 3.2.2). Lat-1 ho-
mozygotes carrying the B0457 cosmid show rescue of this phenotype close to the levels seen in
N2 worms. Since it has been shown that the effect on survival is due to the B0457 cosmid, and
not to the CFP marker gene (Section 3.4.1), this shows that the B0457 cosmid rescues the effects
of the lat-1(ok1465) allele on embryonic and larval lethality. 
Section 3.4.2.2  Effect of B0457 on defecation cycle in lat-1(ok1465) worms
Lat-1(ok1465) worms have a lengthened defecation cycle, with a pBOC-pBOC interval of 80
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seconds (DRB, unpublished data). This defecation cycle is abnormal when compared to wild-
type, which defecate every 45 seconds [64]. The effect of B0457 cosmid on lat-1 (ok1465)
worms was investigated to find out if it rescued the defecation cycle defect. Defecation cycle
analysis (pBoc to pBoc (posterior body muscle contraction)) was carried out as described [63],
[98]. Single L4 hermaphrodites were incubated over-night at 20ºC on bacteria seeded plate and
studied for defecation using Etho [98] software at 20ºC room. The lat-1 animals showed a sig-
nificantly prolonged defecation cycle (80±10 seconds), compared to wild-type worms (45±3
seconds, P<0.0001). lat-1(ok1465) animals that were transgenic for B0457 had a reduced defe-
cation cycle compared to the lat-1(ok1465) parental stock (50±7, P<0.0001). The N2 worms and
B0457 on lat-1 animal has a defecation cycle close to the level of wild-type as described in other
literature [64], [99] (Table 3.9). 
These data show that lat-1(ok1465) worms transgenic for both cosmid B0457 and unc-54::cfp
show rescue of the defecation cycle defect in lat-1(ok1465) worms. It was not possible to obtain
lat-1(ok1465) worms with CFP, as a result of the low survival of these worms (Section 3.4.1),
and so it is not possible to prove that the rescue of the defecation cycle defect is due to the B0457
cosmid and not the CFP construct. However, in view of the fact that it is the B0457 cosmid, and
not the CFP construct, that rescues the lethality in the lat-1(ok1465) worms, it is likely that the
Table 3.9 The B0457 cosmid rescues lat-1(ok1465) phenotypes. 
Genotype No of embryo Brood size Defecation cycle (s) Adults assayed (n)
N2 304±14 304±14 45±3 10
lat-1(ok1465) 220±13 3±8b 80±10b 10
Strain DA 601 286±6 286±6b 50±7b 15
All the genotypes are described above. Table depicts the Mean ± Standard deviation of brood sizes (defined as surviving
adult progeny) and defecation cycle of all the genotypes; N2 wild-type, lat-1(ok1465), Strain DA 601 at 20°C. Brood size
is defined as total number of progeny that reached adulthood over the life time of a single hermaphrodite. P values were
calculated between lat-1 and N2, and Strain DA 601 and lat-1, and P<0.05 is indicated (b). (n) is the number of adult
assayed.
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defect in defection cycle is rescued by the B0457 cosmid also. 
In summary, these results show significant difference in terms of increase in brood size and
length of defecation cycle in lat-1(ok1465) worms that had been injected with the B0457 cos-
mid. Presence of lat-1 gene on B0457 cosmid is likely to be responsible for the rescue of lat-1
(ok1465) worms phenotype, even though some other genes are present on B0457 cosmid.
Hence, these data suggest that it is the lat-1 gene deletion that is important in altering embryonic
developmental processes and defecation cycle control in the lat-1 (ok1465) worm.
Section 3.5 Analysis of lat-1 gene
Section 3.5.1  Full-length lat-1a cDNA rescued the lat-1(ok1465) worms
The B0457 cosmid, containing the full sequence of the lat-1 gene, rescued the lethality of lat-1
(ok1465) worms (Figure 3.3A-B), but this experiment did not prove whether it was the presence
of the lat-1 gene, or another gene on the B0457 cosmid, that was responsible for the rescue of
lethality in lat-1(ok1465) worms. Therefore, the hypothesis that the lat-1 gene was responsible
for rescue of the lat-1(ok1465) phenotype was investigated by introducing a lat-1 cDNA into
these worms. There are three lat-1 transcripts arising from differential exon splicing, designated
lat-1 a-c; the c transcript is likely to be non-functional, and lat-1a was arbitrarily selected for
Figure 3.10 Expression construct for ful-length lat-1a cDNA. The cartoon shows in-frame translational fusion
of lat-1a cDNA to the reporter gene, GFP. ~1.5kb of the 5end of lat-1promoter contains the endogenous start codon ATG
(black arrow) in the middle of exon 1 (yellow) with an intron (black line) and exon 2 (black box) with lat-1a cDNA (blue
box) fused to green fluorescent protein GFP (green box), resulting construct is designated as pAA401. ( see section 2.10.2)
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testing. A cartoon of the lat-1a construct for transgenesis is shown in Figure 3.10; the construct
is driven by ~1.5kb of the 5end of endogenous lat-1 promoter, with lat-1a exons 1 and exon 2
fused to the remainder of the lat-1a cDNA, and fused in-frame at the C-terminus with GFP. This
plasmid is full-length lat-1a cDNA [P 1.5kb lat-1::FL(lat-1a cDNA)::gfp], designated as
[pAA401] (Figure 3.10). 
The full-length lat-1a cDNA was co-injected with mCherry (unc-54::mCherry, pAA414) as a
selectable marker into lat-1 (ok1465) worms. The mCherry was injected into lat-1 (ok1465)
worms as a negative control to ensure that any rescue effect is not caused by the marker. 
Transgenic worms were readily identifiable by red fluorescent body-wall muscle expression us-
ing the mCherry red filter. Four different injected F0 worms gave rise to independent stable lines
from co-injection of full-length lat-1a cDNA and mCherry. In the negative control, three differ-
Table 3.10 Effect of full-length lat-1a cDNA and mCherry DNA on lat-1(ok1465) worms. 
DNA injected Transgenic embryo (F1) Transgenic adult (F1) Stable transgenic line
[P1.5kblat-1::FL(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA401;pAA414]
27 27 13*
25 25 14
17 17 9
21 21 12
Total 90a 90a 48
[unc-54::mCherry] [pAA414]
16 1 0
13 0 0
22 2 0
Total 51b 3b 0
The plasmid DNA from full-length lat-1a cDNA or mCherry construct was injected into the syncytial gonad of lat-
1(ok1465) worms at a concentration of 50-100µg/ml. Transgenic offspring obtained were characterised by the presence
of red fluorescence in the body wall, while uninjected animals yielded no offspring with red fluorescence (data not
shown). The number of transgenic embryos, transgenic adults and stable transgenic lines from each animal is shown.
The statistical significance of the proportion of transgenic worms surviving to adulthood between full-length plasmid
and mCherry plasmid was determined by a Chi squared test (F analysis) and difference between a&b was found to be
significant (P<0.05). * includes a stable line with 100% transmission of array.
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ent F0 worms injected with mCherry produced 51 red fluorescent embryos, with only 3 trans-
genic F1 reaching adulthood, with none producing transgenic offspring (Table 3.10). The
statistical significance of the difference in proportion of transgenic embryo that reached adult-
hood after injection of full-length plasmid or mCherry plasmid was determined by F analysis,
and found to be stastistically significant (P<0.0001). This result shows that when the lat-1a fu-
sion protein was driven by the endogenous lat-1 promoter, it rescued the lethality of lat-
1(ok1465) worms. This result shows that the lat-1a protein is capable of rescuing the lethality
of lat-1(ok1465) worms, and therefore that the lat-1a protein is functional, and is not adversely
affected by the C-terminal fusion of a GFP sequence. Although this construct was capable of
complementing the lethality in the lat-1(ok1465) strain, there was a failure to detect GFP in the
adult transgenic animals. It can be concluded that the lat-1a-GFP fusion is expressed, but that
the failure to detect GFP fluorescence might be due to low levels of expression of the lat-1a-
GFP fusion protein, or to restricted developmental expression. 
Section 3.5.1.1 Stability of mCherry transgene of lat-1a cDNA on lat-1(ok1465) worms 
Four independent stable lines obtained from micro-injection of full-length lat-1a cDNA were
assayed for stability by measuring red fluorescence from mCherry. Each stable line tested
Table 3.11  The mCherry transgene stability of lat-1a cDNA . 
Stable transgenic strain % transmission (mCherry) Brood size Adults assayed (n)
[P1.5kblat-1::FL(lat-1a cDNA)::gfp;unc-
54::m-cherry][pAA401;pAA414]
DA 101 100% 339±7 20
DA 102 98% 284±6 15
DA 103 99% 282±10 15
DA 104 99% 276±5 15
Each transgenic strain was examined for percentage transmission of the mCherry gene, and brood size as described in the
Table 3.11. The percentage of transmission with mCherry plasmid is the percentage of transgenic adult with red
fluorescence. Brood size is the total number of transgenic adult offspring per individual animal (Mean ± Standard
Deviation). n is the number of adult transgenic animal assayed for the study. 
Ademola Adenle   Section 3.5.1
Page 111
(DA101-104) is named in Table 3.11, and the strain transmits mCherry to progeny at between
98%-100%. 
The result shows that the transgene stability varies between strains as demonstrated in the per-
centage of mCherry positive offspring and brood sizes. Strain DA 101 showed 100% transmis-
sion, and was examined to find out if the extrachromosal array was fully integrated into
chromosomal site of transgenic animal as described in section 3.4.1. The results showed that
strain DA 101 exhibits mendelian inheritance (data not shown); therefore, it is an integrated
line.
Section 3.5.1.2 Phenotypic effect of lat-1a cDNA and mCherry on lat-1 (ok1465) worms
Section 3.5.1.2.1  Effect of lat-1a cDNA on developmental lethality 
The effect of full-length lat-1a cDNA plasmid on lethality in lat-1(ok1465) worms was exam-
ined in strain DA 101 by counting the number of embryos and surviving offspring. Wild-type
worms produced 315±14 adult offspring per animal, while the lat-1(ok1465) produced signifi-
cantly less adult offspring, 3±2. Introducing the lat-1a cDNA increased the number of surviving
adults in lat-1(ok1465) worms to 339±7, significantly increased compared to the lat-1(ok1465)
animals. The number of embryos laid by lat-1 worms was reduced by ~30% compared to N2
worms (222±7; P<0.0001), but was significantly increased by the introduction of the lat-1 trans-
gene (Table 3.12).
Table 3.12 Effect of lat-1a cDNA on lat-1 (ok1465) lethality. 
Genotype No of embryos Brood size Defecation cycle (s) Adults assayed (n)
Wild-type 315±14 315±14 45±7 10
lat-1(ok1465) worm 222±7 3±2b 80±11b 10
Strain DA 101 (Full-length ) 339±7 339±7b 49±4b 20
Wild-type, lat-1(ok1465) worm and Strain DA101 (full-length lat-1a cDNA) were assayed at 20°C. The table depicts the
Mean±Standard deviation for number of embryos, brood size (defined as surviving transgenic adult progeny) and
defecation cycle for each genotypes. P values were calculated between lat-1 (ok1465) worm and wild-type, and between
Strain DA 101 and lat-1(ok1465) worm, and P<0.05 is indicated (b). n is the number of adults assayed.
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Table 3.10 shows that the introduction of the lat-1 and mCherry cDNAs rescued defects in em-
bryo number and developmental lethality in the lat-1(ok1465) line; given that Table 3.10 shows
that the lat-1 plasmid is required to obtain viable offspring, it can be concluded that the mCherry
cDNA is not required for rescue of developmental lethality in this strain, and that the lat-1a
cDNA fusion is sufficient to rescue the developmental lethality of the lat-1(ok1465) line.
Section 3.5.1.2.2  Effect of full-length lat-1a cDNA on defecation cycle 
Defecation cycle lengths were measured for wild-type and lat-1(ok1465) worms, and strain
DA101. The lat-1(ok1465) worms shows significantly prolonged defecation cycles (80±11 sec-
onds) compared to N2 wild-type (45±7 seconds, P<0.0001). Transgenic lat-1(ok1465) animals
with the ful-length lat-1a cDNA had a significant reduction in defecation cycle length compared
to lat-1(ok1465) worms (49±4, P<0.0001), and the length of defecation cycle is close to wild-
type. This result shows that the lat-1a cDNA construct rescued the defecation cycle defect in lat-
1(ok1465) worms. The mCherry plasmid failed to produce transgenic animals as a result of em-
bryo lethality (Table 3.10), and that suggests that the rescue of defecation cycle was due to full-
length lat-1a cDNA, not the mCherry construct. 
In summary, these results show that the absence of the lat-1 gene affects embryonic and larval
developmental processes, and defecation cycle control in the lat-1 (ok1465) worms. Moreover,
these data demonstrate that full-length lat-1a cDNA was capable of rescuing lat-1(ok1465) off-
spring lethality and defecation cycle. Therefore, the lat-1a cDNA encodes a functional lat-1a
protein.
Section 3.5.2 Identification of functional domains of lat-1a
The ability of the lat-1a cDNA to rescue the lethality defect in the lat-1(ok1465) worms provides
a simple assay for the endogenous function of the gene. It is possible to identify the functional
regions within lat-1a cDNA since it is not clear what roles each region plays in the rescue of lat-
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1(ok1465) worms. Therefore, identification of regions required for rescue of lat-1(ok1465)
worms should define functional domains within lat-1a protein, and provide information about
the role of these domains; the investigation has been split up into investigating C-terminal or N-
terminal deletion series of the lat-1a cDNA. 
Section 3.5.2.1  Role of the lat-1a C-terminus
 The lat-1a protein has a relatively large C-terminus for a member of the GPCR family, and  in-
cludes identifiable domains such as the four cysteine domain and the canonical GPCR seven
transmembrane domain. To determine the functional roles of C-terminal domains, a series of C-
terminal truncations were created, terminating at the four cysteine domain (amino acid 870,
4xCys), the seven transmembrane domain (amino acid 790 TM7) and at the end of the first
Figure 3.11 Cartoon depicting C-terminal deletions of lat-1a. The first structure shows the full-length lat-1a cDNA
fused to green fluorescent protein (GFP) which has two functional domains with their relative positions (a) seven transmem-
brane domain (TM7) in black colour at amino acid positions between 548-799 and (b) four cysteine domain (4xCys) in gray
colour at amino acid positions between 815-870. (c) four cysteine domain (4xCys) truncated at amino acid 870. (d) seven trans-
membrane domain (TM7) truncated at amino acid 799. (e) transmembrane domain one (TM1) truncated at amino acid 579.
The dotted lines represent the continuation of full-length lat-1a cDNA towards the native N-terminus in each construct desribed
above.
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transmembrane domain (amino acid 579 TM1) (Figure 3.11). 
Each truncated C-terminal clone was translationally fused in-frame at the C-terminus with GFP
and placed under the control of the ~1.5kb lat-1 promoter used in the previous section (Figure
3.10). The plasmids are designated as 4xCys [P 1.5kb lat-1::4xCys(lat-1a cDNA)::gfp] or
[pAA402]; TM7 [P1.5kb lat-1::TM7(lat-1a cDNA)::gfp] or [pAA403]; and TM1 [P1.5kblat-
1::TM1(lat-1a cDNA)::gfp] or [pAA407]. The effect of C-terminal truncations was tested on the
ability to rescue lat-1(ok1465) worms. Individual C-terminus constructs were co-injected with
Table 3.13  Effect of C-terminal lat-1a cDNA and m-Cherry DNA on lat-1(ok1465) worms. 
DNA injected Transgenic embryo (F1) Transgenic adult (F1) Stable transgenic line
[P1.5kblat-1::4xCys(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA402;pAA414]
19
26
18
19
26
18
10*
13
10
Total 63a 63a
[P1.5kblat-1::TM7(lat-1a cDNA)::gfp;unc-
54::mCherry] [pAA403;pAA414] 
24
17
13
9
4
3
2
1
0
Total 54b 16b 3
[P1.5kblat-1::TM1(lat-1a cDNA)::gfp;unc-
54::mCherry] [pAA407;pAA414] 
18
15
25
0
0
0
0
0
0
Total 58c 0c 0
 [unc-54::mCherry] [pAA414] 18
14
8
10
2
1
0
0
0
0
0
0
Total 50d 3d 0
 The syncytial gonad of lat-1(ok1465) worms were injected at the concentration of 50-100µg/ml with plasmid DNA from
each construct as shown in the Table 3.13. Transgenic offspring obtained were examined for the presence of red
fluorescence in the body-wall muscle. The number of transgenic embryos, transgenic adults and stable transgenic lines
from each animal is shown. The statistical significance of the proportion of transgenic worms surviving to adulthood
between 4xCys plasmid, TM7 plasmid or TM1 plasmid and mCherry plasmid was determined by a Chi squared test, and
the difference between a & d, b&d, was found to be highly significant (P<0.05), whereas there was no significant difference
between c&d (P=0.1613). * includes a stable line with 100% transmission of the array
Ademola Adenle   Section 3.5.2
Page 115
the selectable marker, mCherry, into lat-1(ok1465) worms, while the selectable marker was in-
jected into lat-1(ok1465) worms as a negative control. The 4xCys construct produced indepen-
dent stable lines from three different injected F0 worms, the TM7 construct produced
independent stable lines from three different injected F0 worms, but the TM1 construct did not
produce any transgenic adults or stable lines from four different injected F0 worms. 
In the negative control, four different injected F0 worms with mCherry produced red fluorescent
embryos, with only 2 transgenic F1 reaching adulthood and no stable lines (Table 3.13). The dif-
ference in proportion of embryos that reached adulthood after injection of individual construct
or selectable marker was examined by F test analysis. The results were found to be significant-
ly different from the mCherry control for the 4xCys and TM7 plasmids, but not for the TM1
plasmid. This result provides preliminary evidence that sequences C-terminal to the 4xCys do-
main are not required to rescue the lethality of lat-1 (ok1465) worms, and that the 4xCys domain
has an important role, since truncation back to the seven transmembrane domain resulted in only
partial rescue of the lethality of lat-1 (ok1465) worms, while one transmembrane domain failed
Table 3.14 The mCherry transgene of C-terminal lat-1a cDNA stability. 
Stable transgenic strain % transmission (mCherry) Brood size Adults assayed (n)
[P1.5kblat-1::4xCys(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA402;pAA414]
DA 201 100% 223±15 15
DA 202 98% 198±9 15
DA 203 99% 213±11 15
[P1.5kblat-1::TM7(lat-1a cDNA)::gfp;unc-
54::mCherry] [pAA403;pAA414] 
DA 301 99% 18±16 10
DA 302 99% 20±10 10
Transgenic strain from each tested stable line was examined for percentage of transmission and brood size as described
above in the Table 3.14. The percentage of transmission with mCherry plasmid is the proportion of offspring that reached
adulthood with red fluorescence. Brood size is the total number of transgenic adult per individual animal (Mean ±
Standard ). n is the number of adult transgenic animal assayed for the study. 
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to rescue the lethality of lat-1 (ok1465) worms. The TM7 domain is absolutely required, since
deletion of this region yields no rescue of the lethality defect of the lat-1(ok1465) worms.
Section 3.5.2.1.1  Stability of mCherry transgene in transgenic lat-1 (ok1465) worms
The stability of the mCherry transgene in stable lines generated from the 4xCys (n=3) and TM7
(n=2) constructs was examined. Brood size and percentage transmission of extrachromosomal
array is shown in Table 3.14. 
Transgenic strain from 4xCys and TM7 transmit the transgene to adult offspring at between 98-
100%. Strain DA 201 that transmits 100% was tested for the integration of extrachromosomal
array using similar approach as described in Section 3.4.1. The result showed that extrachromo-
somal array was integrated in this strain (data not shown). 
Section 3.5.2.1.2  Effect of C-terminally truncated lat-1a in lat-1(ok1465) worms
Section 3.5.2.1.2.1 Developmental lethality effect 
To examine developmental lethality, embryos from transgenic animals and the number of em-
bryos surviving to adulthood were determined, for wild-type worms, lat-1(ok1465) worms and
the transgenic worms. The transgenic strains with highest percentage of transmssion were ex-
Table 3.15  Effect of C-terminal lat-1 gene on lat-1(ok1465) phenotypes. 
Genotype No of embryos Brood size Defecation cycle (s) Adults assayed (n)
Wild-type 301±10 301±10 45±9 10 
lat-1(ok1465) worm 217±5 3±5b 80±6b 10
Strain DA 201 (4xCys) 223±15 223±15b 47±10b 15
Strain DA 302 (TM7) 218±12 20±7b 57±6b 10
Strain DA 201 and DA 301 from lat-1(ok1465) worms that were transgenic for 4xCys and TM7 constructs were
examined for phenotypes respectively. The table shows the Mean±Standard deviation of brood sizes (defined as surviving
adult progeny) and defecation cycle (measured in seconds). The genotype include wild-type, lat-1(ok1465) worm, strain
DA 201 (4xCys), strain DA 302 (TM7), all examined at 20°C. Brood sizes of transgenic animals and lat-1(ok1465)
worms were compared relative to wild-type level. P values were calculated between lat-1 (ok1465) worms and wild-type,
and strain DA 201 (4xCys), strain DA 302 (TM7) and lat-1 (ok1465) worm and P<0.05 is indicated (b). n is the number of
adult assayed
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amined. From lat-1(ok1465) worms, only 3 adult offspring per animal reached adulthood (Table
3.15). Wild-type worms produced 301±10 adult offspring per animal. The 4xCys transgenic an-
imals had 223±15 embryos, with 100% survival to adulthood (P<0.0001, compared to lat-1).
The lat-1(ok1465) worms transgenic for TM7 produced 20±7 adult offspring per animal from
218±12 (P<0.0001, compared to lat-1). Further analysis of offspring lethality from TM7 trans-
genic animal gave rise to; 153/218 (70%) larval lethality and 45/218 (21%) embryo lethality out
of 218 embryos (n=10).
The result shows that the 4xCys construct on lat-1(ok1465) worms shows complete rescue of
lethality, but the number of embryos laid is unchanged from lat-1 worms. However, the TM7
construct on lat-1(ok1465) worms shows only a partial rescue of phenotype, but still > 6-fold
above lat-1 worms. Therefore, the 4xCys construct rescued the phenotype of lat-1(ok1465)
worms, and partial rescue of the phenotype of lat-1 (ok1465) worms by the TM7 construct was
noted, with offspring lethality during embryonic and larval stage. However, the full-length lat-
1a showed > 300 offspring for the rescue of lat-1 animals brood size, and 4xCys showed 223
offspring. Thus the region after the 4xCys motif is important for rescuing the brood size defect.
Section 3.5.2.1.2.2 Defecation cycle effect in lat-1 (ok1465) worms
Defecation cycles were measured for the 4xCys and TM7 transgenes in lat-1 (ok1465) worms
and also in wild-type and lat-1 (ok1465) worms. The lat-1(ok1465) worms shows significantly
lengthened defecation cycle (80±6 seconds) compared to wild-type animal (45±9, P<0.0001).
Transgenic lat-1(ok1465) animals with the 4xCys or TM7 constructs show a significantly re-
duced defecation cycle compared to lat-1(ok1465) worms (47±10, P<0.0001 or 57±6,
P<0.0001). These two domains of truncated C-terminus lat-1a cDNA show almost similar level
of defecation cycle to the wild-type animal. Surprisingly, the TM7 construct rescued the defe-
cation cycle defect, in contrast to its inability to rescue the lethality of lat-1(ok1465) worms.
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Thus, the 4xCys domain is dispensable for complementation of the defecation cycle defect, but
required for the rescue of developmental lethality in the lat-1(ok1465) worms.
Section 3.5.2.2 Role of the lat-1a N-terminus
The N-terminus of GPCR proteins is believed to be responsible for binding ligands, and the se-
cretin family of GPCRs has a large N-terminal region; it is not clear what regions are involved
in binding any endogenous ligand. Hence, it is important to investigate N-terminal lat-1a trun-
cations to determine which regions are necessary for the rescue of lat-1(ok1465) worms. Three
different constructs were generated, and all three contained amino acids 1-61, which includes
the putative N-terminal signal peptide which is likely required for correct processing and trans-
Figure 3.12 Cartoon depicting deletion of N-terminal lat-1a cDNA. The first structure shows the full-length
N-terminal lat-1a cDNA having five functional domains with their relative amino acid positions: (a)Signal peptide (SP) in
gray colour has amino acid position at between 1-27, (b) Galactose-binding lectin domain in dark gray colour has amino acid
positions at between 51-133, (c) Hormone receptor motif domain (HRM) in red colour has amino acid positions at between
181-240, (d) G-protein coupled receptor proteolysis site (GPS) in blue colour has amino acid positions at between 493-536,
(e) Seven transmembrane domain (TM7) in black colour has amino acid positions at between 548-799. (f) The Galactose-
binding lectin domain (¨GBL) shows truncation of domains at amino acids between ¨62-147. (g) The Hormone receptor
motif domain (¨HRM) shows truncation of domain at amino acid between ¨62-250. (h) The N-terminal (¨N) deletion con-
struct shows deletion between amino acids ¨62-487.
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port of the protein to the cell surface. The first construct has a deletion of the galactose-binding
lectin domain (amino acids 62-147 ǻGBL); the second additionally deletes the hormone re-
ceptor motif domain (amino acids 62-250 ǻHRM); and the third deletes the rest of the N-
terminal domain up to the GPS (amino acids 62-487 ǻN) (Figure 3.12). Using the same ap-
proach as for the C-terminal deletion series, all clones were translationally fused in-frame at the
C-terminus to GFP and placed under the control of ~1.5kb of the endogenous lat-1 promoter.
The plasmids are designated as ǻGBL [P1.5kb lat-1::ǻGBL(lat-1a cDNA)::gfp] or [pAA404];
ǻHRM [P1.5kb lat-1::ǻHRM(lat-1a cDNA)::gfp] or [pAA405]; and ǻN [P1.5kb lat-1::ǻN(lat-1a
cDNA)::gfp] or [pAA408]. Each individual N-terminal truncation was examined for the rescue
of lat-1(ok1465) worms. Individual constructs were co-injected with the selectable marker,
mCherry, into lat-1(ok1465) worms, while the selectable marker was injected into lat-
1(ok1465) worms as a negative control.
The ǻGBL construct produced two independent stable lines from three different injected F0
worms and ǻHRM construct produced one independent stable line from three different injected
F0 worms, ǻN construct did not yield any independent stable line from three different injected
F0 worms.
In the negative control, four different injected F0 worms with mCherry construct produced
mCherry red fluorescent embryos with two transgenic F1 reaching adulthood but failed to pro-
duce transgenic offsprings (Table 3.16). Chi-squared test analysis (F) was used to determine
statistical significance of the difference in proportion of embryos that reached adulthood after
injection of each construct or selectable marker. The result was found to be stastistically signif-
icant for ǻGBL construct or ǻHRM construct but not significantly different for ǻN construct.
Hence, the deletion of galactose-binding lectin domain or hormone motif receptor domain re-
tained the ability of the construct to partially rescue the lethality of lat-1 (ok1465) worms, while
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deletion of the rest of the N-terminal domain abolished the ability of the construct to rescue the
lethality of lat-1(ok1465) worms.
Section 3.5.2.3 Stability of mCherry transgene in transgenic worms
Stable lines were examined for percentage of transmission. The stable lines DA 401 and 402 of
Table 3.16 Effect of N-terminal lat-1 gene and mCherry DNA on lat-1 (ok1465) worms. 
DNA injected Transgenic embryo (F1)  Transgenic adult (F1) Stable transgenic line
[P1.5kb lat-1::ǻGBL(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA404;pAA414]
32 18 12
27 13 6
15 5 0
Total 74a 36a 18
[P1.5kb lat-1::ǻHRM(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA405;pAA414]
23 11 6
14 5 0
16 7 0
Total 53b 23b 6
[P1.5kb lat-1::ǻN(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA408;pAA414] 
21 1 0
25 1 0
18 0 0
Total 64c 2c 0
[unc-54::mCherry] [pAA414] 
25 2 0
17 0 0
16 1 0
Total 58d 3d 0
 DNA from each construct as described in Table 3.16 was injected into the syncytial gonad of lat-1(ok1465) worms at a
concentration of 50-100µg/ml. Transgenic offspring obtained were studied for the presence of red fluorescence in the
body-wall muscle. The number of transgenic embryos, transgenic adults and stable transgenic lines from each injected
animal is shown. The statistical significance of the proportion of transgenic worms surviving to adulthood between ǻGBL
construct, ǻHRM construct, ǻN construct and mCherry construct was determined by a chi squared test, and the difference
between a &d, b&d was found to be significant (P<0.05), whereas there was no significant difference between c&d
(P=0.5847). 
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'GBL transmit mCherry to progeny at between 98-99%. The hormone receptor motif yeided
one strain DA 501, and transmits mCherry to progeny at 98% as shown in Table 3.17 . The result
shows that transgenic stable lines from 'GBL and 'HRM transmit mCherry to a high percent-
age of their adult offspring.
Section 3.5.2.4 Effect of N-terminal deletions in lat-1 (ok1465) worms
Section 3.5.2.4.1  Effect on develepmental lethality of lat-1 (ok1465) worms
To study developmental lethality, transgenic worms carrying either 'GBL or 'HRM constructs
were examined for embryonic survival. The lat-1(ok1465) worms produced only 3 offspring per
Table 3.17 The mCherry transgene of N-terminal lat-1a cDNA stability. 
Stable transgenic strain % transmission (Cherry) Brood size Adults assayed (n)
[P1.5kblat-1::ǻGBL(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA404;pAA414]
DA 401 98% 87±17 15
DA 402 99% 96±9 15
[P1.5kblat-1::ǻHRM(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA405;pAA414]
DA 501 98% 25±6 15
Transgenic strain from each tested stabe line was examined for percentage of transmission and brood size as shown in the
Table 3.17. The percentage of transmission with mCherrry plasmid is the number of transgenic adult animal that reached
adulthood with red fluorescence. Brood size is the total number of transgenic adult per individual animal (Mean ±
Standard ). n is the number of adult transgenic animal assayed for the study.
Table 3.18 Effect of N-terminal lat-1a cDNA on lat-1(ok1465) phenotypes. 
Genotype No of embryos Brood sizes Defecation cycle (s) Adults assayed 
(n)
Wild-type 296±13 296±13 45±3 10
lat-1(ok1465) worm 230±6 3±2b 80±8b 10
Strain DA 402 (ǻGBL) 250±11 96±9b 48±9b 15
Strain DA 501 (ǻHRM) 192±4 25±6b 50±12b 15
Strain DA 402 and DA 501 from transgenic worms carrying ǻGBL and ǻHRM constructs respectively were examined for
phenotypes. Table 3.18 shows the Mean±Standard deviation of brood sizes (defined as surviving adult progeny) and
defecation cycle (measured in seconds) of all genotypes; Wild-type, lat-1(ok1465) worm, strain DA 402 (ǻGBL) strain
DA 501 (ǻHRM) assayed at 20°C. Brood sizes were measured relative to wild-type level. P values were calculated
between lat-1 (ok1465) worm and Wild-type , and between strain DA 402 (ǻGBL) and lat-1(ok1465) worm, strain DA
501 (ǻHRM) and lat-1(ok1465) worm and P<0.05 is indicated (b). n is the number of adult assayed.
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animal that survived to adulthood (Table 3.18), whereas wild-type worms produced 296±13
adult offspring per animal. The number of embryos laid by lat-1(ok1465) worms had a 22% re-
duction (230±6; P<0.0001), significantly different from wild-type worms. 
The 'GBL on lat-1(ok1465) worms produced 250±11 embryos per animal, which was close to
lat-1, and the number of surviving adult offspring was significantly increased compared to lat-
1. 250 embryos were examined from strain 402 for offspring lethality gave rise to; 53/250 (21%)
embryo lethality and 100/250 (40%) larval lethality (n=15). The ǻHRM on lat-1 (ok1465)
worms produced 192±4 embryos per animal, which was significantly lower than lat-1 worms,
and the number of surviving adult offspring was 25±6, significantly greater than in lat-1 worms.
Out of 192 embryos examined from strain 501, the result yielded; 67/192 (35%) embryo lethali-
ty and 100/192 (52%) larval lethality (n=15). The 'GBL and ǻHRM on lat-1(ok1465) worms
only show partial rescue of phenotype, since the rescue is smaller than the levels seen in wild-
type worms. 
However, the effect of the 'GBL locus in rescuing lethality is greater than the ǻHRM construct,
as the number of adult offspring are ~ 4-fold higher. The deletion of the HRM domain in ǻHRM
causes a substantial decrease in the ability to complement the lethality during embryonic and
larval stage in lat-1(ok1465) worms and, therefore, this domain has an essential role in the en-
dogenous function of the lat-1 receptor. 
Section 3.5.2.5 Effect of N-terminal truncations on defecation cycle
Defecation cycles were measured for the ǻGBL or ǻHRM worms on lat-1(ok1465), and com-
pared with wild-type and lat-1(ok1465) worms. The lat-1(ok1465) worms shows a significantly
prolonged defecation cycle, compared to wild-type worms. Lat-1(ok1465) worms that were
transgenic for both ǻGBL and ǻHRM had a reduced defecation cycle compared to the lat-
1(ok1465) animals. Transgenic worms from these two domains of truncated N-terminal lat-1a
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cDNA nearly show the same level of defecation cycle as wild-type worms. Surprisingly, the
ǻGBL and ǻHRM constructs rescued the defecation cycle defect in lat-1(ok1465) worms, de-
spite their inability to rescue the lethality in these worms. Therefore, these data show that neither
the galactose-binding lectin or hormone receptor motif domains of lat-1a are required to rescue
the defecation cycle in lat-1(ok1465) worms.
Section 3.6 Is TM1 a dominant negative? 
A hypothesis is that TM1 would decoy any endogenous ligand from binding to the endogenous
receptor, thus attenuating the endogenous signalling pathway; binding of ligand to the TM1 pro-
tein will result in no intracellular signalling. This hypothesis predicts that the TM1 construct
will produce a mild phenocopy of the lat-1(ok1465) phenotype if injected into N2 worms, there-
fore, acting as a dominant negative. By contrast, although the ǻN N-terminal deletion mutant
yielded no stable lines when injected into lat-1 worms, it does not have a functional ligand-bind-
ing domain, and would be predicted to have no adverse effects if injected into N2 worms.
To test this hypothesis, the TM1 plasmid or ǻN plasmid was injected into wild-type worms. The
selectable marker mCherry plasmid and full-length lat-1a cDNA were injected into wild-type
worm as negative controls. Three different injected F0 worms produced three independent sta-
ble lines each from co-injection of TM1 and mCherry plasmids, the ǻN and mCherry plasmids.
Four different injected F0 worms produced stable lines from co-injection of full-length lat-1a
cDNA and mCherry plasmids, while injection of mCherry plasmid only produced three stable
lines from three injected F0 worms. The statistical significance of the difference in the propor-
tion of transgenic embryos that reached adulthood after injection of TM1 plasmid, ǻN plasmid,
full-length lat-1a cDNA plasmid, or selectable marker, was calculated by F2 analysis.
The result shows a statistically significant difference in the number of transgenic embryos sur-
viving until adulthood between animals transgenic for TM1 plasmid and animals transgenic for
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either mCherry plasmid or full-length lat-1a plasmid, whereas there was no statistically signif-
icant difference between full-length lat-1a cDNA plasmid and mCherry plasmid or with ǻN
plasmid and mCherry plasmid. This result shows that the TM1 construct had a statistically sig-
nificant effect, decreasing viability of wild-type worms by ~ 50%, as reflected in the number of
the transgenic embryo that reached adulthood. The effect on wild-type worms is not as a result
Table 3.19 Effect of TM1 lat-1a cDNA and mCherry DNA on wild-type worms. 
DNA injected Transgenic embryo (F1) Transgenic adult (F1) Stable transgenic line
[P1.5kblat-1::FL(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA401;pAA414]
40
28
34
25
40
28
34
25
28
17
21
12
Total 127a 127a 78
[P1.5kblat-1::TM1(lat-1a cDNA)::gfp;unc-
54::mCherry] [pAA407;pAA414]
22
19
25
11
9
13
6
8
10
Total 66b 33b 9
[P1.5kblat-1::ǻN(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA408;pAA414]
25
22
27
25
22
27
11
8
13
Total 74c 74c 32
[unc-54::mCherry] [pAA414] 28
19
25
28
19
25
14
10
11
Total 72d 72d 35
The syncytial gonad of wild-type worms was injected with plasmid DNA at a concentrattion of 50-100µg/ml. Transgenic
offspring were identified by the presence of red fluorescence in body wall. Table 3.19 shows the number of transgenic em-
bryos, transgenic adults and stable transgenic lines from injection of each construct. The statistical significance of the pro-
portion of transgenic worms surviving to adulthood between a & b, b& c, b &d was found to be significant (P<0.05). While
the difference between a & d, a& c, c & d was found not be significant (P>0.05) (F2 analysis)
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of full-length lat-1a plasmid, ǻN plasmid or mCherry plasmid, but TM1 specific. However, the
effect of truncated TM1 lat-1a construct on wild-type strengthens the hypothesis that TM1
might be decoying ligand from binding to endogenous receptors, given a reduction in the
number of transgenic embryos that survived to adulthood.
Section 3.6.1 Transmission of mCherry transgene 
The percentage transmission of mCherry was studied in the transgenic lines generated in Sec-
tion 3.5.2. At least three independent stable lines were generated from each construct. Each sta-
Table 3.20 The mCherry transgene of TM1 lat-1a cDNA stability . 
Stable transgenic strain % transmission (mCherry) Brood size Adults assayed (n)
[P1.5kblat-1::FL(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA401;pAA414]
DA701 88% 266±16 10
DA702 73% 217±23 10
DA703 59% 195±15 10
DA704 67% 189±13 10
[P1.5kblat-1::TM1(lat-1a cDNA)::gfp;unc-
54::mCherry] [pAA407;pAA414]
DA801 59% 58±9 10
DA802 62% 62±12 10
DA803 75% 82±21 10
[P1.5kblat-1::ǻN(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA408;pAA414]
DA901 55% 143±5 10
DA902 67% 183±14 10
DA903 70% 202±10 10
[unc-54::mCherry] [pAA414]
DA911 85% 242±17 10
DA912 67% 205±11 10
DA913 71% 202±8 10
Stable transgenic strains were obtained from independent stable lines for individual injection of each constructs as
described in Table 3.20. The percentage of transmission was measured for the transgenic adult offspring that transmits
mCherry(red-fluorescence) only. Brood size is the total number of transgenic offspring per individual animal (Mean±
Standard deviation). n is the number of adult transgenic animal assayed for the study.
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ble line, where tested, yielded one strain per individual construct, as named in the Table 3.20,
and the strains transmit mCherry to progeny at 55-88%. All the stable transgenic strains were
examined for brood size and the percentage of transmission .
The result shows that the stable lines obtained from individual constructs differ from one anoth-
er as indicated by the percentage of transmission and brood sizes.
Section 3.6.2 Phenotypic effects of TM1 on wild-type worms
Section 3.6.2.1 Developmental effect of TM1
The effect of the TM1, ǻN and full-length lat-1a constructs or the selectable marker on wild-
type animals were measured for developmental lethality. Developmental lethality was mea-
sured from the transgenic lines with the highest percentage of transmission. N2 worms produced
292±12 adult offspring per animal. Transgenic worms carrying a truncated TM1 construct
showed a significant reduction (~57%) in the number of embryos laid, at 160±9 per adult animal
(P<0.0001, compared to wild-type), and the number of surviving adult offspring was 82±21
(P<0.0001, compared to wild-type). The phenotype of TM1 transgenic worm is characterised
by failure of elongation during embryogenesis and rupture of intestine during larval develop-
ment. Analysis of 160 embryos from strain DA 803 for offspring lethality showed 50/160 (31%)
larval lethality and 28/160 (18%) (n=10). A typical example of embryo or larval arrest is shown
in Figure 3.13.
The data showed no decrease in the number of embryos laid or the number of offspring that
reached adulthood from wild-type worms that were transgenic for ǻN, full-length lat-1a con-
struct or the selectable marker. Hence, these data showed that truncation of C-terminal of lat-1a
to TM1 is toxic to wild-type worms which had significant offspring lethality, and this is con-
sistent with toxicity to transgenic embryos from micro-injection of TM1 construct into lat-
1(ok465) worms, observed in Section 3.5.2.1. Also, the nature of toxicity shown in Figure 3.13
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is similar to the phenotypes of lat-1(ok1465) worms in Figure 3.3. 
However, the ǻN and full-length lat-1a constructs gave transgenic lines which had brood sizes
and offspring survival that was not significantly different from the mCherry transgenic lines.
The fact that the full-length construct does not cause toxicity excludes the possibilities that the
lat-1 is toxic or that the promoter is driving inappropriate temporal or tissue-specific expression
that causes toxicity. Moreover, the finding that the ǻN plasmid transgenic animals are not com-
promised shows that a dysfunctional lat-1 is not sufficient for the toxicity. Therefore, it is a good
evidence for decoying of ligand from endogenous receptors.
Section 3.6.2.2 Effect of TM1 lat-1a cDNA on defecation cycle in wild-type worms
Defecation cycles were measured for the individual constructs, and compared with wild-type
animals. Wild-type worms show a defecation cycle period of 45±14 seconds. But, wild-type an-
imals that were transgenic for TM1 construct shows a prolonged defecation cycle ( 71±4 sec-
onds), significantly greater compared to wild-type worm (P=0.0018). The full-length lat-1a
construct in wild-type worms shows a defecation cycle of 47±5 seconds. The ǻN transgenics
has a defecation cycle of 45±8 seconds and the selectable marker on wild-type worms shows a
Table 3.21 Effect of TM1 lat-1a cDNA on wild-type phenotypes. 
Genotype No of embryos Brood size Defecation cycle (s) Adults assayed 
(n)
Wild-type 292±12 292±12 45±14 10
Strain DA 701 (Full-length ) 297±23 297±23b 47±5b 10
Strain DA 803 (TM1) 160±9 82±21b 71±4b 10
Strain DA 903 (ǻN) 284±7 284±7b 45±8b 10
Strain DA 911 (mCherry) 285±11 285±11b 44±13b 10
Strain DA 701, 803, 903, 911 (genotypes) were obtained from wild-type animals that were transgenic for full-length,
TM1, ǻN, mCherry construct respectively. The table depicts the Mean±Standard deviation of brood sizes (defined as
surviving adult progeny) and defecation cycle (measured in seconds). Brood sizes were measured relative to wild-type. P
values were calculated between wild-type and strain DA 701 (P>0.05) , wild-type and strain DA 803 (TM1) (P<0.05),
wild-type and strain DA 903 (ǻN) (P>0.05) , wild-type and mCherry ( P>0.05). P value is indicated (b). n is the number of
adult assayed
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defecation cycle of 44±13 seconds; none of which are significantly different from wild-type.
These data show that the TM1 construct on wild-type worm caused a significant lengthening of
the defecation cycle, whereas there was no effect in the wild-type animals that were transgenic
for ǻN construct, full-length lat-1a or selectable marker. 
Since the ǻN construct was not toxic to wild-type worms, the failure of the ǻN construct to res-
cue lat-1(ok1465) worms demonstrates that ǻN construct merely lacks the ability to rescue lat-
1(ok1465) worms, but is not toxic to these worms per se. Moreover, micro-injection of full-
length lat-1a or selectable marker had no toxic effect on wild-type worms, showing that the lat-
1a sequence by itself (or the mCherry) has no gross toxicity in wild-type worms. It is therefore
concluded that, truncation of C-terminus of lat-1a to transmembrane domain one is toxic and
Figure 3.13 Phenotypes of TM1 lat-1a cDNA on wild-type worms. The diagram shows the photographs
of arrested embryo and larvae from transgenic animal carrying N2 [P1.5kb lat-1::TM1(lat-1a cDNA)::gfp;unc-
54::mCherry] [pAA407;pAA414]. All images were captured under DIC optics and mCherry filter using the same fo-
cal point at 100x magnification. Embryos were dissected from transgenic adult hermaphrodite as described in section
2.8.1. A is a typical example of 3-fold stage arrested embryo that failed to elongate as indicated by the arrow. B is a
typical example of larval 1 with the rupture of intestine and pharynx as shown by the arrow. Scale bar is 50 µm. 
A
B
Ademola Adenle   Section 3.7.1
Page 129
acts as dominant negative as predicted, and prevents ligand from binding to endogenous lat-1
gene in wild-type worms. 
Section 3.7 Tissue-specific expression of lat-1a
Section 3.7.1 aex-3 promoter driving lat-1a expression
The ~1.5kb lat-1 promoter driving a full-length lat-1a cDNA construct rescues lat-1(ok1465)
worms. It is known that the mammalian latrophilin is expressed at high level in the nervous sys-
tem. Therefore, it was proposed to express lat-1a cDNA constitutively in nerve cells by replac-
ing the lat-1 promoter with the aex-3 promoter, which has been shown to mediate nerve-specific
expression [100]. To study this, the full-length lat-1a cDNA containing exon 1 and exon 2 with
intron was translationally fused in-frame to C-terminal of GFP and driven by ~1.3kb of the aex-
3 promoter; this plasmid is the aex-3 reporter construct; [P 1.3kb aex-3::FL(lat-1a cDNA)::gfp]
designated as [pAA409] (Figure 3.4). 
The primary aim of this experiment was to find out if aex-3 promoter, driving nerve-specific
expression, could rescue the lethality of lat-1 (ok1465) worms, as this would suggest an impor-
tant role for latrophilin in the nervous system. The aex-3 reporter construct was co-injected with
mCherry as a selectable marker into lat-1 (ok1465) worms and mCherry was injected into lat-1
(ok1465) worms as a negative control. 
Figure 3.14 Translational reporter gene fusion of lat-1a cDNA driven by aex-3 promoter.  Cartoon
shows in-frame translational fusion of lat-1a cDNA to reporter gene. ~1.3kb, 5end of aex-3 promoter contains start codon
ATG (black arrow) in the middle of exon 1 (yellow) with an intron (black line) and exon 2 (black box) with lat-1a cDNA
(blue box) fused to green fluorescent protein GFP (green box), resulting construct is designated as pAA409. ( see section
2.10.3)
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The transgenic worms were identified by red-fluorescent body-wall muscle expression from
embryogenesis to adulthood. Micro-injection of aex-3 reporter construct produced red
fluorescent embryos from four different injected F0 worms with ten transgenic F1 reaching
adulthood without producing transgenic progeny. In the negative control experiment, four
different injected F0 worms with mCherry produced red fluorescent embryos from four
different injected worms with five transgenic F1 reaching adulthood but failed to produce
transgenic offspring (Table 3.22). 
The statistical significance of difference in proportion of transgenic embryos that reached
adulthood after injection of aex-3 reporter construct or selectable marker was calculated by
Chi-squared method, and found not to be stastistically significant (P=0.78). The result shows
Table 3.22 Effect of aex-3 reporter construct and mCherry DNA on lat-1 (ok1465) worms. 
DNA injected Transgenic embryo (F1) Transgenic adult (F1) Stable Transgenic line
P 1.3kb aex-3::FL(lat-1a cDNA)::gfp; 
unc-54::mCherry[pAA409;pAA414]
25
18
30
23
2
1
4
3
0
0
0
0
Total 96a 10a 0
unc-54::m-Cherry [pAA414] 24
14
10
16
2
0
1
2
0
0
0
0
Total 64b 5b 0
The plasmid DNA from aex-3 reporter construct or mCherry was injected into the syncytial gonad of lat-1(ok1465) worms
at a concentration of 50-100µg/ml. Transgenic offspring obtained were examined for the presence of red fluorescence in
the body wall. The number of transgenic embryos, transgenic adults and stable transgenic lines from each injected animal
are presented in the Table 3.22. The statistical significance of the proportion of transgenic worms surviving to adulthood
between aex-3 reporter construct and mCherry was determined by a Chi squared test, and the difference between a and b
was found not to be significant (P>0.05) 
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that when fusion protein was driven by aex-3 promoter, it failed to rescue the lethality of lat-
1(ok1465) worms. This could be explained either by a failure of the aex-3 promoter to confer
expression in a tissue relevant for the lethality, or by expression of lat-1 in an inappropriate
tissue causing lethality.
Section 3.7.2  Effect of aex-3 reporter construct on wild-type worms
Micro-injection of aex-3 reporter construct could not rescue the lethality of lat-1 (ok1465)
worms, but produced ten transgenic adults F1 without transgenic offspring. Thus, it was not
possible to study the inappropriate expression of lat-1. A hypothesis is that aex-3 promoter
might drive tissue-specific expression that causes toxicity. It is important to test effect of aex-3
reporter construct on wild-type worms and study the resulting offsprings for any toxic effect.
The aex-3 reporter construct was co-injected with mCherry, while mCherry, the selectable
marker was injected as a negative control. 
Three independent stable lines were obtained from three different injected F0 worms with aex-
3 reporter construct. The injection of selectable marker produced three independent stable lines
Table 3.23 Effect of aex-3 reporter construct and mCherry DNA on wild-type worms. 
DNA injected Transgenic embryo (F1) Transgenic adult (F1) Stable transgenic line
P 1.3kb aex-3::FL(lat-1a cDNA)::gfp; unc-
54::mCherry [pAA409;pAA414]
23
18
29
23
18
29
12
9
10
Total 70a 70a 31
unc-54::mCherry [pAA414] 27
15
33
27
15
33
14
7
17
Total 75b 75b 38
The plamid DNA from each construct was injected into the syncytial gonad of N2 worms at a concentration of 20-50µg/
ml. Transgenic offspring obtained were examined for the presence of red fluorescence in the body wall. Table 3.23 shows
the number of transgenic embryos, transgenic adults and stable transgenic lines. The statistical significance of the
proportion of transgenic worms surviving to adulthood between aex-3 reporter construct and :mCherry was determined by
a Chi squared test, and the difference between a and b was found not to be significant (P>0.05)
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from three different injected F0 worms. The F method was used to calculate the statistical
significance of difference in proportion of transgenic embryos that reached adulthood after
injection of aex-3 reporter construct or selectable marker, and this was found not to be
stastistically significant. These data were not sufficient to characterise the effect of aex-3
reporter construct. Therefore, further characterisation of independent stable lines should define
the roles of aex-3 reporter construct or selectable marker on wild-type worms.
Section 3.7.3 Stability of mCherry transgene of aex-3 reporter construct on wild-type 
Wild-type worms that were transgenic for aex-3 reporter construct or selective marker were
examined for stability. One strain was tested from either aex-3 reporter construct or selectable
marker, and the strains transmit mCherry to progeny at between 39%-77%. All the stable
transgenic strains were studied for brood size and percentage of transmission. 
These data show the level of stability of each strain differs from one another as indicated by
the percentage of transmission of mCherry transgene and brood sizes. However, aex-3 reporter
construct shows relatively low percentage of transmission with smaller brood sizes.
Table 3.24 The mCherry transgene of aex-3 reporter construct stability. 
Stable transgenic strain % transmission (mCherry) Brood size  Adults assayed (n)
[P1.3kb aex-3::FL(lat-1a cDNA)::gfp;unc-
54::mCherry][pAA409;pAA414]
DA 111 45% 75±11 10
DA 112 69% 118±7 10
DA 113 39% 66±4 10
unc-54::mCherry [pAA414]
DA 914 75% 201±17 10
DA 915 58% 168±10 10
DA 916 77% 226±15 10
Stable transgenic strains were obtained from independent stable lines for individual injection of either aex-3 reporter
construct or selectable marker, mCherry. The percentage of transmission was measured for the transgenic adult offspring
that transmits mCherry(red-fluorescence) only. Brood size is the total number of transgenic offspring per individual animal
(Mean± Standard deviation). n is the number of adult transgenic animal assayed for the study.
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Section 3.7.4 Phenotypic effect of aex-3 reporter construct and mCherry on wild-type 
Section 3.7.4.1 Effect of aex-3 construct on development 
Embryos were counted from transgenic worms carrying aex-3 reporter construct or mCherry to
examine the developmental processes. Wild-type worms produced 296±15 offspring per adult
animal. The aex-3 reporter construct on wild-type worm shows a significantly reduced number
of embryos laid per animal (170±18; P<0.0001 compared to wild-type), and the number of sur-
viving adults offspring per animal was 170±18 (P<0.0001, compared to wild-type). However,
mCherry on wild-type worms laid 293±10 embryos per adult animal (P=0.24, compared to
wild-type) and the number of surviving adult offspring per animal was 293±10 (P=0.24, com-
pared to wild-type). The result shows a great reduction in the number of offspring from trans-
genic animal carrying aex-3 reporter construct. However, the result shows no decrease in the
number of offspring from transgenic animal carrying mCherry. Thus, the aex-3 construct causes
a decrease in the brood size, but does not cause developmental lethality.
Section 3.7.4.2 Effect of aex-3 reporter construct on defecation cycle
Defecation cycles were measured for the aex-3 reporter construct and unc-54::mCherry on
wild-type worms. N2 worm shows a defecation cycle of 45±11 seconds. Transgenic worms car-
rying aex-3 reporter construct shows a significantly prolonged defecation cycle (85±6 seconds),
compared to wild-type ( P<0.0001), whereas wild-type worms that were transgenic for mCherry
Table 3.25 Effect of aex-3 construct on wild-type worm phenotypes. 
Genotype No of 
embryos
Brood size Defecation cycle (s) Adults asssayed 
(n)
Wild-type 296±15 296±15 45±11 10
Strain DA 112 ( aex-3 reporter construct) 170±18 170±18b 85±6b 10
Strain DA 916 ( mCherry) 293±10 293±10b 47±13b 10
Strain DA 112, 916 obtained from transgenic worms carrying aex-3 reporter construct and mCherry plasmid respectively
were studied for the phenotypes. The Mean±Standard deviation of the number of embryos, brood sizes (defined as
surviving adult progeny) and defecation cycle (measured in seconds) were represented in the Table 3.25 for all genotypes,
assayed at 20C. Brood sizes were comparedcombined latrotoxinscombined latrotoxins relative to wild-type level. P values
were calculated between wild-type and strain DA112 (aex-3 reporter construct) (P<0.05), wild-type and strain DA 916
(P>0.05). P value is indicated (b), n is the number of adult assayed
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shows a defecation cycle (47±13 seconds) comparable to wild-type (P=0.52). The result shows
that aex-3 reporter construct on wild-type worms had a significant effect due to an increase in
defecation cycle and decrease in the brood size, whereas in the control experiment, there was
no effect of mCherry wild-type worm. 
Section 3.8 The action of Black Widow Spider Venom
Section 3.8.1 Partial purification of toxins from combined latrotoxins
Black widow spider venom (combined latrotoxins) was supplied as a lyophilised extract from
venom sac of Latrodectus mactans tredecimguttatus. Since the crude venom contains a variety
of low molecular weight components in addition to the high molecular weight latrotoxins, it is
necessary to separate these components in order to be able to specifically test for the action of
the high molecular weight latrotoxins. Combined latrotoxins proteins were purified by size-ex-
clusion chromatography, and protein concentration was determined using Bradford assay ac-
cording to the methods described in section 2.9.1 and 2.9.2 respectively. Venom proteins eluted
in 0.5ml fraction were run on a gel using denaturing LDS-PAGE. All the fractions from between
15-34 showed absorbance at 280nm (indicating protein), while fractions 23-27 contained pro-
teins of 110-130kDa characteristic of the latrotoxins, and fractions 28-29 contained lower mo-
lecular weight proteins. It has been previously demonstrated that proteins of ~110kDa are toxic
upon micro-injection into C.elegans [86], [45]. These data show successful size fractionation of
combined latrotoxins extracts, and fractions that contain specific venom protein greater than
110kDa were pooled for micro-injection. 
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Figure 3.15 Purification of combined latrotoxins protein. A Size-exclusion chromatography of combined latro-
toxins. 5mg of lyophilised Black Widow Spider Venom was dissolved in 20mM Tris at pH 8.0, 150mM NaCl, and loaded
onto the Sephacryl S-200 column at 0.5ml/min. The absorbance at 280nm (A280nm) of the fraction eluate is represented by
thick black line. Fractions (0.5ml) were collected ( corresponding to time 23-29) as shown on top of the graph. The position
of pooled peak fractions of the same molecular weights for micro-injection is indicated by the black line (24-27; 118kDa). B
shows denaturing LDS-PAGE of latrotoxin fractions. Fractions from size-exclusion chromatgraphy (A) were collected for
protein analysis. Eluted fractions were separated by running at 180V on 10% Bis-Tris gel for the visualisation of protein and
stained using Coomassie Blue. The sizes of eluted proteins (time 23-29) are identified along side molecular weight marker
(M) as shown above and the pooled fractions ( time 24-27) for micro-injection is underlined as thick lines.
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Section 3.8.2  Effect of combined latrotoxins on C.elegans
It is essential to determine whether the C.elegans lat-1 is required for mediating the toxicity of
combined latrotoxins, prior to further investigation of the role of lat-1 gene in the mechanism
of action of combined latrotoxins. RNAi knockdown of the lat-1 gene in wild-type worms
showed resistance to combined latrotoxins (BWSV) [86], but these experiments are not defini-
tive, since RNAi merely leads to knockdown, and RNAi is frequently tissue specific in C. ele-
gans mCherry[101] [102]. Hence, it was desirable to study a genetic null (ok1465) allele of the
lat-1 gene, to determine if lat-1 is required for the toxic effects of combined latrotoxins. How-
ever, it is important to compare the effect of combined latrotoxins on C.elegans lat-1(ok1465)
worms and wild-type worms, with appropriate controls. Therefore, dose-effect curve of com-
bined latrotoxins was carried out on lat-1(ok1465) worms, wild-type worms, and lat-1(ok1465)
worms carrying various transgenes. 
Section 3.8.2.1 Effect of combined latrotoxins on wild-type worms and lat-1(ok1465) 
worms
It is important to determine the dose-response relationship for combined latrotoxins on wild-
type worms or lat-1(ok1465) worms to characterise its toxicity. Therefore, each concentration
of combined latrotoxins was injected into 20 individual worms to study the effect of combined
latrotoxins. The pooled size-exclusion chromatography column fractions of combined latrotox-
ins protein were at a concentration of 400 Pg/ml, and these were diluted in 10-fold increments
prior to injection. The injected worms were incubated at 20ºC after recovery in M9 buffer and
scored for the effect of combined latrotoxins after 3hrs. Dead worms were characterised by rod-
like shape, slow movement of the body until death, and failure to respond to worm pick.
Wild-type worms were sensitive to combined latrotoxins with an LD50 concentration of ~4 ng/
ml, whereas lat-1(ok1465) worms were refractory to combined latrotoxins with 0% lethality at
400 Pg/ml ( Figure 3.16). As the concentration of combined latrotoxins decreased from 400 Pg/
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ml to 40 fg/ml, the lethality in wild-type worms decreased gradually from 100% to 0%, showing
a shallow dose-response. The results provide strong evidence that the lat-1 gene was responsible
for the toxicity of combined latrotoxins that killed wild-type worms, since the deletion in the
lat-1 gene was correlated with resistance to combined latrotoxins.
Section 3.8.2.2 The lat-1 gene confers sensitivity to combined latrotoxins in lat-
1(ok1465) worms
The lat-1(ok1465) worms contain a deletion in the lat-1 gene, but will additionally contain mu-
tations in other genes, even after 6 outcrosses against N2. In order to investigate the hypothesis
Figure 3.16 A dose curve effect of combined latrotoxins on wild-type and lat-1 worms. 20 wild-type
or lat-1(ok1465) worms for each point were injected with combined latrotoxins in 10-fold serial dilution starting from
concentration of 400 Pg/ml. After injection, worms were recovered in M9 buffer before incubation at 20ºC for 3hrs and
thereafter scored for the effect of combined latrotoxins (section 2.7.3). Percentage of lethality (%) were plotted against
dose concentration 400 Pg/ml - 40 fg/ml. A dose-response curve (black circle) was obtained from the toxicity of com-
bined latrotoxins that killed wild-type worms with LD 50 concentration of ~4 ng/ml. The lat-1(ok1465) worms was re-
sistant to combined latrotoxins without dose-response curve (black box)
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that the deletion in the lat-1 gene is responsible for resistance against combined latrotoxins, var-
ious constructs containing the lat-1 gene were introduced into lat-1(ok1465) worms, and dose-
response curves constructed with the resulting worms. B0457 cosmid contains the full sequence
of the lat-1 gene and rescued lethality and defecation defects in the lat-1(ok1465) worms. 
Wild-type worms and B0457 transgenic worms were sensitive to combined latrotoxins and
showed 100% lethality at the highest concentration dose of injection of 400 Pg/ml, whereas lat-
1(ok1465) worms were less sensitive to combined latrotoxins with 5% lethality at 400 Pg/ml
(Figure 3.17). The LD50 concentration of ~4 ng/ml was obtained from dose-response curve for
the toxicity of combined latrotoxins that killed B0457 transgenic worms and wild-type worms.
The results showed that the B0457 cosmid conferred susceptibility to the toxicity of combined
latrotoxins to lat-1(ok1465) worms.
The B0457 cosmid contains multiple genes in addition to lat-1, and so does not definitively
prove that lat-1 confers sensitivity to combined latrotoxins. Additionally, the full-length lat-1
would presumably result in the generation of the normal three transcripts of lat-1 (i.e. a, b and
c). Hence to definitively test the hypothesis that lat-1a can confer sensitivity to combined latro-
toxins, lat-1(ok1465) worms transgenic for the lat-1a cDNA were tested for sensitivity to com-
bined latrotoxins. Transgenic worms or wild-type worms that were injected at the highest dose
concentration of 400 Pg/ml showed 100% lethality of sensitivity with LD50 concentration of ~4
ng/ml, whereas lat-1(ok1465) worms injected at 400 Pg/ml showed 5% lethality of sensitivity,
as shown in Figure 3.17. 
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The results showed that lat-1a cDNA transgenic worms and wild-type worms were sensitive to
combined latrotoxins, whereas lat-1(ok1465) worm were resistant to combined latrotoxins.
Thus, full-length lat-1a was responsible for the sensitivity to toxicity of combined latrotoxins
that killed transgenic worms, and this proves that the absence of lat-1 gene in lat (ok1465) worm
leads to resistance to combined latrotoxins. 
Section 3.8.2.3 Defining regions of lat-1a required for combined latrotoxins toxicity
Given that the lat-1a gene confers sensitivity to combined latrotoxins on lat-1(ok1465) worms,
it is possible to determine the regions of lat-1 that are required for this functionality by under-
taking a systematic mutagenesis of the lat-1 gene. A series of C- and N- terminal deletions were
Figure 3.17 A dose curve-effect of combined latrotoxins on full-length lat-1a or B0457 cosmid 
worms.  20 worms were injected with combined latrotoxins per point for each genotype at each dose as described in sec-
tion 2.7.3. Percentage of lethality (%) were plotted against dose concentration 400 Pg/ml-40 fg/ml. A dose curve-effect
was obtained from wild-type worms (yellow) and lat-1(ok1465) worms that were transgenic for full-length lat-1a cDNA
(gray) or B0457cosmid (red) with LD 50 concentration of ~4 ng/ml, and with lat-1(ok1465) worms (black).
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constructed, and used to create transgenic lat-1(ok1465) worms; the resulting worms were then
tested for sensitivity to combined latrotoxins.
Section 3.8.2.3.1  C-terminal deletions of lat-1a
Two different types of transgenic animals were obtained from micro-injection of C-terminal lat-
1a deletion constructs into lat-1(ok1465) worms. The 4xCys construct fully rescued lat-
1(ok1465) worms, and the TM7 construct partially rescued lat-1(ok1465) worms. Therefore, it
was important to find out the effect of combined latrotoxins to elucidate the roles of functional
regions of the lat-1a C-terminus in respect of their abilities to mediate the toxicity of combined
latrotoxins. The wild-type worms or lat-1(ok1465) worms carrying 4xCys construct were sen-
sitive to the combined latrotoxins and showed 100% lethality at the highest concentration dose
injection of 400 Pg/ml with an LD50 concentration of ~40 ng/ml, while the TM7 transgenic
worms only showed 50% lethality to combined latrotoxins at the higest concentration of 400
Pg/ml. The lat-1(ok1465) worms injected with combined latrotoxins at 400 Pg/ml showed 0%
lethality. Truncation of the C-terminus of lat-1a to the area of four cysteine domain yielded
worms that had a sensitivity to the toxicity of combined latrotoxins that was close to wild-type,
showing that the region of the C-terminus after the 4xCys domain is not required for signalling
in combined latrotoxins toxicity. However, when the C-terminus was deleted back to the seven
transmembrane domain of lat-1a, the resulting worms were ~104-fold less sensitive to combined
latrotoxins than the corresponding 4xCys worms. Therefore, C-terminal sequence of lat-1 after
the TM7 domain is required for the action of lat-1 mediated combined latrotoxins toxicity, and
the transmembrane domain itself is not sufficient to mediate the toxicity of combined latrotox-
ins in C. elegans. 
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Section 3.8.2.3.2  N-terminal deletions of lat-1a
Two plasmids containing N-terminal deletions of lat-1, ǻGBL and ǻHRM, partially rescued lat-
1(ok1465) worms. It is important to find out the roles of these two regions within lat-1a cDNA
with respect to the toxicity of combined latrotoxins. Transgenic worms carrying ǻGBL and
wild-type worms were sensitive to combined latrotoxins and showed an LD50 concentration of
~4 ng/ml, while lat-1(ok1465) worms that were transgenic for ǻHRM showed ~50% lethality
at 400 Pg/ml. lat-1(ok1465) worms were resistant to combined latrotoxins with 0% lethality at
Pg/ml. Hence, deletion of the galactose-binding lectin domain had little effect on sensitivity
Figure 3.18 Dose-response of combined latrotoxins on C-terminally-truncated lat-1a worms.  20
worms were injected with combined latrotoxins per point for each genotype as described in section 2.7.3. The graph
shows the plot of percentage of lethality (%) against dose concentration 400 Pg/ml-40 fg/ml. A dose-curve effect was
obtained from wild-type worms (red) and lat-1(ok1465) worms (black) that were transgenic for area of four cysteine do-
main [4xCys] (yellow) with LD50 concentration of ~4 ng/ml. The lat-1 (ok1465) worms that were transgenic for seven
transmembrane domain [TM7](magenta) showed 50% lethality at the highest concentration, 400 Pg/ml, while lat-
1(ok1465) worms (black) were refractory to toxin treatment.
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to the toxicity of combined latrotoxins, since the 'GBL transgenic worms had equal sensitivity
to wild-type, while deletion of the hormone receptor motif domain of lat-1a reduced sensitivity
to the toxicity of combined latrotoxins by ~105-fold, compared to 'GBL worms.
Section 3.8.3 Dose-effect curve of potassium cyanide (KCN) on transgenic worms, lat-
1(ok1465) worms and wild-type worms
It is possible that the differential toxicity of combined latrotoxins in the various transgenic
worms could be due to the lat-1 constructs conferring a non-specific susceptibility to toxicity.
In order to show that the results seen are specific to combined latrotoxins, it was important to
test the effect of toxic compound with a distinct mode of action, and potassium cyanide (KCN)
Figure 3.19 Dose-response of combined latrotoxins on N-terminally truncated lat-1a worms. 20
worms were injected with combined latrotoxins per point for each genotype as described in section 2.7.3. The graph
shows the plot of percentage of lethality (%) against dose concentration 400 Pg/ml-40 fg/ml. A dose-curve effect was
obtained from wild-type worm (red) and lat-1(ok1465) worms that were transgenic for galactose-binding lectin domain
deletion[ǻGBL](yellow) with LD50 concentration of ~4 ng/ml. The lat-1(ok1465)worms that were transgenic for hor-
mone receptor motif domain deletion [ǻHRM](mangeta) showed 50% lethality at the highest dose, 400 Pg/ml, while lat-
1(ok1645) worms (black) were insenstive to toxin.
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was used to obtain a dose-effect curve. To study the effect of KCN, 20 transgenic animals in-
cluding the wild-type and lat-1(ok1465) worms were injected in 10-fold serial dilution from
start concentration of 1.5 mM of KCN. The injected worms were recovered in M9 buffer before
incubation at 20ºC for 3hrs and scored for the effect of KCN. All the worms from each genotype
were sensitive to KCN and showed 100% lethality at the highest concentraton, with LD50 con-
centration of ~15 PM. 
The result showed that KCN killed all the injected worms with an LD50 concentration of ~15
PM. These data exclude the possibility of non-specifictity of combined latrotoxins toxicity to
Figure 3.20 A dose curve-effect of KCN on C.elegans. 20 worms were injected with KCN per point for each gen-
otype as described in section 2.7.3. The graph shows the plot of lethality (%) against dose concentration 1.5 mM-150 nM.
A dose-curve effect was obtained from all the injected worms of each genotype; Wild-type [N2] (yellow), lat-1(ok1465)
worms[lat-1] (red), lat-1(ok1465) worms transgenic for full-length lat-1a cDNA[FL] (gray), area of four cysteine do-
main[4xCys](blue), seven transmembrane domain[TM7](green), galactose-binding lectin domain deletion[ǻGBL](magen-
ta), hormone receptor motif domain deletion [ǻHRM](black) or B0457 cosmid [B0457] (brown) with LD50 concentration
of ~15 PM. 
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transgenic animals, wild-type or lat-1(ok1465) worms. Therefore, the sensitivity or resistance
of combined latrotoxins was due to the presence or absence of lat-1 gene respectively.
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Chapter 4 Discussion
Section 4.1 Optimisation of transgenesis
Micro-injection was optimised for transgenesis of C.elegans to overcome the initial failure to
obtain transgenic worms. One difficulty, ensuring accurate injection, was overcome by injecting
rhodamine into the gonad of C.elegans as described in section 3.1.1. This experiment proved to
be successful after targeting the gonad of C.elegans as reflected by the restriction of the red-
fluorescence of rhodamine to the gonad. The installation of air-conditioning in the micro-injec-
tion room gave temperature control and contributed to the survival of injected worms that yield-
ed transgenesis. While it is not possible to definitively identify temperature as the key
determinant for successful transgenesis from this anecdote, it is suggestive that temperature
control is essential for successful transgenesis; this is consistent with previous work, that shows
pgl-1 mutants show meiotic failure at higher temperatures [103].
DNA concentration was optimised for transformation of C.elegans to obtain stable lines. Two
different selectable markers (pRF4:roller phenotype and pAA413:body-wall muscle expression
of the Cerulean GFP) were used to obtain various stable lines with different concentrations as
described in 3.1.2. The highest concentration of individual selectable marker yielded stable line,
and the lowest concentration yielded no stable line. The result showed that it was possible to
obtain stable line at the optimum DNA concentration of >50 µg/ml for either pRF4 or pAA413.
These data are similar to findings reported for micro-injection of DNA into the distal arm of go-
nad [92], [91]. The number of stable lines obtained is dependent on the DNA concentrations
used for injection, and this report is consistent with Mello et al (1991). Therefore, DNA concen-
tration is a key variable for succesful transgenesis in C.elegans.
Section 4.2 The phenotype of lat-1 allele
The deletion of lat-1 gene in ok1465 allele by mutagenesis as described in section 3.2.1 was
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characterised and studied for offspring lethality after outcrossing against wild-type worms six
times. The lat-1 (ok1465) worm was under-represented and this is unlikely to be due to an un-
related mutation present in the ok1465 allele. The under-representation of adult lat-1 homozy-
gous worms was shown to be due to death during embryogenesis or larval stages. Investigation
of lat-1 allele showed that 95-98% of its offpring die during developmental stages with only ~2-
5 adult offspring from about 200 embryos per animal. The rate of lethality in homozygous lat-
1 worms is similar (~95-98%) in offspring derived from either homozygous or heterozygous lat-
1 parents; therefore the lethality is unlikely to be due to a maternal effect gene. Observed em-
bryonic lethality occurs at the time of epithelial morphogenesis, which is late for typical mater-
nal effect genes. Analysis of the ok1465 allele showed developmental lethality in offspring after
it had been outcrossed six times against wild-type animals. It is possible that the lethal pheno-
type manifest in lat-1(ok1465) worms is due to the deletion of lat-1 gene or to a genetically
linked mutation. However, it is important to understand why the offspring of lat-1 animals die
during embryonic or larval stage and determine the cause of the lethality. Therefore, it isessen-
tial to determine the role of the lat-1 sequence in lat-1 (ok1465) worms in order to gain insight
into the understanding of the phenotype of lat-1 worms.
Section 4.3 Expression of lat-1 reporter gene
It is important to know in which cells the endogenous lat-1 gene is expressed in the wild-type
worm as this will help to clarify the role of lat-1 gene. Therefore, a transcriptional fusion of lat-
1 gene under the control of the lat-1 promoter fused to lacZ reporter gene (ȕ-galactosidase nu-
clear localisation signal) or gfp reporter gene (green fluorescent protein) was examined: both of
the gfp or lacZ reporters allow microscopic visualization in C.elegans, allowing characterisation
for the expression of the gene of interest [97] [104]. The idea of using different reporter genes
was to find out if the same promoter driving two different reporter genes e.g gfp or lacZ would
produce similar expression patterns for the study of lat-1 promoter, and thereby provide a more
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robust characterisation of the level and cell-specificty of lat-1 gene expression. Analysis of em-
bryos with the lat-1::gfp reporter fusion showed that GFP was expressed in hypodermal cells
during dorsal intercalation (Figure 3.6C) and continued in 2-3-fold stage embryonic develop-
ment as described in section 3.3.2. This expression pattern of lat-1 gene promoter in the gut cells
of 3-fold stage of the gfp reporter fusion is similar to the gut expression of 3-fold stage of lacZ
fusion either for ~1.5kb or ~3kb of lat-1 gene promoter, but technical difficulties precluded
analysis of the lacZ fusions in earlier embryos. The expression of lat-1 gene promoter detected
in the gut cells and two tail neurons of larval or adult stage for ~1.5kb, lacZ transgenic worm is
similar to that of ~3kb, lacZ transgenic worm. The same expression pattern (gut cells, two tail
neurons) is found in larval or adult stages of ~1.5kb, gfp transgenic worm as described in section
3.3.2. 
The expression pattern of gfp or lacZ reporter genes was detected in the same cells of all stages
of trangenic worms obtained. The fact that two different lengths of lat-1 promoter (the ~3 and
~1.5 kb fragments), and different reporter genes, in multiple independent transgenic worms,
show similar and consistent expression patterns is a strong indication that these findings are ro-
bust and indicate the expression pattern of the endogenous lat-1 gene. The high expression of
these reporter genes in embryonic stages of the worm is also consistent with real-time PCR anal-
ysis of lat-1 transcripts (Susann Lehmann, unpublished data) showing higher expression of lat-
1 in embryonic stages. This finding is consistent with data that showed lacZ/gfp reporter gene
expression was detected in the same cells [105] [106] [107] [108].
Section 4.3.1 Expression of lat-1 gene and physiological relevance
The expression of the lat-1 reporter gene in hypodermal cells during epidermal enclosure is con-
sistent with a role for lat-1 in the embryonic arrest seen in the lat-1(ok1465) worm during epi-
dermal morphogenesis, suggesting that the lat-1 gene is important in embryonic development.
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Additionally, both marker genes driven by the lat-1 promoter were expressed in the embryonic
and larval gut, and this is the site where the gut fails to attach to the pharynx in larval arrest of
some lat-1(ok1465) larvae (Figure 3.3A). The concordance between site of expression and the
site of the phenotype in lat-1(ok1465) worms is further evidence that the lat-1 gene causes the
phenotype. This result is similar to the finding that showed cpl-1 gene is important for the de-
velopment of embryos in mutant worms with embryonic lethality, and also consistent with the
expression of cpl-1 gene using lacZ or gfp transcriptional fusion that produced gut cell expres-
sion during embryogenesis [106].
Expression of lat-1 gene in the gut of wild-type worm in larval stages and in adult can be cor-
related with the extended defecation cycle phenotype seen in lat-1(ok1465) worm. It is possible
that lat-1 gene is important for development of gut in the larval stages of lat-1 (ok1465) worms
as the lat-1 gene is expressed in L1 stage of wild-type worm, and is responsible for the rescue
of defecation cycle extension in lat-1(ok1465) animals. It is known that defecation cycle defects
can be caused either by defects in the innervation of the defecation cycle machinery, or defects
in the guts and excretory cells themselves [66] [109] [98]. Thus the fact lat-1 promoter is capa-
ble of driving lacZ or gfp reporter fusion for gut cell expression, together with the fact that the
lat-1a cDNA rescues the defecation cycle defect in lat-1(ok1465) worms, make a compelling
case that it is gut expression of lat-1 which is affecting the defecation cycle.
The ability of lat-1 gene to express in the intestinal cell of C.elegans suggests that the gut could
be the site of action for the toxicity of combined latrotoxins (BWSV) that killed C.elegans, sug-
gesting a distinct site for the activity of toxins. The expression of lat-1 in identified tail neurons
that are known to serve as interneurons that regulates fowards and backwards locomotions, is
unlikely to account for the toxicity of combined latrotoxins in C.elegans; these neurons are not
necessary for development or survival of C. elegans. The highly restricted expression of lat-1
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in the C.elegans nervous system is in marked contrast to the restricted expression of mammalian
latrophilin-1 in the rat nervous system [110]. By contrast, mammalian latrophilins 2 and 3 show
widespread expression outside the nervous system [15], and these are therefore more likely to
be playing an analogous role to lat-1 in the worm.
Section 4.3.2 Characterisation of rescue of lat-1 (ok1465) worm phenotype
The initial study of lat-1 (ok1465) worm showed that lat-1 animal has ~95% offspring lethality
and outcrossing of lat-1 worm against N2 worm six times did not rescue the lethality. Micro-
injection of B0457 cosmid that contains the full-sequence of lat-1 gene rescued the lethality of
lat-1(ok1465) worms, indicative of the importance of the lat-1 gene on the B0457 cosmid. Fur-
ther analysis of the transgenic worms showed that all of these rescues were full rescues; the def-
ecation defect or developmental arrest phenotype was rescued to the point where animals that
contained a copy of the rescuing cosmid were able to grow to adulthood and produce progeny,
and also showed defecation cycle close to wild-type worm. The lat-1a transcript of lat-1 gene
was tested to support the prove that the presence of lat-1 gene was responsible for the rescue of
lethality of lat-1(ok1465) worms, as this experiment is required to exclude the possibility that
other genes on the B0457 cosmid could ameliorate the phenotype of lat-1(ok1465) worms. The
data showed that full-length lat-1a fusion rescued the developmental lethality of lat-1(ok1465)
worm as described in section 3.5.1. It has been reported that cosmid containing full sequence of
dpy 20 gene rescued mutant phenoptype of animal homozygous for dpy 20 allele back to wild-
type worm [111]; this type of analysis provides compelling evidence of the importance of the
lat-1 gene in the rescue of lat-1(ok1465) worms. 
In passing, this experiment additionally confirms that the ~1.5kb promoter of lat-1 is driving the
expression of the lat-1 cDNA at appropriate time to complement the lethality in lat-1(ok1465)
worms, arguing that this promoter drives physiologically relevant expression. Further, the lat-
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1a cDNA must be physiologically functional, since it complements the lat-1(ok1465) allele.
There is no obvious consequence of losing the lat-1b transcript, since the lat-1a transgenic ani-
mals are not different from wild-type animals; it is therefore not clear if any distinct physiolog-
ical role is served by the lat-1a and lat-1b transcripts.
The finding that latrophilin, a GPCR, plays an important role in development, is not unprece-
dented. The GPCRs signal principally through a pathway involving G-proteins [112], and G-
proteins are known to play an essential role in development [113] [114]. For example, they are
known to regulate cardiogenesis in the mouse [115] and play an important role in the orientaton
of cell division during embryonic development of C.elegans [116]. GPCRs are frequently tar-
geted during drug development [117], but the class B (secretin) family of GPCRs are less well
understood or characterised in their physiological roles. One class B GPCR plays an essential
role for physiological functions to target drugs for various diseases [118]. As a member of class
B/secretin subfamily of GPCRs, lat-1 gene has a critical role in development and the defecation
cycle in the worm, and so this system offers the ability to investigate the role of the class B GP-
CRs in developmental processes. 
These results show that transgenic expression of lat-1a rescues the lat-1(ok1465) worms, and
provides compelling evidence that the lat-1 defect is responsible for the phenotype seen in lat-
1(ok1465) worms. This work therefore corroborates the bioinformatic analysis of the function
of this gene, and suggests that the ok1465 allele yields non-functional variants of lat-1. 
Section 4.4  The role of lat-1 gene in C.elegans 
Section 4.4.1 Importance of lat-1a C-terminus
The role of lat-1a C-terminus is investigated to understand the importance of this region with
respect to the rescue lat-1(ok1465) worm. Three various truncations of lat-1a C-terminus;
4xCys, TM7, TM1 were investigated to determine whether a truncated lat-1a protein rescued
Ademola Adenle   Section 4.4.2
Page 151
the developmental lethality of lat-1(ok1465) worm. The 4xCys rescued lat-1 animals, TM7 par-
tially rescued lat-1 animals, while TM1 failed to rescue lat-1 animals as described in section
3.5.2. Interestingly, the rescue of developmental lethality in 4xCys worm is similar to that of
full-length lat-1a worm, indicating that the sequence after the 4xCys domain is not required for
phenotypic rescue. However, the failure of the TM1 construct to rescue lat-1(ok1465) worm in-
dicates that the TM7 domain of lat-1a is important for intracellular signalling. 
All GPCRs contain a TM7 domain that plays an important role in intracellular signalling [9].
This finding has demonstrated the importance of the TM7 domains in the rescue of lat-
1(ok1465) worms as deletion of C-terminus lat-1a to transmembrane one showed no function-
ality, suggesting that intracellular signalling is important. It has been shown that an analogous
TM1 deletion mutant of rat latrophilin (deletion of six of seven transmembrane domains; TM7)
binds to D-latrotoxin, that the extracellular domain binds to this ligand, and thus suggesting that
the failure of the C. elegans TM1 construct to rescue lat-1 worms should be viewed as a failure
not of ligand-binding, but of signal transmission into the cell. Moreover, the rat latrophilin TM1
mutant had a reduced ability to allow calcium entry elicited by binding of D-latrotoxin, indicat-
ing its inability to activate G-protein for cell signalling [5], and consistent with the finding that
shows the TM7 domain of lat-1a is required for the rescue of lat-1 (ok1465) worm. Taken to-
gether, TM7 domain of latrophilin is important for intracellular signalling in the endogenous
function of this receptor.
Section 4.4.2 Importance of lat-1a N-terminus
The role of lat-1a N-terminus was investigated in the rescue of lat-1(ok1465) worms, since the
mammalian latrophilin (a member of GPCRs) is known to bind ligand [7]. A series of lat-1a N-
terminus deletion made include; ǻGBL, ǻHRM, ǻN and they were tested for the ability to res-
cue the developmental lethality of lat-1(ok1465) worms. The ǻGBL or ǻHRM construct par-
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tially rescued the developmental lethality of lat-1(ok1465) worms, and ǻN construct failed to
rescue the lethality of lat-1(ok1465) worms, indicating the importance of GBL or HRM for the
rescue of lat-1(ok1465) worms.
It is interesting to find out that ǻGBL or ǻHRM construct rescued defecation defect in lat-
1(ok1465) worms but failed to fully rescue lat-1 worms; one possibility is that different ligands
are required for rescue of the defecation cycle, and lethality, and this is reflected in the require-
ment for different domains of the N-terminus of lat-1. Thus, the presence of galactose-binding
or hormone receptor motif domain is important for the rescue of developmental lethality, but
not required for defecation defect in lat-1(ok1465) worms. However, another possibility is that
the same ligand is involved in both phenotypes, but that there is a bias in measurement; specif-
ically, that the worms which die during development would have a defect in defecation cycle,
but that those worms which happen to survive during development do so by means of some
compensating adjustment which also restores the defecation cycle. A recent finding is that the
galactose-binding lectin like domain of mouse latrophilin-1(lat-1) is functional in a carbohy-
drate binding assay [119]. However, this functionality is not the key ligand-binding role of lat-
1, since the galactose-binding lectin domain of C.elegans lat-1a has only a minor effect in res-
cuing lat-1(ok1465) worms. It may be that the GBL domain serves to anchor the lat-1 protein
so that ligand can more efficiently bind to the HRM domain.
The GBL and HRM domains are conserved in the N-terminus of latrophilin (also known as
CIRL), which is known to bind to D-latrotoxin [7], [120]. Deletion of residues from 467-538 in
the N-terminus of rat latrophilin resulted in a failure to bind toxin, and this region (477-537)
corresponds to the HRM domain; deletion of sequences N-terminal to 467 (i.e. the olfactomedin
and galactose-binding lectin domains) did not affect the ability of constructs to bind to D-latro-
toxin [5]. The failure in function of the C. elegans lat-1 after the deletion of analogous domains
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of the protein suggests that the HRM domain of latrophilin is essential for rescue of worms be-
cause of its ability to bind to a ligand. 
Section 4.5 TM1 acts as a dominant negative
The failure of the TM1 truncation in the C-terminus of lat-1a or the ǻN truncation in the N-ter-
minus of lat-1a to yield stable lines when injected into lat-1(ok1465) worm suggests that these
constructs may not only fail to confer complementation, but could additionally have a frank tox-
ic effect. A hypothesis is that when the TM1 construct is introduced into wild-type worm, the
TM1 receptor will decoy ligand from binding to the endogenous receptor, hence resulting in
lack of intracellular signalling. This hypothesis suggests the TM1 construct will be a dominant
negative in wild-type worms by preventing intracellular signalling, as shown in Figure 4.1A. An
essential control is to test whether ectopic expression of the lat-1a cDNA is per se capable of
causing adverse effects; however, according to the hypothesis, when full-length lat-1a interacts
with ligand, it presumably causes intracellular signalling through G-protein pathway (Figure
4.1B). 
To test the hypothesis, the injection of TM1, ǻN, full-length lat-1a or mCherry construct into
wild-type worms was carried out. N2 worms transgenic for the TM1 construct showed a signif-
icant reduction (~50%) in the number of the embryo that reached adulthood, characterised by
embryonic arrest or larval death, and an increased defecation cycle; these are the characteristic
features of the lat-1(ok1465) allele. The effect of TM1 can not be a non-specific toxicity arising
from overexpression of lat-1a or a defective lat-1a, because the full-length lat-1a construct had
no adverse effect. Also, it can not be a non-specific consequence of a non-functional lat-1a, as
ǻN truncation of lat-1a did not have any adverse effect either. Therefore, the TM1 construct acts
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as a dominant negative in wild-type worms to phenocopy the lat-1 null.
Section 4.6  aex-3 promoter for tissue-specific expression of lat-1a
Latrophilin was originally isolated and expressed in mammalian brain, and previous findings
have demonstrated that mammalian latrophilin-1 is highly expressed in nervous system [6]
[110]  [121]. Latrophilin-1, latrophilin-2, and latrophilin-3 are known to have different tissue
distributions in mammals, and all three share homology with C.elegans lat-1 [15]  [87]. Latro-
philin was expressed in the nervous system of C.elegans to determine if expression of the C.
elegans lat-1 in the nervous system can complement the lethality of the ok1465 worm. Iwasaki
and his group have shown that the aex-3 promoter confers nerve-specific expression [100]. The
Figure 4.1 TM1 decoying pathway. A shows TM1 interaction with ligand and decoying of ligand from endog-
enous receptors which results in a lack of intracellular signalling. B shows full-length lat-1a interaction with ligand, and
binding of ligand to receptor results in intracellular signalling.
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aex-3 promoter was swapped with the lat-1 promoter driving full-length lat-1a cDNA and mi-
cro-injection of aex-3 construct into lat-1(ok1465) worms produced many transgenic embryos
but failed to yield stable lines, showing that the aex-3 promoter driving lat-1a cDNA could not
rescue the lethality of lat-1(ok1465) worms. It can therefore be concluded that the aex-3 pro-
moter was not capable of driving lat-1a cDNA to rescue lat-1 animals, and this suggests that
expression of lat-1 in the nervous system is not critical for the role of lat-1 in C.elegans.
The aex-3 construct was tested on wild-type worms as it could not rescue lat-1(ok1465) worms,
therefore testing the hypothesis that nerve-specific expression of lat-1a might be toxic to wild-
type worms. Micro-injection of aex-3 construct or mCherry into wild-type worms produced
many transgenic embryos that survived to adulthood. The aex-3::lat-1a worm and mCherry
worm were further characterised and aex-3::lat-1a worm produced half of normal brood size of
wild-type worm or mCherry worm, showing an adverse effect of the aex-3 construct. Notably,
embryos from aex-3::lat-1a worm survived to adulthood without showing developmental ar-
rest, in contrast to lat-1(ok1465) worms, which show embryonic and larval lethality. Thus, the
aex-3::lat-1a worm does not exhibit the same phenotype of lat-1(ok1465) worm, although there
is a reduction in brood size. Study of the defecation cycle in aex-3::lat-1a worms showed that
it was significantly increased when compared to wild-type worm or mCherry worm, and this
was due to the effect of aex-3 construct. The fact that aex-3::lat-1a worm did not show devel-
opmental lethality shows that this defect is not a phenocopy of the lat-1 null defect, but that the
aex-3 promoter is driving inappropriate or tissue-specific expression that causes reduction of
brood sizes in wild-type worms. The aex-3::lat-1a influenced the defecation cycle of wild-type
worm; however it is known that aex-3 is important for some aspect of C.elegans defecation cy-
cle [65], and that the nerve cell expression of aex-3 affects defecation cycle [100], [122]. Thus
it is not surprising that a physiological function of lat-1a in cells that are known to control def-
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ecation cycle, can lead to alterations in defecation cycle. However, the functions of the majority
of adhesion GPCRs, including latrophilin-1, are yet to be fully understood with only a few that
are expressed in tissue [123]. While the lat-1 gene promoter confers expression in tail neurons
of wild-type C.elegans nervous system, tissue-specific expression of lat-1 gene under the con-
trol of aex-3 promoter in C.elegans nervous system had adventitious toxicity in wild-type
worms, and failed to rescue lat-1(ok1465) animals. It is difficult to sustain the notion that the
expression of lat-1 in the nervous system is critical for the role of lat-1 in C.elegans.
Section 4.7 Mechanism of action of combined latrotoxins in C.elegans
One of the aims of this thesis is to understand the action of combined latrotoxins on latrophilin
(lat-1) in C.elegans. The wild-type worm and lat-1(ok1465) worm were injected with combined
latrotoxins to investigate the level of toxicity and thereby characterise the role of endogenous
lat-1 receptor. Figure 3.17 showed a dose-curve response with LD50 at 4 ng/ml for wild-type
worm, indicating that endogenous lat-1 gene mediates the toxicity of combined latrotoxins. At
400 Pg/ml (~105-fold greater than LD50 at 4 ng/ml), there was no effect of combined latrotoxins
in lat-1(ok1465) worm with 0% lethality, suggesting that deletion of lat-1 gene conferred the
resistance. Although, lat-1(ok1465) worm has a deletion of the lat-1 gene which conferred re-
sistance to combined latrotoxins, the presence of other receptors such as neurexin and phos-
phatase-sigma in lat-1 (ok1465) worms did not mediate any toxicity from combined latrotoxins.
Therefore, lat-1 gene is solely responsible for the toxicity of combined latrotoxins.
Section 4.7.1 Combined latrotoxins are sensitive to lat-1 gene in lat-1(ok1465) worm
It is important to investigate the hypothesis that absence of lat-1 gene is responsible for the tox-
icity of combined latrotoxins, thus lat-1 worms carrying various constructs containing lat-1
gene were injected with combined latrotoxins to obtain dose-curve response. Combined latro-
toxins killed B0457worm and full-length lat-1a worm with an LD50 of 4 ng/ml, which is con-
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sistent with the concentration (LD50 4 ng/ml) that killed wild-type worm (Figure 3.16, 3.17,
4.2A), indicating the importance of lat-1 gene in the toxicity of combined latrotoxins. These
data are consistent with the finding that the lat-1 gene is important for the rescue of lat-
1(ok1465) worms (Figure 4.2A). The sensitivity of B0457 worm to combined latrotoxins re-
flects the presence and ability of lat-1 gene on B0457 cosmid to mediate the toxicity of com-
bined latrotoxins. The mediation of toxicity by full-length lat-1a ablates the possibility that
presence of other genes on B0457 cosmid that could mediate the toxicity of combined latrotox-
ins. It can therefore be concluded the presence of lat-1 gene on B0457 cosmid was responsible
for the toxicity of combined latrotoxins that killed B0457 worms. These data have shown that
lat-1 gene is important for the rescue of lat-1(ok1465) worm, and that lat-1 gene was responsible
for the toxicity of combined latrotoxins. One possible way to explain this mechanism of action
of combined latrotoxins that killed wild-type worm, B0457 worm and full-length lat-1a worm
is that presence of endogenous or exogenous lat-1 receptor mediates the toxicity of combined
latrotoxins presumably through a G-protein pathway [124], [125].
Moreover, it is likely that the mechanism of action for the toxicity of combined latrotoxins in
C. elegans is similar to the activation of Į-latrotoxin by mammalian latrophilin that suggests the
mechanism of intracellular signalling through G-protein [126]. The mechanism of action of
combined latrotoxins can be corroborated by investigating various regions of full-length lat-1a
in the context of intracellular signalling in order to strengthen the hypothesis.
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Figure 4.2 Effect of latrophilin in C.elegans lat-1 (ok1465) worms and mammals. A shows C.elegans
lat-1. The 1st structure shows full-length lat-1a fused to green fluorescent protein (GFP) made up of signal peptide do-
main, galactose-binding lectin domain (GBL), hormone receptor motif domain (HRM), G-protein couple receptor pro-
teolysis motif domain (GPS), seven transmembrane domain (TM7), area of four cysteine domain. 2nd structure shows
truncation of 4xCys at amino acid 870. 3rd structure shows truncation of TM7 at amino acid 790. 4th structure shows
truncation of TM1 at amino acid 579. 5th structure is ǻGBL that shows truncation of domains at amino acid between 62-
147. 6th structure is ǻGBL that shows truncation of domains between 62-250. 7th structure is ǻN that shows truncation
of amino acid between 62-487. Each truncation construct shows its effect with respect to rescue of lethality or defecation
cycle and combined latrotoxins. For lethality and defecation, + means full rescue, +- means partial rescue, - means no
rescue, * means not tested. For combined latrotoxins, + means 100% lethality at ~4ng/ml, +- means 50% lethality at
400Pg/ml, *means not tested. B shows SP, GBL, HRM, GPS on the rat latrophilin sequence as present on C.elegans lat-
1. 1st structure shows the full-length of N-terminus rat latrophilin between amino acids 1-856. 2nd structure shows de-
letion of domains between amino acid 538-856 . 3rd structure shows deletion of domains between amino acid 185-856.
4th structure shows deletion of domains between amino acid 394-856. 5th structure shows deletion of domains between
amino acid 538-856. 6th structure shows deletion of domains between amino acids 467-705. Each truncation construct
shows its effect with respect to Į-latrotoxin binding. + means toxin binding, - means no toxin binding. The figure 4.2B
is reproduced from [5]. 
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Section 4.7.2 The role of lat-1a C-terminus in combined latrotoxin toxicity
The role of intracellular signalling in the mechanism of action of lat-1 was investigated with
worms transgenic for truncated C-terminus lat-1a constructs, which were tested for the toxicity
of combined latrotoxins in transgenic worms. The 4xCys worms showed similar sensitivity to
wild-type worms (LD50 ~40 ng/ml), indicating the region of the C-terminus distal to the 4xCys
domain is not required for signalling the toxicity of combined latrotoxins, consistent with the
finding that the 4xCys domain is not required for defecation cycle defect in lat-1(ok1465)
worms. However, deletion of the 4xCys domain in C-terminus lat-1a resulting to TM7 construct
yielded TM7 worms that were ~104-fold less sensitive to combined latrotoxins than 4xCys
worms, consistent with the finding that the 4xCys domain is required for the rescue of lat-
1(ok1465) worms (Figure 4.2A). Therefore, 4xCys domain is important for the toxicity of com-
bined latrotoxins. 
This report showed that C-terminus of lat-1a is required for the toxicity of combined latrotoxins,
and it suggests the ability of lat-1 gene to trigger signal through its C-terminal domain is re-
quired for the toxic action of combined latrotoxins. This finding is in contrast to the hypothesis
that suggests latrophilin merely acts as a tether to signalling action of combined latrotoxins, and
that intracellular signalling from lat-1 is not relevant [2], [1], [110], [127]. Fig 1.2 described the
model that signalling is not relevant to trigger exocytosis when Į-latrotoxin binds to latrophilin,
whereas these data suggest that lat-1 gene is important for signalling action of toxicity of com-
bined latrotoxins. Sugita and his colleagues (1998) have shown that latrophilin (CIRL) as a G-
protein coupled receptor is not required for signalling to stimulate exocytosis during Į-latrotox-
in receptor binding, but rather recruit toxin to the membrane without participating in neurotrans-
mitter release. Moreover, this finding supports the idea that latrophilin mediates the action of Į-
latrotoxin through intracellular signalling [128], [126], [125]. Volynski et al (2000) had shown
that it may be possible that latrophilin is involved in intracellular signalling of pore formation
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but its mechanism of action remains unclear. However, this finding in C.elegans showed the im-
portance of intracellular signalling of C-terminal lat-1a in the rescue and toxicity of combined
latrotoxins for transgenic lat-1 worms.
Section 4.7.3 The role of lat-1a N-terminus in combined latrotoxin toxicity
The N-terminal of mammalian latrophilin is an important ligand-binding for D-latrotoxin, there-
fore, it is important to identify the regions within N-terminal of C-elegans lat-1 that are required
for the toxicity of combined latrotoxins. The ǻGBL worms were sensitive to the toxicity of
combined latrotoxins at LD50 4 ng/ml while ǻHRM worms were only sensitive at 400 Pg/ml,
105-fold greater than ǻGBL worms. These data showed that deletion of the galactose-binding
lectin domain (GBL) of the N-terminus lat-1a did not affect the sensitivity for the toxicity of
combined latrotoxins, which is consistent with the finding that showed deletion of GBL domain
is not required for the binding of toxin [5], suggesting the GBL domain by itself is not essential
for the toxin binding activity (Figure 4.2A&B). Deletion of hormone receptor motif domain
(HRM) of N-terminus lat-1a showed a reduced sensitivity to combined latrotoxins by ~105-fold,
thus indicating the importance of HRM in the toxicity of combined latrotoxins. This finding is
consistent with data that requires HRM domain for the rescue of lat-1(ok1465) worms, and the
fact that deletion of the rat latrophilin HRM ablates the ability of the protein to bind to D-latro-
toxin [5]. Therefore, the HRM domain is important for the rescue of the lat-1 animal lethality
and toxicity of combined latrotoxins, and the data of Krasnoperov (1999) suggests that this is
because the HRM binds to the latrotoxins. It is likely that the GBL and HRM domains have dis-
tinct functions, as the GBL domain is not required for the toxicity of combined latrotoxins,
whereas the HRM domain is required for the toxicity of combined latrotoxins. In agreement,
deletion of the GBL domain alone failed to fully rescue lat-1 (ok1465) worms, showing that this
regions has a role in the rescue of lat-1 animals. The deletion of both the GBL and HRM domain
drastically reduced rescue of lat-1 worms, and in conjunction with the greatly reduced toxicity
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of combined latrotoxins in 'HRM worms, suggests that the HRM is the ligand-binding domain
of lat-1a for both the endogenous ligand(s) and latrotoxins.
Section 4.7.4 The toxicity of Potassium cyanide (KCN) 
All transgenic animals including wild-type and lat-1(ok1465) worms were injected with KCN
to disqualify the possibility of non-specificity of lat-1 constructs for the toxicity of combined
latrotoxins. This control experiment is important in order to understand whether worm lethality
or survival was a result of lat-1 gene specific for the toxicity of combined latrotoxins or absence
of lat-1 gene confered resistance on the toxicity of combined latrotoxins.However, these data
showed that all transgenic animals, lat-1 animals and wild-type worms were equally sensitive
to chemical toxicity, and that the various lat-1 constructs do not confer any non-specific sensi-
tivity to chemical toxins. By contrast, the specific sensitivity to of these various constructs to
combined latrotoxins must be due to a specific interaction between lat-1a and combined latro-
toxins, and given the known interaction of mammalian latrophilins with D-latrotoxin, this seems
a likely possibility. 
Section 4.8 Future work
This research has provided great understanding about the role of the lat-1 gene in lat-1(ok1465)
worms and more importantly to the role of latrophilin as a receptor of combined latrotoxins. It
is also very important to investigate other related genes that perform similar functions to the la-
trophilin either in C.elegans or in mammals such as rat. Some of the future works that are ex-
pected to be carried out are described. The lethality of the lat-1(ok1465) shows an important role
for the endogenous lat-1 gene, and it would be interesting to see if this is conserved with mam-
malian latrophilins, e.g. by testing to see if rat lat-1 receptor under the control of C.elegans lat-
1 promoter rescues lat-1(ok1465) animals and confers susceptibility to combined latrotoxins.
The site of action of latrophilin is unclear, and given that lat-1 gene is expressed in gut cells, it
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will be important to express the lat-1a::gfp fusion under the control of gut-specific promoter, to
test for rescue of lat-1 animals and susceptibility of combined latrotoxins. Finally, the C. ele-
gans lat-1 protein is not characterised, and detecting this protein by Western blotting will help
to understand the properties associated with lat-1 protein and provide more clues with respect
to the function of lat-1 gene.
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